Zebrafish Trap230/Med12 is required for Sox9 activity and limb induction by Rau, Marlene Juliane & Renkawitz-Pohl, Renate (Prof. Dr.)
Zebrafish Trap230/Med12 is required for 
Sox9 activity and limb induction 
 
DISSERTATION 
zur Erlangung des Doktorgrades der Naturwissenschaften 
 
Doctor rerum naturalium 
(Dr. rer. nat.) 
 
dem Fachbereich Biologie  
der Philipps-Universität Marburg 
vorgelegt von 
Dipl.-Biol. Marlene Juliane Rau 
aus Marburg 
 
Marburg/ Lahn 2005 
  
Vom Fachbereich Biologie  
der Philipps-Universität Marburg als Dissertation am 
angenommen. 
 
Erstgutachterin:  Prof. Dr. Renate Renkawitz-Pohl 
Zweitgutachter : Prof. Dr. Michael Bölker 
 
Tag der mündlichen Prüfung: 07.12.2005 
  
 
 
 
 
Zebrafish Trap230/Med12 is required for 
Sox9 activity and limb induction 
  
 
 
 
 
 
 
 
 
 
To all the people who continuously encouraged me to keep going 
 
 
 Acknowledgements 
I want to thank everyone who supported me during the last three years while this work was 
ongoing. In particular, I'd like to thank… 
 
Carl Neumann, for giving me the opportunity to pursue this work in his lab and for unbroken 
optimism throughout the whole time. 
 
The members of the Neumann lab, past and present, who contributed significantly to this 
work in many little ways, from encouragement and helpful discussions over providing a 
great humourous atmosphere up to sharedly proofreading this "masterpiece". Special thanks 
go to Sabine Fischer and Gillian Brunt for continous technical support and to Sarika Sharma 
for participating in the Neumann lab age of mapping. 
 
The members of my thesis advisory committee at EMBL, Dr. Steve Cohen, Dr. Damian 
Brunner and also Dr. Jürg Müller, for strong support and interest, and helpful advice. 
 
My external supervisors at the Philipps-Universität Marburg, Prof. Dr. Renate Renkawitz-
Pohl, Prof. Dr. Michael Bölker, Prof. Dr. Monika Hassel und PD Dr. Detlev Buttgereit, for 
agreeing to referee this thesis. Very special thanks to Prof. Dr. Renate Renkawitz-Pohl for 
continous support over the last seven years, kick-starting my interest in developmental 
biology in the first place, and being a great example of integrating science, life and family to 
me. 
 
Florian Raible, Thomas Sandmann, Bernadett Papp, Nadine Keller, Corinna Berger, Manuel 
Klang and Paulo Cunha for special scientific and moral support over the last years – I 
promise not to talk to you about mapping any more! 
 
My friends, who make life (in Heidelberg) worth living; Florian Wintgens and Frank 
Wigger, who unexpectedly shared the manifold burden of encouraging me to start, pursue 
and finish this thesis – und schliesslich meinen Eltern, für alles. 
 Table of contents 
1 INTRODUCTION .................................................................................................... 1 
1.1 Zebrafish as a model system ....................................................................................... 2 
1.2 Screening .................................................................................................................... 2 
1.3 Mapping and positional cloning ................................................................................. 3 
1.4 The Mediator complex .............................................................................................. 10 
1.4.1 Trap230 and the kinase subcomplex ............................................................................ 15 
1.5 Sox9........................................................................................................................... 25 
1.6 Pectoral fin development .......................................................................................... 29 
1.7 Aim of this thesis ....................................................................................................... 31 
2 RESULTS ................................................................................................................ 33 
2.1 Mapping and cloning the zebrafish trapped mutant ................................................. 34 
2.1.1 Rough mapping ............................................................................................................ 34 
2.1.2 Fine mapping................................................................................................................ 35 
2.1.3 Cloning......................................................................................................................... 39 
2.1.4 Expression of Trap230 ................................................................................................. 41 
2.1.5 Phenotype of the embryo.............................................................................................. 42 
2.1.6 Phenocopy by morpholino injections ........................................................................... 43 
2.2 Trap230 and Sox9..................................................................................................... 44 
2.2.1 The Trap230 loss-of-function phenotype resembles loss of Sox9 activity in many 
different tissues ............................................................................................................ 44 
2.2.2 Trap230 is required for Sox9-dependent neural crest fates and craniofacial cartilage 
formation ...................................................................................................................... 47 
2.2.3 The role of Trap230 in Sox9-dependent ear development ........................................... 50 
2.3 Trap230 is required for Sox9 activity ....................................................................... 52 
2.3.1 Sox9 expression in tpd is mostly normal...................................................................... 52 
2.3.2 Sox9 overexpression cannot rescue tpd mutants .......................................................... 53 
2.4 A Sox9-independent role of Trap230 in forelimb development ................................ 54 
2.5 Other Phenotypes...................................................................................................... 56 
2.5.1 Brain phenotype ........................................................................................................... 57 
2.5.2 Eye and axon guidance phenotypes.............................................................................. 58 
2.5.3 Heart and circulation phenotype................................................................................... 63 
2.5.4 Somite phenotype......................................................................................................... 64 
TABLE OF CONTENTS  
 
 
iii
2.5.5 Overall downregulation of Fgf signalling and gut phenotype ...................................... 64 
3 DISCUSSION .......................................................................................................... 66 
3.1 tpd encodes a mutation in the Mediator complex component Trap230 .................... 67 
3.2 Interaction of Sox9 + Trap230 ................................................................................. 70 
3.2.1 The trapped mutation shares many phenotypes with Sox9 mutants ............................. 70 
3.2.2 The role of Trap230 in Sox9 activity ........................................................................... 72 
3.2.3 Trap230 as a transcriptional co-regulator during vertebrate development ................... 76 
3.3 The role of Trap230 in forelimb initiation ................................................................ 77 
3.4 Other phenotypes ...................................................................................................... 79 
3.4.1 Brain and muscle phenotypes....................................................................................... 79 
3.4.2 Eye and axon guidance phenotypes.............................................................................. 80 
3.4.3 Heart and circulation phenotype................................................................................... 82 
3.4.4 Somite phenotype......................................................................................................... 83 
3.4.5 Overall downregulation of Fgf signalling and gut phenotype ...................................... 83 
3.4.6 Outlook......................................................................................................................... 85 
4 MATERIALS AND METHODS ........................................................................... 88 
4.1 Fish stocks................................................................................................................. 89 
4.2 Chemicals and solutions ........................................................................................... 89 
4.3 Linkage analysis and genetic mapping ..................................................................... 90 
4.3.1 Quick lysis of embryos................................................................................................. 90 
4.3.2 Finclipping ................................................................................................................... 90 
4.3.3 SSLP markers used....................................................................................................... 90 
4.3.4 Bulked segregant analysis ............................................................................................ 91 
4.3.5 Fine mapping................................................................................................................ 91 
4.3.6 Websites ....................................................................................................................... 91 
4.4 Histochemical methods ............................................................................................. 92 
4.4.1 Whole mount in situ hybridization (WMISH).............................................................. 92 
4.4.2 Cryosections ................................................................................................................. 95 
4.4.3 Antibody stainings........................................................................................................ 95 
4.4.4 Methylene blue staining ............................................................................................... 98 
4.4.5 Alcian blue staining...................................................................................................... 98 
4.4.6 TUNEL staining ........................................................................................................... 99 
4.5 Total RNA isolation from embryos ........................................................................... 99 
4.6 cDNA synthesis ....................................................................................................... 100 
TABLE OF CONTENTS  
 
 
iv
4.7 General gene cloning procedure ............................................................................ 100 
4.7.1 Trap230 primers ......................................................................................................... 100 
4.8 Sequencing .............................................................................................................. 101 
4.9 Sequence alignments............................................................................................... 101 
4.10 Microinjection of morpholino oligonucleotides and mRNA ................................... 101 
4.11 Further molecular standard techniques.................................................................. 102 
5 REFERENCES...................................................................................................... 103 
6 APPENDIX............................................................................................................ 128 
6.1 Sequence alignments............................................................................................... 129 
6.2 Phylogenetic trees................................................................................................... 138 
6.3 Mediator complex components ............................................................................... 139 
6.4 Abbreviations .......................................................................................................... 143 
 Index of Figures 
Figure 1. Map cross and bulked segregant analysis of a recessive zebrafish mutation......................... 4 
Figure 2. Linkage analysis of individual embryos. ................................................................................ 7 
Figure 3. Topological organisation of yeast Mediator. ....................................................................... 12 
Figure 4. Model of positive and negative regulation by yeast Mediator.............................................. 17 
Figure 5. Conserved regions within SoxE proteins.............................................................................. 25 
Figure 6. Forelimb outgrowth cascade model. .................................................................................... 29 
Figure 7. Molecular interactions that coordinate limb growth and patterning along the three limb 
axes. ............................................................................................................................................ 30 
Figure 8. Bulked segregant analysis using marker Z20214. ................................................................ 35 
Figure 9. Section of linkage group 14 on the meiotic MGH panel (Knapik et al., 1996)..................... 35 
Figure 10. Annotated genomic region of linkage group 14 in Zv4 containing the putative mutation.. 36 
Figure 11. Annotated region containing assembled BAC sequences between Z53264 and Z7495 in 
VEGA.......................................................................................................................................... 37 
Figure 12. Annotated genomic region of linkage group 14 in Zv4 containing the putative mutation.. 38 
Figure 13. Molecular characterisation of the tpd25870 locus. ............................................................... 40 
Figure 14. The mutation in tpdt25870 as a SNP...................................................................................... 41 
Figure 15. Trap230 RNA expression.................................................................................................... 42 
Figure 16. The tpd pectoral fin phenotype. .......................................................................................... 42 
Figure 17. The overall tpd phenotype. ................................................................................................. 42 
Figure 18. The Trap230-morpholino targets the exon 26/intron 26 splice junction. ........................... 43 
Figure 19. Trap230 morphant at 3dpf.................................................................................................. 43 
Figure 20. Trap230 MO effectively targets splicing of the exon 26/intron 26 splice junction. ............ 44 
Figure 21. Ear phenotype of tpd mutants............................................................................................. 45 
Figure 22. Ear phenotype of Trap230 morphants at 4dpf.................................................................... 45 
Figure 23. tpd iridophore phenotype. .................................................................................................. 45 
Figure 24. Trap230 loss-of-function melanophore phenotype. ............................................................ 46 
Figure 25. Expression of col2a1 at 68hpf in the head, lateral view..................................................... 47 
Figure 26. Alcian blue stained cartilages at 5dpf, ventral view........................................................... 47 
Figure 27. Expression of neural crest markers at 3 somites, dorsal view............................................ 48 
Figure 28. Expression of dlx2a at 24hpf in the pharyngeal arches, dorsal view. ................................ 48 
Figure 29. Apoptosis at 4dpf. ............................................................................................................... 49 
Figure 30. Dorsal root ganglion neurons at 3dpf (arrows). ................................................................ 49 
Figure 31. Expression of sox9a, sox9b and pax8 in the otic placode of Trap230 morphants.............. 51 
Figure 32. Expression of pax2.1 in the otic placode at 24hpf in wild type and Trap230 morphant 
embryos....................................................................................................................................... 51 
Figure 33. Expression of sox9a and sox9b is mostly normal in Trap230 loss-of-function embryos. ... 52 
Figure 34. Overexpression of sox9b-mRNA fails to rescue neural crest marker expression in tpd 
embryos....................................................................................................................................... 54 
  
 
 
vi
Figure 35. The pectoral fin phenotype of tpd mutants. ........................................................................ 55 
Figure 36. Defective formation of the MHB in tpd embryos. ............................................................... 57 
Figure 37. Midbrain ventricle inflation. .............................................................................................. 57 
Figure 38. Eye phenotype of tpd embryos. ........................................................................................... 58 
Figure 39. Eye morphology of tpd embryos at 2 and 3dpf visualised by antibody staining................. 59 
Figure 40. Axons stained with anti-acetylated tubulin antibody at 2dpf.............................................. 61 
Figure 41. Loss of Trap230 leads to formation of a coloboma in the eye............................................ 61 
Figure 42. Expression of pax2a in the optic stalk. ............................................................................... 62 
Figure 43. Expression of fgfs in the eye of tpd embryos....................................................................... 62 
Figure 44. Expression of tbx5 in the eye. ............................................................................................. 63 
Figure 45. Heart phenotype of tpd embryos......................................................................................... 63 
Figure 46. Expression of fgf10 is reduced in the fin bud of 30hpf tpd embryos (dorsal view)............. 64 
Figure 47. Expression of fgfs in tpd branchial arches. ........................................................................ 65 
Figure 48. Gut phenotype of tpd embryos. ........................................................................................... 65 
Figure 49. Sequences of Trap230 primers used in this study............................................................. 101 
Figure 50. Alignment of zebrafish Trap230 sequences. ..................................................................... 132 
Figure 51. Alignment of Trap230 and related proteins across species (Clustalw). ........................... 137 
Figure 52. Cladogram of Trap230 and related proteins across species (Clustalw). ......................... 138 
Figure 53. A phylogenetic tree for Sox9-related genes. ..................................................................... 138 
Figure 54. Mediator subunits. New nomenclature and comparison of synonyms across species. ..... 139 
Figure 55. Comparison of mammalian Mediator-like complexes. ..................................................... 140 
Figure 56. Location of conserved regions within human Mediator subunits. .................................... 141 
Figure 57. The role of Mediator in cellular signalling. ..................................................................... 142 
 
 1 INTRODUCTION 
INTRODUCTION  
 
 
2
1.1 Zebrafish as a model system 
Over the last decade, the zebrafish (Danio rerio) has been established as a successful 
and popular model organism for studying vertebrate development (Anderson and 
Ingham, 2003; Detrich et al., 1999; Eisen, 1996). Zebrafish are easy to keep and 
breed, have a relatively short generation time (3-4 months), produce large numbers 
of embryos (100-200 per mating) and provide easy access to all developmental 
stages due to external fertilisation. The embryos are optically transparent and 
develop rapidly. Within three days, all important structures of an adult fish are 
established. Since defined strains are available and the sequencing of the zebrafish 
genome was started in 2001 by the Sanger Institute, zebrafish are also useful to study 
genetics. They present a unique opportunity to study not only embryology but also 
genetically inherited diseases and the genetics underlying developmental biology 
(Shin and Fishman, 2002), making zebrafish an attractive model system (Neumann, 
2002). 
In the context of limb development zebrafish offer the new possibility of using a 
forward genetics approach in a vertebrate, which allows the discovery of new genes 
involved in this process. 
As part of this thesis, I analysed pectoral fin formation in a novel zebrafish mutant, 
trapped. 
1.2 Screening 
Already more than two decades ago, the aptness of zebrafish for random mutagenesis 
and mutant screening was pointed out (Streisinger et al., 1981) and consequently, a 
large scale screening protocol was developed at the Max-Planck-Institute for 
Developmental Biology in Tübingen (Mullins et al., 1994). This protocol was then 
employed in a large-scale screen in 1996 (Haffter et al., 1996). In the years 2000/01, 
a second large-scale screen, with the aim of reaching saturation and hitting every 
gene essential for embryonic development was performed (Aldhous, 2000). 
Germ line cells of male zebrafish of the Tübingen (TU (Haffter et al., 1996) strain 
(P0 generation) were mutagenised by placing the fish in water containing ENU (1-
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ethyl-1-nitrosourea (Werner, 1919)), a synthetic compound of pH-dependent stability 
which causes point mutations in the genome. This most likely leads to GC to AT 
transitions, although all types of transitions and transversions are possible (Knapik, 
2000). By crossing three week old males to non-mutagenised females, premeiotic 
mutagenised germ cells were recovered to prevent mosaic offspring. A classical 
three-generation screen (Haldane, 1956) strategy was employed. P0 males were 
outcrossed to wild type Tübingen females and an F1 generation of non-mosaic 
founder fish, carrying one or more mutations in their germ line were raised. To drive 
the mutation to homozygosity, random pairwise matings between founder fish were 
performed, resulting in F2 families. Since half of the fish in each of the F2 families 
are heterozygotes for any segregating recessive mutation, crosses within the family 
will reveal homozygote embryos that display the mutant phenotype. F2 fish were 
subsequently visually screened for various phenotypes, including defects in pectoral 
fin development. 
Heterozygous mutant lines of the Tübingen strain carrying an interesting phenotype, 
presumably due to a recessive point mutation, were then kept, and pectoral fin 
mutants brought to Heidelberg. 
1.3 Mapping and positional cloning 
The process of mapping and positional cloning involves unique issues for each 
organism. Success is usually based on experience. The mapping and cloning methods 
and facilities used for this dissertation were newly established in the lab in 
collaboration with William Norton. 
Before embarking on the meticulous and time-consuming process of mapping 
(Fishman, 1999), it may be useful to set up complementation crosses of a 
heterozygous carrier of an unknown mutation with a heterozygous carrier of (known 
or unknown) mutants with similar phenotypes to identify multiple alleles of the same 
gene. If the mutations do not complement, i.e. one quarter of the offspring show the 
expected mutant phenotype, the mutants should be considered as alleles of the same 
gene. However, this test is not fool-proof and occasionally different genes acting in 
the same pathway may also fail to complement. 
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To identify the gene affected in a zebrafish ENU mutant, the most common mapping 
strategy uses SSLPs (single sequence length polymorphisms), CA-repeats whose 
lengths are polymorphic with respect to different strains of zebrafish (Beier, 1998; 
Postlethwait and Talbot, 1997). A mapping cross is up, outcrossing heterozygous 
mutant carriers - in this case of the Tübingen (TU) strain - to wild type fish of 
another – in this case the WIK (Wild India Kalkutta (Rauch, 1997)) strain (P0 
generation, cf. Figure 1). 
 
Figure 1. Map cross and bulked segregant analysis of a recessive zebrafish mutation. 
(Geisler, 2002) WIK/WIK, reference fish; mut/Tü, fish carrying the mutation in Tü background. Band 
sizes and intensities of a representative SSLP marker are indicated schematically. In case of no 
linkage between the mutation and the marker, the intensities in the mutant and sibling pool are the 
same. In case of a linkage, the Tü band is stronger in the mutant pool and the WIK band in the sibling 
pool. Only a quarter of F1 crosses consist of two mutant carriers and yield mutant F2 as shown, the 
others are discarded.  
However, these and all other widely available zebrafish strains are not entirely 
inbred. Genetic polymorphisms may be present within a given family of fish and the 
strains are not as isogenic as inbred strains of mice. Heterozygous F1 carriers of the 
mutation are then identified by multiple random incrossing. As many of the 
mutations are homozygous lethal, they are kept as heterozygote carriers. Individual 
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identified F1 carriers are set aside pairwise for ongoing incross embryo collection. 
Of these mapping pairs, embryos are collected and then visually sorted into 
phenotypically mutant and wild type siblings. According to Mendelian genetics, one 
quarter of the embryos should be mutants. Genomic DNA from individual embryos 
is then extracted. 
The positional cloning approach is based on assessing meiotic recombination 
frequencies between the mutation to be mapped and defined SSLP markers of a 
known position within the genome. To this aim, linkage analysis with SSLP markers 
is performed. 
For low resolution or rough mapping, bulked segregant analysis is employed 
(Michelmore et al., 1991). Its goal is to locate the linkage group (which equals one of 
the 25 chromosomes of zebrafish) - or better rough region of a linkage group - on 
which the mutation lies, by scanning microsatellite markers (SSLPs) throughout the 
genome. For this study, a set of 192 agarose scorable markers optimised for 
polymorphism between the TU and WIK strains were used. About two thirds of the 
markers in this set were usually polymorphic. This SSLP set covers the entire 
genome (2500cM) (Postlethwait et al., 1994) with an average distance of about 13 
cM (centiMorgan, 1cM = 1 recombination event within 100 meioses) between 
markers. It has been developed in the lab of Robert Geisler (Geisler, 2002) and 
markers have previously been mapped to the meiotic MGH panel (Knapik et al., 
1996), so their location within the genome is roughly known. Pools of DNA 
extracted from 48 mutant and wild type embryos each from the same F1 mapping 
pair  are used to PCR-amplify the SSLPs set using a defined flanking primer pair for 
each marker. The products are electrophoretically separated on agarose gels. If an 
SSLP is polymorphic for the two strains used, the band size will be different for the 
two alleles, since the length of the CA repeats will differ between the strains. Bands 
are typically 100-400bp long and the size difference between alleles will be roughly 
between 20 and 150bp, which makes it necessary to perform the analysis under high 
resolution conditions. 
For markers which are not physically close to the location of the mutation and 
therefore not linked to it, there will be no difference in the band pattern between 
mutants and wild types – both will show the mutant (TU) and wild type (WIK) 
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alleles (Figure 1). However, markers which are linked to the mutation, will co-
segregate with it. Without meiotic recombination, the expected result for a marker on 
the same linkage group as the mutation would be that mutant pool DNA will show 
only the mutant (TU) band. This occurs since the embryos can only be 
phenotypically mutant if they are homozygous for the mutation, which was originally 
made on a chromosome of the mutant strain (TU). Pools of phenotypically wild type 
siblings will show both the mutant (TU) and wild type (WIK) bands, since they are a 
mixture of genotypically wild type and heterozygous embryos. 
However, as meiotic recombination takes place, part of the F2 chromosome 
containing the mutation may actually be of wild type (WIK) origin. And if this part 
of the chromosome contains the marker being checked, the wild type (WIK) band 
will also show up in the PCR. The closer the marker being tested physically is to the 
mutation, the less often a recombination event will occur between the two. So the 
weaker the wild type (WIK) band amplified from a pool of mutant DNA for an 
individual marker is, the tighter its linkage to the mutation. Since it is not usually 
known which size the band should have for any given strain (due to polymorphism 
also within strains), the bands amplified by a pair of PCRs on DNA pools from 
mutant and wild type siblings (F2) with the same SSLP-flanking primer pair must be 
checked for a typical two-band-in-wild type-pool one-band-considerably-weaker-in-
mutant-pool pattern (Figure 1). These will then be recorded as potential linkages. 
False-positive linkages are not uncommon, therefore they must be confirmed by PCR 
on individual embryos. This also enables the calculation of the distance between 
marker and mutation by analysing the recombination rate between the marker and the 
mutation. DNA from the same individual embryos which were pooled for bulked 
segregant analysis is used. Mutant embryos should show either one (not 
recombinant) or two bands (recombinant), while wild type siblings will have two 
(heterozygotes) or either one (homozygous wild types or recombinants) of the two 
bands, if they are truly linked (Figure 2). 
The distance between marker and mutation is calculated as follows: 
Distance (cM) = (number of recombinant mutant embryos) x 100 
 2 x (number of all mutant embryos analysed) 
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The number of mutant embryos analysed has to be doubled since each embryo will 
represent two meioses and therefore possible recombination events – that of the 
father and the mother. 
 
Figure 2. Linkage analysis of individual embryos. 
(Geisler, 2002) In the heterozygous F1 the mutant Tü (red, 
bearing an asterisk indicating linkage with the mutation) and 
wild type WIK (blue) alleles from the P0 generation are 
meiotically recombined (R!) to the F2 generation. Individual 
wild type siblings (S) will have the wild type (blue) allele or be 
heterozygous (red and blue), plus some recombinants with the 
Tü allele (red). Mutants (M) will have the Tü allele (red). Two 
recombinant mutant individuals (red and blue) are represented. 
Here, there are two recombinants out of six (17% 
recombination, 17cM). 
However, there are several caveats. First of all, the recombination rates of males is 
about 10-15 times lower than that of females, especially close to centromeres and 
telomeres, where recombination is generally repressed. The calculations above will 
give an average distance which will be the more accurate the higher the number of 
embryos that were actually counted and the closer the marker is to the mutation (up 
to a limit of about 0.1-0.3cM, where inaccuracy in a too-close-area begins again). It 
is also necessary to make sure that F1 parents are truly heterozygous for the marker 
in question. Otherwise, only the meioses of mother or father will be counted, and the 
number of embryos analysed in the formula above should not be doubled any more. 
The distance calculated will be much too low if only the father was heterozygous. To 
deal with this problem, F1 fish are regularly fin-clipped  and DNA is extracted from 
a cut-off piece of the tail fin. Carriers are then genotyped for their allele composition 
of the marker being used to calculate the distance. 
Another problem is caused by markers which give multiple bands. Band systems of 
one to five bands are common. Often it may be difficult to assess which bands are 
actually the ones that should be scored and markers will have to be abandoned. 
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Also, if the distance between marker and mutation is too high (more than about 5-
10cM), double recombination events will obscure the correct recombination 
frequency, making it impossible to calculate distance. 
At the same time, missorted wild type embryos can distort the calculations and 
appear as false-positive recombinants. 
Once the distance between a marker and the mutation has been established, it is 
necessary to find out in which direction along the chromosome the mutation lies. To 
this aim, SSLP markers on the same linkage group are chosen accordingly (eg. from 
the meiotic MGH panel) to define a set of two markers between which the mutation 
lies. Since accurate distance calculation can be impaired for the above reasons, it is 
recommendable to define a pair of markers which can reliably be said to lie on either 
side of the mutation. To this end, the same individual embryos are tested with 
different markers. If mutually exclusive recombinants can be found, that is to say, if 
embryos can be found which are recombinant for one marker but not the other and 
vice versa, it can be assumed that the markers lie on different sides of the mutation. 
If they share a set of recombinant embryos, they will lie on the same side, the marker 
with less recombinants being closer to the mutation. 
However, there are different scenarios in which the decision as to whether two 
markers lie on the same or opposite sides of the mutation is not that straightforward. 
One problem can again be missorted wild type embryos, which will then occur in 
markers on both sides of the mutation as false-positive recombinants. To address this 
problem, individual embryos then have to be tested with markers which were 
previously proven to definitely lie on different sides of the mutation. If they still 
appear recombinant for both, they must be either missorted wild types – or double 
recombinants, if the markers are too far apart. Thus, possible recombinants have to 
be confirmed, or markers can wrongly be assumed to lie on the same side of the 
mutation. Another problem occurs if for one of the markers tested only the F1 female 
is heterozygous, for the other marker only the F1 male. Such couples of markers will 
never show overlapping recombinants, no matter which side of the mutation they are 
on. If it is impossible to find markers for which both parents of a mapping pair are 
heterozygous, it is advisable to use markers for which at least the female meioses can 
be counted. Since the male recombination frequency is much lower, relying on such 
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markers means that 10-15 times more embryos need to be scored until a recombinant 
can be found, making a reasonable estimate of the distance virtually impossible. 
Once a clear interval containing the mutation is identified, closer markers are sought 
to narrow it down as much as possible. This process is called fine mapping. To this 
end, markers from the meiotic MGH panel are used to exhaustion and tested for 
polymorphism and for which side of the mutation they are on. Several thousand 
individual mutant embryos from parents which are heterozygous for the respective 
markers have to be collected to refine the distance calculations. The aim of fine 
mapping is to get considerably closer than 1cM to the mutation from either side. On 
average, 1cM corresponds to 625kb of the zebrafish genome (Postlethwait et al., 
1994). The SSLPs from the MGH panel can then be used to identify the actual 
genomic region encompassed by finding them in the zebrafish genome database 
(http://ensembl.org/Danio_rerio/), either by annotation or BLAST search of 
primer/marker sequences. This will sometimes prove difficult, since the genome is 
still patchy in parts and contains a large number of gaps. The genomic sequence 
between the closest markers can then be searched for simple repeats using the 
RepeatMasker program (http://www.repeatmasker.org), and flanking primers 
designed for these. These self-designed SSLP markers will then be tested for 
polymorphism and linkage, and typically about 20% of them yield useful results. By 
this method, the mutation can be fine-mapped until no further SSLP markers are 
available. 
Should this region happen to contain sequence gaps, they can be filled by searching 
an assembly of sequenced zebrafish BAC (bacterial artificial chromosome) and PAC 
(P1-derived artificial chromosome) clones (http://vega.sanger.ac.uk/Danio_rerio/) or, 
failing that, by BAC-walking. 
The available sequence can then be assessed for possible candidate genes using the 
distances calculated between markers and mutation and fitting predicted gene 
functions to the mutant phenotype. Candidate gene cDNA will then be cloned and 
sequenced from both mutant and wild type embryos to compare the sequence and 
look for possible point mutations. Failing that, introns, promoters and enhancers may 
also be cloned and analysed. RNA expression patterns and previously known data of 
individual genes can be taken into account when looking for possible candidates. 
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1.4 The Mediator complex 
Much of biological regulation occurs at the level of transcription initiation. Protein-
coding genes contain promoter sequences that are bound by transcriptional activators 
and repressors, which then recruit the transcription initiation machinery, consisting 
of RNA polymeras II (pol II) and at least 50 additional components. This complex 
contains DNA-binding factors, cyclin-dependent kinases (Cdks) and chromatin 
modifying enzymes (Lemon and Tjian, 2000). 
Pol II itself is a 12-subunit complex in which the largest subunit contains a C-
terminal domain (CTD) composed of a conserved heptapeptide sequence 
(YSPTSPS), rich in amino acids that can be phosphorylated. This phosphorylation is 
highly regulated and modulates the association of proteins with pol II. Elongating, 
transcriptionally active pol II contains a highly phosphorylated CTD (Cho et al., 
1998). 
The Mediator complex is a multifunctional key coactivator acting as a bridge 
between DNA-binding transcription factors (TF) and pol II, thus conveying 
regulatory information from enhancer elements to the basal transcription machinery 
(reviewed in (Bjorklund and Gustafsson, 2005; Kim and Lis, 2005; Malik and 
Roeder, 2005). It is involved in integrating both positive and negative transcriptional 
regulation (Carlson, 1997; Hampsey, 1998; Ito et al., 2000; Kuchin et al., 1995; Song 
et al., 1996) and stimulates basal, activator-independent transcription (Baek et al., 
2002; Cho et al., 1998). Moreover, it is important to regulate and control the 
phosphorylation state of pol II CTD at Serines 2 and 5 in concert with TFIIH, a 
member of the transcription initiation complex (Bjorklund et al., 2001; Park et al., 
2001a). Coactivators are defined as required for function of DNA-binding activators 
and by themselves show no site-specific binding (Malik and Roeder, 2000). Distinct 
activators can bind simultaneously to Mediator, providing a mechanism for 
synergistic functions of activators (Ptashne and Gann, 1997). 
Recruitment of Mediator to promoters occurs by binding of TFs to different 
activation domains in a chromatin-dependent fashion (Naar et al., 1999). This is 
mostly preceded by chromatin-remodeling cofactors with histone acetyltransferase 
(HAT) activity like CBP/p300 and p160 making the DNA accessible (Fondell et al., 
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1999; Malik and Roeder, 2000). Yet, Mediator itself can also bind to nucleosomes, 
and one of its subunits, Med5 has HAT activity (Bjorklund et al., 2001; Boube et al., 
2002; Zhang and Emmons, 2001). 
Pol II is then recruited to the complex, rather than being a stoichiometric component 
of it (Park et al., 2001b; Rachez and Freedman, 2001). Mediator can override 
transcription factors of the basal machinery in some cases, in others they function 
synergistically (Malik and Roeder, 2000).It does not act instead of other coactivators, 
but mostly in concert with them (Malik and Roeder, 2000). 
When transcription has been initiated, Mediator and some general transcription 
factors remain at the promoter, forming a scaffold onto which pol II and other 
components of the transcription initiation complex can reassemble to reinitiate 
transcription (Rachez and Freedman, 2001). 
Apart from components of the transcription initiation machinery and chromatin 
remodelling enzymes, mammalian Mediator has also been copurified with RNA 
processing, DNA repair and elongation factors, suggesting a complex involvement in 
many DNA-related processes (Cho et al., 1998). 
The first Mediator components were identified as suppressors of a yeast pol II CTD 
mutant phenotype (Thompson et al., 1993). Mediator complexes of differing 
composition were subsequently identified using different purification approaches and 
in different species (Malik and Roeder, 2000), but ultimately found to be essentially 
conserved as one (Figures 54, 55 appendix) (Boube et al., 2002; Sato et al., 2004). 
Consequently, a multitude of names for each subunit and subcomplex exist, which 
has recently been attempted to simplify by a unified nomenclature (Bourbon et al., 
2004). There appears to be an intrinsic modular organisation, and the variations 
found may not only reflect different purification procedures, but also different 
physiological states of the cell (Malik and Roeder, 2000). Thus, the selectivity of 
transcriptional control may lie in subtle differences in the particular composition of 
Mediator. It may besides be influenced by combinations of activators and the context 
of enhancer sequences to which they are bound at the promoters of specific target 
genes (Rachez et al., 1999). 
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Electron-microscopic 3D-structures of yeast and murine Mediator are remarkably 
similar, implicating constraints imposed by the highly conserved shape of pol II, with 
which Mediator interacts (Asturias et al., 1999; Malik and Roeder, 2000). 
Essentially, the up to 30 components of Mediator are divided into three core parts - a 
head domain, closest to the CTD and most conserved among species, a less 
conserved middle domain, which interacts with other parts of pol II (Jiang et al., 
1998; Malik and Roeder, 2000), and the divergent tail, which is thought to bind the 
TFs (Figure 3) (Bjorklund et al., 2001). 
 
Figure 3. Topological organisation of yeast Mediator. 
(Guglielmi et al., 2004) This model was made taking into account direct links between subunits found 
in (Guglielmi et al., 2004; Ito et al., 2001; Kang et al., 2001; Koh et al., 1998; Lee et al., 1998; Uetz et 
al., 2000). 
Upon pol II binding, a conformational change from a compact structure to a form in 
which the three modules are wrapped around the globular pol II takes place (Asturias 
et al., 1999; Naar et al., 2002; Woychik and Hampsey, 2002). Moreover, human 
Mediator has been shown to change shape dramatically depending on which 
activator is bound to it (Taatjes et al., 2002). Apart from the core modules, a 
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detachable kinase subcomplex, composed of Trap230/Med12, Trap240/Med13, 
cyclinC (cycC) and its cyclin dependent kinase Cdk8, has been identified. 
Still, there are some subunits which have not yet found their corresponding match 
across the phyla, namely Med2/3/5 in yeast, and Med23-30 as well as the recently 
identified Med12L, Med13L and Cdk11 in metazoans. Considering the discrepancy 
in numbers, it seems less likely that these subsets perform equivalent functions than 
that they represent species- or phylum-specific components added to an ancient 
protocomplex (Boube et al., 2002; Sato et al., 2004). 
Interestingly, some of these derived subunits (Med28-30) are part of the Mediator 
head, which had been proposed as most conserved Mediator module. The others are 
part of the middle and tail modules (Med2/3/5), the kinase submodule (Med12L, 
Med13L, Cdk11) or still unassigned. 
While some Mediator subunits appear to be universally required for the transcription 
of all genes, a number of subunits are dedicated to the regulation of specific genes 
(Bjorklund and Kim, 1996; Kwon et al., 1999). The specialised (activator-dedicated) 
subunits may fulfil a recruitment function, while a more kinetic, post-recruitment 
role could be carried out by a core complex (Malik and Roeder, 2000). Yeast 
Mediator subunits have been described to regulate distinct families of target genes of 
varying size and compositions (Holstege et al., 1998), while certain submodules are 
thought to constitute specialised targets for a subset of activators (Malik and Roeder, 
2000). 
For example, in yeast, C. elegans and Drosophila, mutations in Med6 are cell-lethal 
(Boube et al., 2002; Gim et al., 2001; Kwon and Lee, 2001) as well as Med17 in 
yeast and Drosophila (Boube et al., 2002) and Med21 in mouse (Tudor et al., 1999), 
all components of the Mediator head module (Figure 3), suggesting these subunits 
are essential for general functions of the Mediator complex. Nevertheless, Med6 is 
not required for integrity of the overall Mediator complex, nor for transcription of all 
genes in all tissues (Gim et al., 2001). 
Mutations in yeast and metazoan Trap230/Med12 (hereafter called Trap230) and 
Trap240/Med13, (hereafter called Trap240) on the other hand, are cell-viable yet 
organism-lethal, due to their roles in environment-directed cell fate decisions and 
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development (Boube et al., 2002; Janody et al., 2003; Yoda et al., 2005). These 
subunits are named Trap (thyroid hormone receptor associated protein) after the 
specific Mediator complex in which they were identified, characterised by its binding 
ability to thyroid hormone receptors and other nuclear receptors (Yuan et al., 1998). 
Notably, the C. elegans tail component Med14 is broadly required for transcription 
and phosphorylation of Serins 2 and 5 in the CTD, possibly indicating requirement at 
an early recruitment/initiation step (Shim et al., 2002), suggesting that the idea of the 
head module being most important in this respect may not exclusively hold true. 
Moreover, this subunit enhances ligand-dependent androgen receptor activity (Wang 
et al., 2002). 
To date, little genetic evidence is available on the vertebrate Mediator complex. 
Mouse Med1 mutants are viable and show specific defects in embryonic 
development, cell cycle regulation, cell survival, function of the pituitary-thyroid 
axis and a hypoplastic heart. The protein interacts with several nuclear hormone 
receptors. Additionally, fibroblasts derived from Med1 mutants fail to differentiate 
into adipocytes in response to PPARγ2 (peroxisome proliferator-activated receptor 
gamma 2, a nuclear receptor essential for adipogenesis) (Ge et al., 2002; Ito et al., 
2000). 
Med1 yeast and C. elegans mutants are also viable, and in C. elegans have a similar 
phenotype to those of Trap230, both being required for Wnt-dependently 
suppressing a Hox (homeobox transcription factor) gene (egl-5) in the postembryonic 
neuroectodermal lineage (Zhang and Emmons, 2001). 
Knockdown of Med15 is also not cell-lethal in yeast (Boube et al., 2002) and 
Xenopus, there leading to defects in Activin and Nodal, but not BMP, signaling 
through Smad transcription factors (Kato et al., 2002). Its specific function in 
signalling by these human tumour suppressors suggests it may itself be a tumour 
suppressor (Kato et al., 2002). 
Concerning the metazoan-only-components, Med24 mutant mice are embryonic 
lethal. They also lack the metazoan Med23 and conserved Med16 as well as having 
reduced amounts of Cdk8. The other three components of the kinase submodule are 
still present. This suggests a stabilising role for Med24 in the interaction of Cdk8 
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with CycC, as well as the existence of a Med16/Med23/Med24 submodule (Ito et al., 
2002), which, notably, contains both conserved and metazoan subunits. The residual 
complex shows unaltered binding to pol II and various activators. Med24, as Med1, 
interacts with nuclear receptors (Ito et al., 2002; Wang et al., 2002). Med24, Med1 
and Trap240 have the same spatiotemporal expression pattern, being ubiquitous, but 
almost absent in small intestine and weak in pancreas and skeletal muscle (Ito et al., 
2002). 
1.4.1 Trap230 and the kinase subcomplex 
The Mediator kinase subcomplex was identified as a part of the Mediator which is 
not present in all preparations. It consists of Trap230, Trap240, cyclin C and CDK8 
(Myer and Young, 1998). Cyclins are a conserved family of proteins required for 
activation of a class of protein kinases termed CDKs (cyclin dependent kinases). 
Originally, cyclins were described as proteins whose abundance oscillated during the 
cell cycle (Evans et al., 1983). CycC was originally isolated in yeast assuming it to 
be a G1 cyclin, since its expression increases during G1 phase in the mammalian cell 
cycle (Lahue et al., 1991). It may be important for regulating cell proliferation, since 
it is expressed in reponse to growth factor stimulation and oscillates throughout the 
cell cycle (Liu et al., 1998b). However, it is not entirely clear whether this function is 
achieved independently of the Mediator complex or through it, by regulating the 
level of transcriptional activation. Trap230 and Trap240, the largest Mediator 
subunits, named after their molecular weight, seem to be required for the integrity of 
the subcomplex – loss of either one will abrogate function of the entire subcomplex, 
which is thought to be defined mainly via the cdk8 kinase function (Spahr et al., 
2003). 
In contrast to the Mediator core, this subunit has been implicated in transcriptional 
repression rather than activation. In both yeast and metazoans, a subset of genes has 
been found to be repressed by this subcomplex (Holstege et al., 1998; Samuelsen et 
al., 2003). This is a promoter-specific function, and thought to be mediated by 
phosphorylation of the CTD through cdk8 and cdk8-stimultaed TFIIH before the 
binding of pol II to the transcription initiation machinery, inhibiting this (Bregman et 
al., 2000; Hengartner et al., 1998; Nair et al., 2005; Sun et al., 1998). This idea is 
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supported by the reduction of basal transcription levels in presence of the kinase 
submodule (Spahr et al., 2003). Nevertheless, CTD-independent repression through 
Mediator also occurs (Rachez and Freedman, 2001). Additionally, instances where 
the kinase subcomplex, or one of its members, may play an activating transcriptional 
role, have been described (Chang et al., 2001; Green and Johnson, 2004). 
In addition to the CTD, CycC/Cdk8 in yeast phosphorylates other substrates within 
the initiation complex that could also influence transcriptional events. It can 
phosphorylate cycH, the cyclin partner of Cdk7, leading to inhibition of Cdk7 
activity (Akoulitchev et al., 2000), subunits of the TFIID complex, Fal4 or Sip4, to 
increase the efficiency of inducing galactose respective glucose-responsive genes, 
transcription factors such as Gcn4 and Ste12, targeting them for ubiquitin-mediated 
degradation (Ansari et al., 2005; Chi et al., 2001), and other activators (Ansari et al., 
2002; Baxter et al., 2004; Borggrefe et al., 2002; Boube et al., 2002; Hengartner et 
al., 1998; Lee et al., 2000; Song et al., 1998). 
Consistent with the different interaction partners of Mediator copurified aside from 
the transcription machinery, cdk/cyclin complexes have been reported to connect 
transcription and RNA splicing, suggesting cdk8/cycC may be one of them (Loyer et 
al., 2005). Moreover, chromatin remodelling has also been attributed as a function to 
the human subcomplex (Cho et al., 1998). 
Absence of the kinase subunit coincides with presence of the Med26 subunit in 
human cells, therefore distinguishing small and large Mediator (Naar et al., 2002; 
Taatjes et al., 2002; Wang et al., 2001). Absence of this subunit has been proposed as 
an alternative reason for the repressive function of large Mediator (Akoulitchev et 
al., 2000). However, since this subunit is metazoan-specific, this does not provide a 
sufficiently good explanation for the observations in yeast. The fact that small 
Mediator is still highly active in transcription confirms the idea that the kinase 
subcomplex is not required for Mediator function per se (Naar et al., 1999). Also, 
free Mediator was found to lack the kinase subcomplex (Myers et al., 1998) and 
large Mediator fails to bind the CTD (Naar et al., 2002). Moreover, different Cdk8-
containing complexes have been separated in human cells, suggesting an even further 
modular composition of Mediator (Cho et al., 1998; Wilson et al., 1996). 
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Recruitment of Mediator to the yeast HO and Drosophila HSF promoters in absence 
of pol II supports the view that large Mediator may bind to activators, then, when pol 
II is recruited, the kinase submodule leaves (Figure 4). Lack of the submodule may 
have more profound effects on kinetics and timing of transcriptional activation at 
specific promoters, rather than on the overall levels of gene expression (Samuelsen et 
al., 2003). 
 
Figure 4. Model of positive and negative regulation by yeast Mediator. 
(Bjorklund and Gustafsson, 2005) (A) Mediator (blue) functions as a bridge between gene-specific 
activators (ACT; red) and the general pol II transcription machinery (purple) at the promoter. 
Activator interactions mainly take place within the tail region of Mediator, whereas contacts with pol 
II are localised to the head and middle region. A kinase subgroup of Mediator components – Srb8 
(Med12), Srb9 (Med13), Srb10 (Cdk8) and Srb11 (CycC) – forms a module (pink) that is involved in 
negative regulation of transcription. (B) Only Mediator lacking the Srb8–11 module can associate 
with pol II. Gene-specific repressors (REPR; green) interact with specific Mediator subunits (blue) 
and recruit the complex to upstream regulatory DNA sequences. Mediator that is recruited by 
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repressors contains the Srb8–11 (Med12–Med13–Cdk8–CycC) module (pink), which prevents 
interactions with pol II and the basal transcription machinery (violet). 
All members of the kinase subcomplex have been knocked down in yeast, and some 
also in metazoans. The general consensus is that they may perform very similar 
functions or all just aid Cdk8 kinase activity, since their phenotypes are said to be 
indistinguishable (Carlson, 1997; Hengartner et al., 1995). This is supposedly the 
case because loss of one subunit leads to disintegration of the whole subcomplex 
(Spahr et al., 2003). 
Nevertheless, cyclin C and cdk8 have special functions in their roles as kinase and 
cyclin partners, also outside of Mediator, suggesting the situation may actually be 
more complex. Also Trap230 and Trap240, who have repeatedly been reported to 
share all functions and phenotypes, have been assigned differential functions, though 
this has mostly gone unnoticed. Some of these differences may be due to the analysis 
of only one of the two genes in a study, others, however, clearly mark them for 
distinction. 
In yeast (S. cerevisiae), the components of the kinase subcomplex regulate genes 
involed in nutrient stress response, repressing genes required for gluconeogenic 
growth (Balciunas et al., 1999; Balciunas and Ronne, 1995; Holstege et al., 1998). 
The subcomplex itself is regulated by a stress response pathway under the influence 
of Ras, which by elevating intracellular cAMP levels activates a PKA homologue 
(Chang et al., 2004; Cooper et al., 1997; Woods et al., 1994). This PKA, which is 
inactive in presence of glucose, will mark the subcomplex for degradation, when a 
lack of nutrients occurs (Hengartner et al., 1998), by phosphorylation of Trap240 
(Chang et al., 2004). Whether Trap230 is also phosphorylated, was not studied, but 
phosphorylation of Trap240 seems sufficient. Loss of kinase subcomplex function 
derepresses genes important for entry into stationary phase/G0 (Spahr et al., 2003). 
Therefore, mutants in these genes are also not cell-lethal (Boube et al., 2002). 
Another feature of these cells is then the formation of clumps (flocculation) in liquid 
culture, suggesting a change in cell affinities (Chang et al., 2004; Nair et al., 2005). 
Some genes have been found to be regulated by both Cdk8 and and the head 
component Med18 (Holstege et al., 1998). Both Cdk8 and a HDAC1 (histone 
deacetylase 1) homologue in yeast mediate transcriptional repression by the Groucho 
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homologue Tup-1 (human TLE) through different mechanisms, either on their own 
or synergistically (Green and Johnson, 2004). Cdk8 plays a role in both Groucho-
dependent and independent repression, and was also found to act as an activator in 
cases (Green and Johnson, 2004). Trap240 was also described to show an HDAC1-
like phenotype, as well as an HMG box protein. Other than above, neither Cdk8 nor 
the other two members of the kinase subcomplex showed a similar function in this 
study (Larschan and Winston, 2005). 
Trap240 plays a role in blocking transcript cleavage when pol II is arrested. For this, 
it interacts with the N-terminus of the elongation factor TFIIS on the outer surface of 
pol II (Kettenberger et al., 2003). This conserved N-terminus has significant 
homology to that of Med26 (Bourbon et al., 2004; Ryu et al., 1999). However, it is 
not clear, when an interaction between Med26 and Trap240 should take place, since 
they are mutually exclusive in Mediator. Trap240 was found to probably change the 
phosphorylation pattern of TFIIS in this context and interact with the SAGA 
coactivator (Wery et al., 2004). It is unclear whether this function is specific to 
Trap240 or whether Trap230 was just not mentioned. 
Similar to S. cerevisiae, Trap230 and Trap240 mutants in S. pombe were described to 
show a nutrient limitation and flocculation phenotype, suggesting this may be a 
conserved specific process. Expression of only 10 genes was affected, especially 
those known to be involved in flocculation (Samuelsen et al., 2003). 
In Dictyostelium discoideum, Trap230 and Trap240 were also found to affect a 
growth/differentiation transition in a cAMP-dependent signalling pathway upon 
nutrient-deprivation (Kon et al., 2000). A functional conservation from yeast to fly, 
involving specific effects on cell differentiation, notably in response to cell signalling 
pathways, has been suggested for Trap230 and Trap240 (Boube et al., 2002). 
Dictyostelium Cdk8 was found to be required specifically for spore differentiation 
(Lin et al., 2004). 
Trap230 and Trap240 in C. elegans were found to have similar phenotypes and 
operate on common pathways. They are expressed ubiquitously and have maternal 
contribution, the protein localising to the nucleus. Yet, their loss does not incresase 
all gene expression (Wang et al., 2004a; Zhang and Emmons, 2000). The functional 
interaction between the two is conserved from yeast to mammals, but the 
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subcomplex modulates metazoan-specific genetic pathways in addition to the ones in 
yeast. In vulval development, they relay signals downstream of Wnt, via β-catenin, 
to block activation of a homologue of the homeobox gene caudal through one of two 
known pathways (Zhang and Emmons, 2000; Zhang and Emmons, 2001). This 
results in a transcription factor activation cascade, from expression of a homologue 
of the Antennapedia homeobox gene (mab-5), to the Abdominal B homeobox gene 
(egl-5) and a homologue of the basic helix-loop-helix (bHLH) factor atonal (lin32) 
(Zhang and Emmons, 2000). 
Trap230 and Trap240 are specifically required for the regulation of genes controlling 
asymmetric cell division in a complex with Med23 and Med6 (Yoda et al., 2005). In 
this function, they again repress a Hox gene (lin-39) through Wnt signalling via β-
catenin. The canonical Wnt pathway shares some components with the Wnt pathway 
controlling polarity of cell division, suggesting that this pathway may be affected 
here. A different function of the Wnt/β-catenin pathway, the posterior migration of 
the QL neuroblast, is however not defective in Trap230/Trap240 mutants, indicating 
the tissue specificity of Trap230/Trap240 function (Yoda et al., 2005). 
For Trap230, a Wnt-independent function in negative regulation of the RTK/Ras 
pathway by EGFR was identified. While the glutamine-rich C-terminus of Trap230 
is important for β-catenin-dependent gene expression, it is dispensable for inhibition 
of Ras-dependent cell differentiation, therefore contributing to the specificity of 
protein (Moghal and Sternberg, 2003). The above lin-39 is a common target for Ras 
and Wnt signalling in C. elegans vulval development (Eisenmann et al., 1998; 
Maloof and Kenyon, 1998). Trap230 in one study is proposed to act largely on the 
Ras pathway rather than the Wnt pathway in this context (Moghal and Sternberg, 
2003), consistent with its role in yeast an Dictyostelium. The metazoan-specific 
Med23 is also downstream of Ras, through the MAPK pathway, in C. elegans and 
human (Boyer et al., 1999; Singh and Han, 1995). Yet, its function is different from 
Trap230, suggesting that different Mediator components have selective effects in 
promoting different transcriptional regulatory signals, although Trap230 and Med23 
interact to control asymmetric cell division (Zhang and Emmons, 2000). Also, it 
suggests that, unlike Med23, Trap230 may be activated through PKA 
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phosphorylation, as is the case for Trap240 in yeast. This agrees with a proposed 
ligand-independent activation of Trap230 (Zhang and Emmons, 2000). 
EGFR function is inhibited by two pathways – by the Antennapedia homeobox gene 
mab-5 through Trap230/Trap240, and by HDAC complex components (Chen and 
Han, 2001; Lu and Horvitz, 1998; Solari and Ahringer, 2000). This is reminiscent of 
the situation in yeast, where HDAC1 and the kinase subcomplex have some common 
functions (Green and Johnson, 2004). 
The intrinsic repressive function of C. elegans Trap240 has been located in one of 
four domains conserved to human, which affects specific genes (Wang et al., 2004a). 
Neither Trap230 nor Trap240 influence the phosphorylation at Serine 2 of the CTD 
(Wang et al., 2004a), indicating that a similarity to a Cdk8 phenotype may rather be 
due to a secondary loss of Cdk8 function. 
The conserved C-terminus of Trap230 in yeast, Dictyostelium, C. elegans and 
Drosophila suggests its importance for their function, and was found to be essential 
for relaying Wnt downstream signals. Interestingly, strong and weak Trap230 loss-
of-function mutants have opposite effects on mab-5 expression, which may suggest a 
tricky dose-dependent effect (Yoda et al., 2005). 
As in C. elegans, Trap230 and Trap240 in Drosophila have similar effects, and, 
moreover, were shown to physically interact with one another, forming a submodule. 
They are required to regulate specific target genes, including those controlling cell 
affinity, possibly through Ci (Cubitus interruptus), although a direct interaction could 
not be shown (Janody, 2001). Mutants show misregulation of specific genes during 
imaginal disc development (Janody et al., 2003). Trap230/Trap240 do not seem to be 
required for cell proliferation but for differentiation, eg. of photoreceptors (Janody et 
al., 2004). Reminiscent of the strong and weak C. elegans Trap230 alleles, 
conflicting reports exist about the phenotypes elicited by different Trap240 alleles – 
some affect wing, eye and antenna, while others seem to be wing and leg-specific 
(Boube et al., 2000; Janody et al., 2003). 
These discrepancies are further underlined, by Drosophila Trap230 and Trap240 
alleles being divergingly described as members of the Trithorax or Polycomb groups 
of proteins, sometimes with opposing functions to each other (Bajusz et al., 2001; 
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Gindhart and Kaufman, 1995; Gutierrez et al., 2003; Kennison and Tamkun, 1988; 
Papoulas et al., 1998). Mostly, however, they are grouped as trithorax type genes, 
which are defined as activators of homeotic genes (Janody et al., 2004; Kennison and 
Tamkun, 1988). Notably, this suggests they can have activating function, in 
agreement with reports from C. elegans, where they were found to both activate and 
repress diverse homeobox transcription factors (Yoda et al., 2005; Zhang and 
Emmons, 2000; Zhang and Emmons, 2001). 
Trap230/Trap240 in Drosophila function as specific adaptors for signalling pathways 
including Notch and Wingless (Wnt). Supposedly, this effect is mediated by physical 
interaction with the transcriptional complexes regulated by these pathways, 
modulating the association of activating or repressing cofactors at downstream target 
genes (Carrera, 2003). Expression of Notch and Wingless themselves is normal 
(Janody, 2001). Interestingly, Cdk8/CycC in human cells have been shown to 
promote the degradation and turnover of the Notch ICD (intracellular domain) at 
target enhancers through phosphorylation (Fryer et al., 2004). The mutant eye 
phenotype observed is reminiscent of BMP overexpression, and both eye and wing 
discs show misregulation of some, but not all Hedgehog targets in both ways, 
indicating gene-specific functions (Janody et al., 2004). Interestingly, one of these 
targets is atonal, a bHLH TF which is also ectopically activated in C. elegans 
Trap230/Trap240 mutants as a downstream function of Wnt signalling (Zhang and 
Emmons, 2000). 
Also in the eyes, Trap230 was found to be downstream of unpaired, a secreted ligand 
in the JAK/STAT pathway (Bach et al., 2003). Moreover, Trap230 has been reported 
to act downstream of the sevenless receptor tyrosine kinase in Drosophila, 
suppressing its Ras/RTK mutant phenotype (Maixner et al., 1998). Thus, 
Trap230/Trap240 have been implicated in a substantial number of signalling 
pathways, and it remains to be seen, which functions may be direct and specific, and 
which may result indirectly from crosstalk among the pathways. 
Moreover, a cell-cycle regulated function for Trap230 downstream of cyclin E has 
been suggested (Brumby et al., 2002), in line with the proposed requirement of 
Trap230 for cell differentiation (Janody et al., 2004) and the implication of kinase 
subcomplex components in the mammalian cell cycle (Liu et al., 1998a; Liu et al., 
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1998b). CycC has been implicated in the vertebrate cell cycle, specifically an 
alternatively spliced smaller chick variant, which shows a pattern of cell cycle 
variation similar to cycB2 (Lew et al., 1991; Li et al., 1996; Liu et al., 1998b). CycC 
expression can be induced in response to serum or cytokine stimulation. The role in 
cell cycle regulation and mediating changes in cell adhesion in vertebrates has been 
demonstrated to be Cdk8-independent (Liu et al., 1998a) although the two are 
specific interaction partners for each other (Tassan et al., 1995). 
Interestingly, this coincides with the cell adhesion phenotype observed in Drosophila 
Trap230/Trap240 mutants (Janody, 2001; Treisman, 2001) as well as the flocculation 
phenotypes in S. cerevisiae (Hengartner et al., 1998) and S. pombe (Samuelsen et al., 
2003). This leaves the question open of whether it is a direct function of CycC for 
which an intact kinase subcomplex is needed, or whether it is an intrinsic function of 
another subcomplex component, eg. Trap240, indirectly attributed to CycC. The 
intriguing discrepancy is the flocculation phenotype observed also in yeast Cdk8 
mutants, which, however, has been attributed to Trap240 phosphorylation (Chang et 
al., 2004) and the finding that the cell adhesion function of CycC is Cdk8-
independent (Liu et al., 1998a). 
Synergistic genetic interactions between Trap240 and Med17 have been observed in 
relaying the activity of a Hoxb5 homologue, indicating a shared function in 
specification of adult cell and segment identity within the Mediator complex (Boube 
et al., 2000). Med6 mutants show a significant reduction of Trap240 (Gim et al., 
2001). However, Trap230 and Trap240, unlike Med6 and Med17 are not required for 
cell proliferation or survival (Boube et al., 2000; Gim et al., 2001; Treisman, 2001). 
A differential function for Trap240 as opposed to Trap230 and Med17 has been 
reported concerning a strong interaction with tonally, a protein involved in 
posttranslational modification of transcriptional complexes (sumoylation), indicating 
that Trap240 may thus be modified, while the other two Mediator components are 
not (Gutierrez et al., 2003). Moreover, a link between BEAF32A, with known 
chromatin insulator function, and Trap230, but not Trap240, has been described 
(Yamaguchi et al., 2001). 
The repressive effect of Trap230/Trap240 could be mediated by preventing the 
Mediator complex from acting on certain enhancers while promoting its activity on 
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others (Janody, 2001). These very large and higly conserved proteins are likely to 
present a large number of interaction surfaces or perhaps even exhibit enzymatic 
activities (Janody, 2001). 
Interestingly, on the vertebrate side, while Trap240 is otherwise known to be 
ubiquitously expressed, its expression in newborn mice appears to be almost gone 
(Ito et al., 2002). The human protein contains two LXXLL sequences, potential 
nuclear receptor (NR) binding sites, suggesting a function in relaying nuclear 
hormone signals, as Med1 has (Ge et al., 2002; Ito et al., 1999; Ito et al., 2000). The 
phenotype of Med1 mutants has been described to resemble that of CycC in yeast 
(Balciunas et al., 1999) and Trap230 in C. elegans (Zhang and Emmons, 2001). It is 
negatively controlled by CycC-dependent phosphorylation (Balciunas et al., 1999; 
Bjorklund and Gustafsson, 2004). Med1 constitutes one of the core subunits to which 
the kinase module attaches, namely through Cdk8, which interacts also with Med4 
and Med9. An additional interaction is that of Med21 with Cdk8 and CycC (Cho et 
al., 1998; Kang et al., 2001). 
Recently, three new members of the kinase subcomplex have been identified in 
human cells (Sato et al., 2004), Med12L, Med13L and Cdk11, suggesting they may 
take the place of the canonical subunits under certain circumstances. Med13L was 
originally identified in human patients suffering from a congenital heart condition 
including looping defects. Subsequently, it was cloned from human and mouse and 
found to be rather ubiquitously expressed, but most strongly in heart and skeleton. 
This protein has conserved LXXLL putative NR binding sites (Musante et al., 2004). 
Other interactions identified for the kinase subcomplex include a binding of Trap230 
to the RTA transcription activator of Kaposi's sarcoma-associated herpesvirus 
(KSHV). This protein acts as a molecular switch for lytic reactivation of the virus 
and is essential in its life cycle. It also interacts with Med6, Med16, Med17, Med21 
and Med30, but most strongly with the C-terminal domain of Trap230. The resulting 
complex includes the whole large Mediator and the RTA, as well as a chromatin 
remodelling complex (Gwack et al., 2003). 
Most importantly for this work, the C-terminal domain of human Trap230 has also 
been found to interact with the transcription factor Sox9 (Zhou et al., 2002). 
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1.5 Sox9 
The precise control of transcription is of central importance during the development 
of multicellular animals, as it leads to cell type-specific gene expression required for 
differentiation. Sox (Sry-type high-mobility group box) proteins are a large family of 
transcription factors implicated in the control of a variety of developmental processes 
not only in vertebrates, but also in C. elegans and Drosophila (Pevny and Lovell-
Badge, 1997; Wegner, 1999). They often play roles in determining early cell fates 
and are suggested to act in a dose-dependent manner (Pevny and Lovell-Badge, 
1997). They are characterised by the presence of a single HMG (high mobility 
group) box, a high affinity DNA-binding domain of 70-80 amino acids, which also 
contains a nuclear localisation signal (Wegner, 1999), and by their homology to 
SRY, the mammalian testis-determining factor (reviewed in (Pevny and Lovell-
Badge, 1997; Wegner, 1999). Among HMG box proteins, DNA binding sequence 
specificity is unique to Sox and TCF/LEF (Laudet et al., 1993), to which they are 
closely related (Pevny and Lovell-Badge, 1997). Sox proteins show highly restricted 
tissue distribution (Ner, 1992). 
They display properties of both classical transcription factors and architectural 
components of chromatin (Pevny and Lovell-Badge, 1997). Upon binding to the 
minor groove of DNA (unusually for a transcription factor) at enhancers distal to the 
basal promoter, they cause DNA to bend at an acute angle (Ferrari and Kosher, 2002; 
Giese et al., 1992). 
Five groups of Sox proteins are distinguished, termed A-G (Wegner, 1999). Group E 
features a conserved region of 36 amino acids N-terminal of the HMG box and a 
transactivation domain at the far C terminus (Figure 5) (Wegner, 1999). 
 
Figure 5. Conserved regions within SoxE proteins. 
(Wegner, 1999) black HMG box, TA transactivation domain, percent conservation between vertebrate 
members of this goup. 
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It consists of three members, Sox8, Sox9 and Sox10. Sox8 is expressed in the neural 
crest and its derivatives, in the pituitary and gonads (Cheung and Briscoe, 2003; 
Wegner, 1999). 
Sox10 is expressed in the premigratory and migrating neural crest, restricted to its 
derivatives of the glial lineage – early in the embryonic PNS (peripheral nervous 
system), and late in the embryonic CNS (central nervous system), pigment cells, 
enteric nervous system and Schwann cells (Barembaum and Bronner-Fraser, 2005; 
Wegner, 1999). Sox10 is found to undergo nucleocytoplasmic shuttling, for which 
Sox9 contains identical regulatory sequences. Thus, regulating the balance of nuclear 
import and export might provide a mechanism to regulate transcriptional activity of 
these proteins  (Rehberg et al., 2002). 
Sox8 and Sox10 expression patterns overlap and functional redundancy among Sox E 
genes in the neural crest has been suggested (Cheung and Briscoe, 2003). 
Expression of Sox9 is already found maternally (Spokony et al., 2002). During 
embryogenesis, Sox9 is expressed in premigratory neural crest, prior to other markers 
(Cheung and Briscoe, 2003), in mesenchymal condensations and later on in 
chondrocytes, in the kidney, sex-dysmorphically first in the genital ridge of both 
male and female, later only in the adult testis, notochord and epithelial placodes (otic 
and nasal), tubular heart structures and the CNS (Kent et al., 1996; Morais da Silva et 
al., 1996; Ng et al., 1997; Wagner et al., 1994; Wegner, 1999; Zhao et al., 1997). 
A Sox9 homologue in Drosophila has been identified, named Sox100B. It is also 
expressed male-specifically at the time of initial gonadal formation, as in vertebrates. 
This is a strikingly conserved pathway controlling gonad sexual dimporphism 
(DeFalco et al., 2003). 
Due to the additional genome duplication at the base of the teleost radiation, 
(Amores et al., 1998; Meyer and Schartl, 1999; Postlethwait et al., 1998; Taylor et 
al., 2001; Van de Peer et al., 2002) followed by nonfunctionalisation, zebrafish retain 
duplicate orthologs of about 30% of tetrapod genes (Postlethwait et al., 2000). 
Subfunctionalisation may preserve duplicate genes (Force et al., 1999; Stoltzfus, 
1999) and ancestral functions may assort to different duplicate copies. Therefore, 
zebrafish have two Sox9 co-orthologs: Sox9a and Sox9b (Chiang et al., 2001). 
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Functional analysis indicates that these two Sox9 orthologs have partitioned the 
various functions of the ancestral Sox9 gene, leaving each with a subset of the 
original functions (Yan et al., 2002; Yan et al., 2005). This subfunctionalisation 
appears to be achieved at the level of transcription, as Sox9a and Sox9b are expressed 
in largely complementary domains that together approximate the expression of Sox9 
in tetrapods (Cresko et al., 2003; Spokony et al., 2002; Wright et al., 1995; Yan et 
al., 2002). A phylogenetic tree for Sox9-related genes (Sox E group) can be found in 
the appendix. 
There are substantial differences among expression and function of Sox genes 
throughout vertebrates. In chick, for example, Sox4, L-Sox5 and Sox11 also occur in 
neural crest progenitors and derivatives, while this is not the case for zebrafish Sox11 
and has not been studied for Sox4 and L-Sox5 in the fish. Concerning members of 
the SoxE group, Sox8 is not expressed in the zebrafish neural crest, in contrast to 
mouse and chick, and Sox9a and b do not appear to be expressed in the heart, other 
than in mouse and chick. Zebrafish Sox10 is also different in that it is not expressed 
in pharyngeal arches, yet in the pectoral fin bud and otic placode. Nevertheless, 
common domains of Sox9 expression are the neural crest progenitors and pharyngeal 
arch crest derivatives, and for Sox10 the neural crest progenitors, PNS, pigment cells 
and enteric ganglia, which zebrafish share with other vertebrates (Hong and Saint-
Jeannet, 2005). 
Sox9 plays an important role in sex determination. Interestingly, in zebrafish gonads, 
Sox9b is expressed in the ovary and Sox9a in the testes (Chiang et al., 2001). In 
mammals, only the testes express Sox9 (Morais da Silva et al., 1996). 
Besides sex determination, for which Sox9 is thought to be the ancestral protein, 
rather than SRY (Wegner, 1999), Sox9 plays important roles in development of 
neural crest and cartilage/bone, as well as epidermal placode formation. Neural crest 
and epidermal placodes (ears, olfactory organs, lens, lateral line and some cranial 
ganglia) are vertebrate innovations. 
Human patients with mutations in Sox9 suffer from campomelic dysplasia, a skeletal 
malformation condition concurrent with renal malformations, absence of olfactory 
bulbs, heart and lung defects, deafness, mental retardation and male XY sex reversal. 
This disease reflects the Sox9 expression pattern in mouse (Wegner, 1999). 
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Neural crest cells are induced at the interface between non-neural ectoderm and 
neural plate, with both tissues contributing to them (Liem et al., 1995; Selleck and 
Bronner-Fraser, 1995). From there, they delaminate and migrate along specific 
routes to many destinations in the vertebrate embryo. They differentiate into a wide 
variety of cell types, including neurons and glial cells of the PNS, pigment cells 
(melanocytes), smooth muscle of the heart, head cartilage and skeleton (Christiansen 
et al., 2000). Migratory routes and cell types formed vary with their rostrocaudal 
position of origin along the embryonic axis. The frontmost, cranial neural crest, 
contributes to facial cartilage and bone as well as neurons and all the glia of the 
cranial ganglia. The vagal crest, arising from the caudal hindbrain, contributes to the 
heart and, together with the sacral neural crest at the most caudal part of the embryo, 
forms the enteric nervous system of the gut. Trunk neural crest gives rise to sensory 
and sympathetic ganglia and adrenal medulla. Pigment cells throughout the body 
arise from virtually all levels of neural crest (Barembaum and Bronner-Fraser, 2005). 
All members of the Sox E group are expressed in the neural crest (Cheung and 
Briscoe, 2003), though not equally in all organisms. SoxE proteins can initiate neural 
crest formation, but are not sufficient for delamination from the neural tube (Cheung 
and Briscoe, 2003). 
Growth factor signalling is essential for neural crest induction. An interplay of BMPs 
in the non-neural ectoderm, BMP antagonists like noggin and chordin in the 
ectoderm (Spokony et al., 2002), fine-tuning of Delta/Notch signalling to inhibit 
neurogenesis (Gammill and Bronner-Fraser, 2003), and Wnt signalling inducing the 
expression of Fgfs is necessary (Barembaum and Bronner-Fraser, 2005). 
Sox9 provides competence for neural crest cells to undergo an EMT (epithelial-
mesenchymal transition), essential for the cells to migrate, and is required for trunk 
neural crest survival – in its absence, cells undergo apoptosis prior to or shortly after 
delamination (Cheung et al., 2005). 
Moreover, Sox9 is essential for cartilage and bone formation. In this context, it 
directly activates the cartilage extracellular matrix proteins col2a1, col11a2 and 
aggrecan (Bi et al 1999, Lefebvre & de Crombrugghe 1998). 
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1.6 Pectoral fin development 
Classically, limb development has been most studied in Drosophila for invertebrates, 
chick and mouse for vertebrates and amphibians for regeneration (Capdevila and 
Izpisua Belmonte, 2001). Lately, zebrafish (Danio rerio) pectoral fins (Sordino et al., 
1995), being homologueous to tetrapod forelimbs, have also been investigated as a 
complementary model system for vertebrate limb development. One of their main 
advantages is the possibility to use forward genetics in a vertebrate to identify new 
genes involved in the process (Neumann, 2002). 
However, it must be taken into account that in contrast to chondrichtyans and 
sarcopterygians (to which the tetrapods belong), zebrafish lack the structural 
equivalent of the distalmost limb, the autopod (Sordino et al., 1995) and first develop 
larval pectoral fins first which later undergo morphogenesis into adult structures 
(Grandel and Schulte-Merker, 1998). 
 
Figure 6. Forelimb outgrowth cascade model. 
This is a model of the right hand side of an embryo in dorsal view. A retinoic acid (RA) gradient 
along the midline (SO: somites) induces a specifix Hox code in the forelimb field. This will lead to 
limb field specification via Wnt and Fgf signalling in the lateral plate mesoderm (LPM). Expression 
of tbx5 specifies forelimb versus hindlimb. A regulatory Fgf10/Fgf8 loop between mesoderm and 
overlying ectoderm will induce the apical ectodermal ridge (AER), the signalling centre for the 
proximodistal axis, characterised by expression of Bmps and dlx2, among others. These processes lead 
to outgrowth of the forelimb bud. 
Fins and limbs develop from buds formed by lateral plate mesoderm (LPM). The 
anteroposterior location of these along the embryonic flank is designated by 
combined expression of certain Hox genes, induced by retinoic acid, Fgfs and TGFβs 
(Capdevila and Izpisua Belmonte, 2001) (Figure 6). Bud induction is initiated by 
INTRODUCTION  
 
 
30
interactions between LPM and more medial axial tissues, namely kidney-forming 
intermediate mesoderm (IM) and possibly also somites (Capdevila and Izpisua 
Belmonte, 2001). This interaction is supposedly mediated by expression of Fgfs and 
Wnts, with Wnt2b/β-catenin mediating an Fgf8/Fgf10 loop between mesoderm and 
overlying ectoderm (Figure 6). In hindlimb buds, Wnt8c plays the role of Wnt2b 
(Kawakami et al., 2001). Budding is achieved through differential cell proliferation, 
bud cells proliferating faster than those around them (Searls and Janners, 1971). 
Depending on the expression of specific transcription factors (Pitx, Tbx, Hox genes), 
pectoral or pelvic fins will develop (Capdevila and Izpisua Belmonte, 2001). 
 
Figure 7. Molecular interactions that coordinate limb growth and patterning along the three 
limb axes. 
(Niswander, 2003) Proximal–distal (Pr–D) axis is under the control of fibroblast growth factors (Fgfs; 
blue) from the apical ectodermal ridge (AER), the anterior–posterior (A–P) axis is under the control of 
Sonic hedgehog (Shh; red) from the zone of polarising activity in the posterior mesenchyme, and the 
dorsal–ventral (D–V) axis is under the control of bone morphogenetic proteins (Bmps) and Engrailed1 
(En1; both in pink) from the ventral ectoderm and Wnt7a (green) from the dorsal ectoderm. 
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In the bud, there are organising centres for each of the three-dimensional axes. These 
three axes cross-talk to each other: Proximodistal patterning and bud outgrowth are 
directed by the apical ectodermal ridge (AER, Fgfs), an epidermal thickening on the 
dorsoventral border of the distal bud tip (Figure 7). Anteroposterior patterning is 
controlled by the zone of polarising activity (ZPA, Shh), a region in the posterior bud 
mesenchyme (Figure 7). The dorsoventral axis is patterned by signals from the non-
ridge ectoderm (Wnt7a, Bmp/En1) (Figure 7) (Capdevila and Izpisua Belmonte, 
2001; Niswander, 2003). Especially important is the epithelial-mesenchymal 
interaction between AER and ZPA, which maintain each other’s activity (Capdevila 
and Izpisua Belmonte, 2001; Neumann et al., 1999; Ng et al., 1999; Niswander, 
2003; Panman and Zeller, 2003). 
Members of all major growth factor families are involved in this process: Fgfs are 
secreted by the LPM, IM and AER, Bmps and Wnts by the LPM and ectoderm, 
Hedgehogs by the ZPA (Capdevila and Izpisua Belmonte, 2001; Niswander, 2003). 
Patterning and growth mainly proceed in a proximal-to-distal fashion, whereby there 
are two controversial models. Positional information along this axis could either be 
specified very early on in individual cells or cell groups (early specification model) 
or be acquired in a time-dependent manner by a clock-like mechanism (progress 
zone model) (Duboule, 2002; Dudley et al., 2002; Saunders, 2002; Sun et al., 2002; 
Tickle, 2003; Wolpert, 2002). 
1.7 Aim of this thesis 
A novel zebrafish mutant named trapped (tpd), carrying a recessive point mutation 
had been identified in a chemical mutagenesis screen performed in Tübingen in 
2000/01 by its pectoral fin phenotype. Two alleles, tpdt25870 and tpdt24970, were 
identified, of which tpdt25870 is the stronger one. Tpd mutants show a complex 
pleiotropic phenotype including reduced embryonic pectoral fins, defects in neural 
crest derived structures, cartilage and placode formation as well as defects in other 
embryonic structures. 
The aim of this thesis was the identification of the mutated gene responsible for the 
tpd phenotype and an initial characterisation of the mutant, since it is too complex 
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for a fully detailed analysis during the course of this work. One focus was on the 
developmental defect of the pectoral fins, since this is a strong phenotype by which 
the mutation was originally identified. A second focus became a comparative 
analysis of the tpd phenotype with that of Sox9a/Sox9b double mutants and the role 
of the mutated Trap230/Med12 gene in mediating Sox9 activity. 
Both tpd and Sox9a/Sox9b mutants strongly resemble each other and Sox9 activity is 
impaired in tpd embryos, indicating that Trap230, a component of the Mediator 
transcriptional cofactor complex, is directly required for the activity of Sox9. Finally, 
I show that Trap230 functions downstream of Tbx5 and upstream of Fgf24 during 
pectoral fin induction, indicating that it also participates in Sox9-independent 
signaling events. This is the first genetic analysis of Trap230 in a vertebrate species, 
and reveals that vertebrate Trap230 is remarkably specific in mediating Sox9 
activity. 
 
 2 RESULTS 
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2.1 Mapping and cloning the zebrafish trapped 
mutant 
2.1.1 Rough mapping 
In a large-scale genetic screen to identify genes required for zebrafish embryonic 
development (Habeck et al., 2002), a number of mutants with defects in pectoral fin 
development were isolated. Before mapping, complementation crosses were set up 
for mutant lines with similar phenotypes. This showed that the mutant lines tpdt24970 
and tpdt25870 are allelic, tpdt24970 being the weaker allele. However, they complement 
the known pectoral fin mutants heartstings (tbx5, (Garrity et al., 2002), dackel (ext2, 
(Grandel et al., 2000; Lee et al., 2004), boxer (extl3(Lee et al., 2004; Trowe et al., 
1996), neckless (raldh2, (Begemann et al., 2001; Grandel et al., 2002), and also hand 
(hand2, (Yelon et al., 2000), which are all phenotypically related. 
For tpdt24970 and tpdt25870, sufficient embryos from four pairs each could be collected 
to start rough-mapping them. This was done using SSLP (single sequence length 
polymorphism) markers according to (Geisler, 2002) using bulked segregant 
analysis. Potential linkages were identified. 
According to both the complementation analysis and the fact that similar linkages 
were found for both, tpdt24970/tpdt25870 would presumably be two alleles of the same 
gene. This novel mutant was named trapped (tpd). Besides the defects in pectoral fin 
outgrowth, tpd also has problems in craniofacial development, pigmentation, ear and 
eye development as well as slightly U-shaped somites and defective axon guidance 
and brain formation. In addition, tpd mutants have a heart edema and a curly-down 
body axis. 
The phenotypic analysis was mostly pursued with tpdt25870 embryos, this being the 
more penetrant allele, while for mapping more embryos from tpdt24970 were used, 
since more pairs showed polymorphisms in the available markers. 
In order to identify the molecular nature of tpd, bulked segregant analysis 
(Michelmore et al., 1991) was used to map it to linkage group 14 (Figures 8 and 9), 
close to marker Z20214 at 60.6cM from the top. 
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Figure 8. Bulked segregant analysis using marker Z20214. 
PCR was performed on DNA pools from mutant (mut) and wild 
type (WT) siblings from both alleles. Both alleles show potential 
linkage to this marker. 
2.1.2 Fine mapping 
Fine mapping using CA-repeat based markers from the meiotic MGH panel (Knapik 
et al., 1996), localised the mutation in a region at 49.8cM on linkage group 14 
between markers Z53264 (0.35 cM away, 5 recombinations in 1288 meioses) and 
Z11725 (0.58 cM away, 7 recombinations in 1207 meioses) (Figure 9). 
Figure 9. Section of linkage group 14 on the 
meiotic MGH panel (Knapik et al., 1996). 
Markers on linkage group 14 of the zebrafish 
MGH map between 49.8cM and 50.5cM. 
Numbers at the left indicate absolute cM 
(centiMorgan) count on the linkage group from 0 
at the "northern" telomere. Black numbers to the 
right indicate relative distance in cM between 
given markers. SSLPs are given in brown. They 
are usually named "Z" followed by a number. 
Z11725 and Z53264 are boxed in red, Z20214 in 
green as important for this work. Known genes 
are indicated in blue, mutants in red. 
While Z53264 was identified at 24.7Mb on chromosome 14 in the Zv4 version of the 
zebrafish genome (http://ensembl.org/Danio_rerio/), Z11725 was found at 25.8Mb. 
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The low recombination frequency corresponded to an apparently incompatibly large 
genomic region - 1100kb correspond to 0.93cM between the two markers, while the 
average distance corresponding to 1cM is 625kb (Postlethwait et al., 1994), so the 
expected distance for 0.93cM would be about 580kb. This genomic region still 
contained sequencing gaps which suggested the region may actually be even larger. 
It was supposed that the recombination in this region may be suppressed due to 
proximity of the centromere (Johnson et al., 1996). 
However, detailed analysis of the various gene predictions annotated within this 
region finally revealed that part of the region in question had been triplicated in the 
genome assembly (Figure 10). This was reported to the Sanger Centre and the 
mistake confirmed. 
 
Figure 10. Annotated genomic region of linkage group 14 in Zv4 containing the putative 
mutation. 
Assembled contigs in blue in the centre. Homology annotation for predicted protein sequences in 
yellow, for mRNAs in red. Red and green circles indicate predicted open reading frames 
homologueous to the same set of genes/proteins, which occur in triplicate with different orientations 
and lengths. 
Z7495 is another marker identified to lie on the same side of the mutation as Z11725, 
also at 49.8cM on the MGH mapping panel. However, it is not to be found in the 
genomic zebrafish sequence by either annotation or sequence alignment (BLAST 
search). Its exact distance from the mutation remained elusive due to its failure to be 
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polymorphic in most of the mapping fish pairs used. Referring back to an assembly 
of sequenced zebrafish BAC and PAC clones 
(http://vega.sanger.ac.uk/Danio_rerio/), it was possible to identify an assembly of 
BAC sequences between Z53264 and Z7495, which also contained the two 
triplicated genes annotated in the genome sequence between Z53264 and Z11725 
(Figure 11). Z11725 was annotated to be further away from the mutation, the 
distance between Z11725 and Z53264 now being about 710kb (including two gaps), 
a much more plausible number. 
 
Figure 11. Annotated region containing assembled BAC sequences between Z53264 and Z7495 
in VEGA. 
Assembled BACs in blue in the centre. The black circle indicates a gap in the assembly. Red and 
green circles indicate the same pair of predicted genes found in Figure 10. Note the pink circle 
indicating a homology annotation for a short C-terminus of a protein. The red cross indicates position 
of marker P1. 
By making use of the zebrafish genomic sequence (http://ensembl.org/Danio_rerio/ 
and http://vega.sanger.ac.uk/Danio_rerio/) available for this interval, new SSLP 
markers based on CA and other simple sequence repeats were designed. For one of 
these markers, termed P1, no recombinants out of 2894 meioses with tpd (tpdt24970) 
were obtained, indicating that it must lie very close to the tpd mutation (Figure 11, 
red cross), but failing to indicate to which side of P1 it had to be. 
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Importantly, the region which must include the mutation still contained a sequence 
gap, right next to P1. In the worst case the gene containing the mutation could be 
present within this gap, which should therefore be closed. 
A first hint to tackle this problem was found in form of a tiny bit of a protein 
homology annotated right next to the gap (Figure 11, pink circle). Looking back at 
the scrambled triplicated genome sequence, a gene prediction with the same 
homology annotation could be found, this time containing an almost full-length gene 
(Figure 12). 
 
Figure 12. Annotated genomic region of linkage group 14 in Zv4 containing the putative 
mutation. 
Red and green circles indicate a triplicated set of similarly annotated gene predictions. Note the pink 
circle indicating an almost complete open reading frame of the 3' end found in Figure 11. 
The zebrafish BAC fingerprinting contig (BAC-FPC) database 
(http://www.sanger.ac.uk/Projects/D_rerio/WebFPC/zebrafish/small.shtml) revealed 
a BAC (zK87D3) whose ends aligned nicely with the BACs at either side of the gap. 
Therefore a BAC to bridge it was found. However, the shotgunning and sequencing 
of this BAC had only just begun, and none of the BAC sequence appeared to 
correspond to any part of the predicted sequence of the gene in the gap. The 
estimated length of the BAC from the fingerprinting data was about 150kb (Mario 
Caccamo, Sanger Centre, personal communication). Considering that its overlap with 
RESULTS  
 
 
39
the flanking BACs (as estimated from the alignment of the zK87D3 BAC end 
sequences with them) is about 41kb, the gap should then be about 109kb long. The 
sequence of the predicted gene covered 61kb plus an estimated 2kb for the missing 5' 
end predicted from homology to human, so this gene appeared to make up about two 
thirds of the gap, which was a reasonably good coverage. 
2.1.3 Cloning 
Since none of the genes annotated in the region was an obvious candidate for causing 
the tpd phenotype according to previously published data, we considered several 
candidate genes in the region close to P1 and cloned their cDNAs from both wild 
type and tpd embryos. I also tested their expression pattern by in situ hybridisation 
on wild type and tpd embryos. 
While one of the candidates, a gene for a homologue of the multi-drug-resistance 
protein MRP5, showed a spatiotemporal expression pattern corresponding to the 
mutant phenotypes, no mutation in the cDNA sequence could be identified. 
Another of these candidates, Trap230/Med12, was ubiquitously expressed. Although 
it was therefore not considered a prime candidate, a difference in cDNA sequence 
between wild type and mutants was found (Figure 13). This happens to be the 
predicted gene in the gap. 
The open reading frame of the predicted cDNA is about 6kb long and was therefore 
amplified in several parts for ease of cloning and sequencing (primers used cf. 
Materials and Methods). Firstly, polymorphisms and possible PCR artefacts had to 
be excluded as misinterpreted point mutations. Therefore, cDNA from several 
individual preparations was used, and several PCR reactions and individually picked 
clones were compared. Wild type sequences were aligned with sequences of both 
alleles. This excluded a large number of possible point mutations. 
From the mapping data, the mutation in tpdt25870 was expected to lie further 5' in the 
affected gene than the mutation in tpdt24970 (Z53264 was unfortunately not 
polymorphic in any tpdt25870 fish, but Z11725 – which is downstream of Trap230 - 
had one recombinant in 154 meioses for tpdt25870, corresponding to 0.65cM and 6 
recombinants in 1053 meioses for tpdt24970, corresponding to 0.57cM). 
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For tpdt24970, several cDNA variants were found with various deletions within a range 
of three exons in the 3' end of the gene. None of them corresponded to the use of 
cryptic splice sites or to otherwise obvious specific point mutations. This allele also 
being the weaker one, it was decided to abandon its detailed analysis and concentrate 
on tpdt25870. 
As two different forms of cDNA were found in tpdt25870 that could both be explained 
by aberrant splicing at the exon 12/intron 12 junction, the genomic locus of tpdt25870 
was also sequenced. The splice donor site of intron 12 was found to be altered from 
CAgtgag to CAgcgag (capitalized nucleotides belong to exon12; Figure 13). 
 
Figure 13. Molecular characterisation of the tpd25870 locus. 
(A) tpd25870 maps to linkage group (LG) 14, between markers Z53264 and Z11725, close to marker 
P1. (B) The tpd25870 mutation (marked in red) causes an alteration of the splice donor site of intron 12. 
Two defectively spliced transcripts are generated as a result of this mutation. cDNA1 is spliced at a 
cryptic splice site (shaded in yellow) within exon 12. This leads to a frame shift and a stop codon after 
93 amino acids. cDNA2 contains unspliced intron 12, leading to a stop codon after 6 amino acids. L: 
leucine-rich domain; LS leucine-and-serine-rich domain; PQL: proline-, glutamine-, and leucine-rich 
domain; OPA: glutamine-rich domain. 
This mutation changes the highly conserved GU found at the intronic 5’ splice site to 
GC, and results in two types of aberrant splicing in tpdt25870mutants: In type 1 
cDNAs, a cryptic splice site (CTgtgct) located 7 bases 5’ of the correct splice site is 
used, resulting in a frame shift and a stop codon 93 amino acids downstream of this 
point (Figure 13). In type 2 cDNAs, intron 12 fails to be spliced at all, and its 
translation generates a stop codon 6 amino acids downstream of this point (Figure 
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13). In both cases, the tpdt25870 mutation results in a severely truncated Trap230 
protein, in which more than half the C-terminus is missing (Figure 13). Nevertheless, 
this tpd allele may be hypomorphic, as it shows some variability in its phenotype 
(Figure 13). 
Several attempts were made at cloning the missing 5' end of the gene, using 5' RACE 
(rapid amplification of cDNA ends) and degenerate PCR methods making use of a 
putative conservation of the ATG region as defined by comparison of the sequences 
of Homo sapiens and Fugu rubripes. Nevertheless, the sequence of an estimated 
three exons and 142 amino acids at the 5' end remains to be ultimately identified. 
The full-length wild type and predicted sequences can be found aligned in the 
appendix. 
Taking advantage of the fact that the point mutation of tpdt25870 lies within the 
recognition site of the restriction enzyme Est1, this enzyme was used to confirm the 
mutation and identify further carriers with the point mutation as SNP (single 
nucleotide polymorphism). A band of 282bp comprising the exon12/intron12 
boundary was PCR-amplified from genomic DNA of individual tpdt25870 mutant and 
sibling embryos and then cut with Est1. While two bands are visible for the tpdt25870 
embryos, corresponding to 25% of the batch, one third of the wild type siblings has 
one band (being homozygous wild type embryos) and two thirds have three bands, 
showing one cut (mutant) and one uncut (wild type) allele and therefore 
corresponding to heterozygous embryos (Figure 14). 
 
Figure 14. The mutation in tpdt25870 as a SNP. 
Restriction enzyme Est1 cuts genomic tpdt25870 but not 
wild type DNA due to the point mutation in its 
recognition site. het: DNA from a heterozygous embryo, 
WT: wild type, tpd: . tpdt25870. 
2.1.4 Expression of Trap230 
The trap230 transcript is expressed ubiquitously throughout the embryo, and is also 
deposited maternally (Figure 15). This is in agreement with the findings in other 
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organisms (Janody, 2001; Treisman, 2001; Wang et al., 2004a; Zhang and Emmons, 
2000). The sequence used for the in situ probe comprised the 3' end of the gene. No 
change in the expression was found in tpdt25870 embryos compared to wild type. 
Hereafter, tpd will be used to indicate the tpdt25870 mutant allele, since phenotypic 
characterisation was carried out with this allele. 
Figure 15. Trap230 RNA expression. 
(A) 4-cell-stage, animal pole to the top. (B) 
3-somite stage, lateral view, dorsal to the top, 
anterior to the left. 
2.1.5 Phenotype of the embryo 
The tpd mutants were originally identified for their defect in pectoral fin 
development (Figure 16). 
 
Figure 16. The tpd pectoral fin phenotype. 
Methylene blue-stained (Humphrey and Pittman, 1974) transverse sections at the level of the pectoral 
fin buds (arrows and asterisks) through 3dpf wild type (WT) and tpd embryos showing absence of 
buds in the mutant. 
 
Figure 17. The overall tpd phenotype. 
Wild type and tpd embryos at 3dpf.  
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Moreover, defects are apparent in craniofacial development, pigmentation, ear and 
eye development, and it shows slightly U-shaped somites, defective axon guidance 
and brain formation. In addition, tpd mutants have a heart edema and a curly-down 
body axis (Figure 17). 
2.1.6 Phenocopy by morpholino injections 
To further investigate the possibility that tpd disrupts Trap230, a morpholino 
oligonucleotide was designed to block splicing of the trap230 transcript at the exon 
26/intron 26 splice junction (Figure 18). It is not targeted against the exon-intron 
boundary containing the actual mutation because this experiment preceded the 
cloning of the point mutation. 
GAGATGCTGAGCTGAAAGGCTCAGGCTTTTCCCATCCTGCTGGTCTGGATGATATTGGAGAGGATGAC
ATGGGCTCTAAAAAATCTGGGGGACGTAATGTCTCTATTGAAACAGCCAGTCTGGTGGTTTACGCCAA
GTATGTGCTGAAGAGCATCTGCCACCAGGTGATGATTTTTAGAGGATCTGTATAATCCAAATTACAAT
TACTGTAGAGCTTAAAGTTGTGAGACTATTTTAAGAGATATCTATTCCCAACTACTGGAACACAATTT
GATGTTGTGGAAATGCCTATAATTGTGCTTCTCTGATACTGTAATGGACTAAGGCCACTAAAGTGATT
AATATCAGAATTACTCTGCTCACTTCCAGCGGAGATGAGATGATTTTCATAGGAAAAGCTTAGAAATG
CTGGTTTTAATGTATGAAGCTTGTTTGATTGAGCTGATTTGTGTCTGTGGTTCAGGAATGGGTTGG 
Figure 18. The Trap230-morpholino targets the exon 26/intron 26 splice junction. 
Partial genomic sequence of zebrafish Trap230 as predicted in the Zv4 genome annotation. Sequences 
of exon 26 and start of exon 27 in red, intron 26 in black. The sequence targeted by the Trap230-
morpholino is shaded in yellow. 
It was found that injection of this morpholino into fertilised 1-cell stage zebrafish 
embryos generates a phenocopy of tpd mutants, including absence of pectoral fins, 
identical ear, pigmentation and craniofacial defects, heart, brain and somite 
phenotype and a curly-down body axis (Figure 19). 
 
Figure 19. Trap230 morphant at 3dpf. 
 
To confirm the functionality of the Trap230 morpholino, an RT-PCR product was 
amplified from exons 26 and 27 of both wild type and morpholino-injected embryos. 
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Morpholino-injected embryos lack this product, since intron 26 fails to be spliced out 
(Figure 20). 
 
Figure 20. Trap230 MO effectively targets splicing 
of the exon 26/intron 26 splice junction. 
Trap230 morphants lack the RT-PCR product amplified 
from exons 26 and 27, since intron 26 fails to be spliced 
out. 
 
Taken together, these data show that the tpd phenotype is due to disruption of 
zebrafish Trap230 function. 
2.2 Trap230 and Sox9 
2.2.1 The Trap230 loss-of-function phenotype 
resembles loss of Sox9 activity in many different 
tissues 
Since several of the phenotypes observed in tpd mutants affect cell types known to 
depend on Sox9 function, the characterised phenotypes of zebrafish Sox9a/Sox9b 
single and double mutants (Yan et al., 2005) were systematically compared to the 
phenotypes present in tpd embryos. In Sox9a/Sox9b double mutants, the ear fails to 
form, while it is only partially reduced in Sox9a or Sox9b single mutants. One of the 
prominent functions of Sox9 is its requirement for the development of epidermal 
placodes, like the otic placode (Saint-Germain et al., 2004; Yan et al., 2005). We find 
the ear is variably reduced in tpd mutants (Figure 21), similar to Sox9b mutants, 
showing an overall size reduction and smaller otoliths of equal size instead of one 
large and one small otolith (Figure 21 A). Additionally, some embryos show three 
otoliths instead of two, a phenotype so far only described for zebrafish runx1 mutants 
(Kalev-Zylinska et al., 2002), a gene otherwise implicated in hematopoiesis. 
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Figure 21. Ear phenotype of tpd mutants. 
Ears of WT (A) and tpd (B and C) embryos at 4dpf. Note partial reduction of the overall ear, smaller 
otoliths and irregular number in tpd. 
In Trap230 morphants, however, the ear is either partially reduced or completely 
absent (Figure 22), similar to Sox9a/Sox9b double mutants, suggesting the morphant 
gives a stronger reduction of Trap230 function than the tpd mutation, and further 
indicating that tpdt25870 is a hypomorphic mutation. 
 
Figure 22. Ear phenotype of Trap230 
morphants at 4dpf. 
(A) reduced size and absence of 
otoliths. (B) absent ear. 
 
Sox9 activity is also important for specification of neural crest cells. Pigment cells 
derive from the neural crest – in zebrafish three types are known: melanophores, 
xanthophores and iridophores. In Sox9b or Sox9a/Sox9b double mutants, there is an 
absence of iridophores, which can be detected as bright, shiny cells in darkfield 
microscopy. As in Sox9b single mutants or Sox9a/Sox9b double mutants, no 
iridophores are detected in tpd mutants (Figure 23). 
 
Figure 23. tpd iridophore phenotype. 
Dark field microscopy, revealing iridophores (bright shiny cells), present in WT, but not in tpd 
mutants at 4dpf in dorsal view. 
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The decision to form either pigment cells or neural derivatives is supposedly made 
early during migration. In zebrafish, medially located cranial neural crest cells are 
induced by local Wnt1 and Wnt3a signals to form pigment cells, whereas lateral cells 
that are further from the Wnt signals form neurons (Dorsky et al., 1998). 
This is mediated through Tcf/Lef1 directly activating nacre/mitfa, which is essential 
for melanophore differentiation (Dorsky et al., 2000; Lister et al., 1999) and was 
reported to be normally expressed in sox9a/sox9b double mutants (Yan et al., 2005). 
Sox9 mutants have largely unperturbed pigment cells, since Sox9 is primarily 
involved in cranial neural crest development and pigment cells derive from neural 
crest all along the embryonic crest (Spokony et al., 2002). 
Therefore, melanocytes are present in Sox9a/Sox9b mutants, but are larger than in 
wild types, due to dispersed melanosomes even in bright light (Yan et al., 2005). 
Melanocytes are similarly enlarged in tpd mutants and in Trap230 morphants (Figure 
24). This is a physiological rather than developmental consequence because both 
Sox9a/Sox9b and tpd mutants have eye defects and are presumably blind, so that 
light cannot be detected to elicit a light-dependent response of the melanophores. 
Formation of xanthophores, the third pigment phenotype, is not impaired in either 
Sox9 or tpd mutants (Yan et al., 2005) (not shown). 
 
Figure 24. Trap230 loss-of-function melanophore phenotype. 
Trunk melanocytes (dark cells, arrows) in wild type embryos contract under influence of light, but not 
in tpd mutants and Trap230 morphants. 
Sox9b mutants fail to straighten the body axis, resulting in a curly-down tail, 
probably due to Sox9b function in the notochord (Yan et al., 2005). A similar curly-
down body axis is observed in tpd mutants (90% of embryos in tpd25870, n=272) and 
Trap230 morphants (Figures 17 and 19). 
Taken together, these results show that Trap230 loss-of-function strongly resembles 
zebrafish Sox9a/Sox9b mutants with respect to ear, pigmentation, and body axis 
development. 
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2.2.2 Trap230 is required for Sox9-dependent neural 
crest fates and craniofacial cartilage formation 
To further investigate the role of Trap230 in Sox9 signaling, an analysis of neural 
crest and cartilage-related phenotypes was perfomed. Craniofacial cartilage derives 
from head neural crest. Therefore, the expression of col2a1 was examined, which is 
expressed during the differentiation of craniofacial cartilage elements, and known as 
a direct target of Sox9 binding and activation (Bell et al., 1997; Lefebvre et al., 1997; 
Ng et al., 1997; Zhou et al., 1998). In Sox9b and Sox9a/Sox9b double mutants, 
col2a1 expression is strongly reduced, although not completely absent, in the 
pharyngeal arches. It is also present in reduced amounts in the eye capsule and otic 
vesicle (Yan et al., 2005). A similar reduction of col2a1 in these expression domains 
is found in tpd embryos (Figure 25). 
Figure 25. Expression of col2a1 
at 68hpf in the head, lateral 
view. 
 
While either Sox9a or Sox9b single mutants show partial absence of craniofacial 
cartilages, the Sox9a/Sox9b double mutant animals lack all traces of pharyngeal 
cartilages and the neurocranium (Yan et al., 2005). Likewise, tpd mutants have a 
complete absence of both the pharyngeal cartilages and the neurocranium, as well as 
total absence of the pectoral fin skeleton (Figure 26). In contrast to Sox9a/Sox9b 
double mutants, tpd mutants also lack the entire shoulder girdle including a 
cleithrum, hinting to a further function of Trap230. 
Figure 26. Alcian 
blue stained 
cartilages at 5dpf, 
ventral view. 
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The earliest known response to neural crest induction through Sox9 is expression of 
slug/snail zinc finger transcription factors (Nieto et al., 1994; Sefton et al., 1998). 
Snail-mediated repression is an important mechanism for the induction of an EMT 
and hence for initiating neural crest migration. This is thought to occur through 
targeting of cadherins (Christiansen et al., 2000). Loss of Sox9 impairs expression of 
slug/snail as well as foxd3, sox10 and other transcription factors in premigratory 
neural crest dose-dependently (Bronner-Fraser, 1986; Cheng et al., 2000; Nakagawa 
and Takeichi, 1998; Spokony et al., 2002). 
In zebrafish premigratory cephalic and trunk neural crest cells of Sox9b single 
mutants or in Sox9a/Sox9b double mutants, expression of snai1b is reduced, as are 
foxd3 and sox10. This can also be seen in tpd mutants (Figure 27). 
Figure 27. Expression of 
neural crest markers at 3 
somites, dorsal view. 
 
Neural crest cells originating from the hindbrain express dlx2a during their migration 
into the visceral arch primordia (Akimenko et al., 1994; Ellies et al., 1997). In Sox9b 
and Sox9a/Sox9b double mutants, expression of the migratory neural crest marker 
dlx2a is only slightly reduced, with the strongest reduction in the posterior branchial 
arches, indicating that the cells are specified normally and also start to migrate (Yan 
et al., 2005). 
Figure 28. 
Expression of dlx2a 
at 24hpf in the 
pharyngeal arches, 
dorsal view. 
 
In tpd mutants, there is a similar reduction of dlx2a, which is also more pronounced 
in the posterior arches (Figure 28). Trap230, as Sox9 function, is not essential for 
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cranial crest migration, but Sox9b and Trap230 may help determine the size of the 
dlx2a-expressing cell population (Yan et al., 2005). 
Both in mouse Sox9 mutants and in zebrafish Sox9b and Sox9a/Sox9b double 
mutants, neural crest cells are induced, but then undergo apoptosis, indicating that 
Sox9 acts as a survival factor (Cheung et al., 2005; Yan et al., 2005). A similar 
increase of apoptotic cells was detected by TUNEL labeling in tpd mutants (Figure 
29). 
Figure 29. Apoptosis at 4dpf. 
TUNEL staining reveals apoptotic 
neural crest cells in tpd but not wild 
type embryos.. 
 
An important derivative of trunk neural crest are the neurons and glia found in dorsal 
root ganglia (DRG), and in mouse Sox9 mutants, these cell types are strongly 
reduced (Cheung et al., 2005). Similarly, no Hu-positive DRG neurons could be 
detected in Trap230 morphants, Hu being a neuron-specific RNA-binding protein in 
vertebrates (Marusich et al., 1994) (Figure 30). 
 
Figure 30. Dorsal root ganglion neurons at 3dpf (arrows). 
Dorsal root ganglion neurons detected by Hu and Islet1 (Isl1) antibodies at 3dpf are absent in tpd 
embryos. Note the circular structure of the ganglia stained with Islet1. 
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Staining with Islet-1 (Isl1) as another neuronal marker (Cheung et al., 2005) was 
similarly reduced in DRGs (Figure 30). 
Altogether, these results show that Trap230 activity is crucial for Sox9-dependent 
neural crest development and cartilage differentiation, and that many of the defects 
found in tpd embryos are identical to those found in Sox9 mutants. While some of the 
phenotypes can be explained by loss of Sox9b activity only, others like the ear and 
cartilage phenotypes clearly indicate that functions depending on both Sox9a and 
Sox9b synergistically are impaired in tpd. 
2.2.3 The role of Trap230 in Sox9-dependent ear 
development 
The vertebrate inner ear develops from a thickening of the embryonic ectoderm, 
adjacent to the hindbrain, known as the otic placode. Otic Sox9 expression, initiated 
in the prospective otic placode, a bilateral cell patch adjacent to the cranial neural 
crest shortly after gastrulation by Fgf and Wnt signalling (Pfeffer et al., 1998; Saint-
Germain et al., 2004), is required for specification of the otic placode. Patients 
suffering of campomelic dysplasia due to mutations in Sox9 are often deaf (Saint-
Germain et al., 2004). 
Sox9 is one of the earliest genes expressed in the otic placode, and knockdown of 
Sox9 activity in Xenopus leads to complete absence of the ear (Saint-Germain et al., 
2004). pax8 is also expressed very early in the otic placode, and pax8 expression 
fails to be activated following Sox9 knockdown (Saint-Germain et al., 2004). 
Similarly, no pax8 expression is detected in the otic placode of Trap230 morphants 
(Figure 31 E and F), even though Sox9a and Sox9b expression are present in the 
presumptive otic placode of these morphants, although at partially reduced levels 
(Figure 31 A-D). 
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Figure 31. Expression of sox9a, sox9b and pax8 in the otic placode of Trap230 morphants. 
Expression of sox9a (A, B) and sox9b (C, D) in the otic preplacode region of wild type (A, C) and 
Trap230 morphant (B, D) embryos at 3 somites. Expression of pax8 (E, F) in wiltdype and Trap230 
morphant embryos at tailbud stage. Arrows indicate expression domain. 
 
Figure 32. Expression of pax2.1 in the otic placode at 24hpf in wild type and Trap230 morphant 
embryos. 
In the majority of Trap230 morphants, there is a partial recovery of ear development 
later on, leading to a reduced number of cells expressing pax2.1 compared to wild 
type siblings at 24hpf (Figure 32). 
This partial recovery of morphants is likely due to incomplete blockage of trap230 
splicing, since a small number of morphants do not have any signs of ear 
development (cf. Figure 22 B). 
These results show that Trap230 is required for Sox9-dependent activation of pax8 in 
the ear and for Sox9-dependent ear development, and further indicate that Trap230 is 
required for Sox9 activity. 
RESULTS  
 
 
52
2.3 Trap230 is required for Sox9 activity 
As tpd mutants are very similar to Sox9a/Sox9b mutants, one can hypothesise that 
this could potentially reflect two different modes of regulatory interaction between 
Trap230 and Sox9. Since Trap230 is a transcriptional regulator, it might be required 
for expression of Sox9a and Sox9b. Alternatively, it might participate together with 
Sox9 proteins in regulating Sox9 targets. 
2.3.1 Sox9 expression in tpd is mostly normal 
To distinguish between these possibilities, first the expression of Sox9a and Sox9b 
mRNA in the absence of Trap230 activity were examined. Sox9a expression was 
found to be largely normal in tpd mutants compared to wild type siblings, both at 
10hpf and at 24hpf (Figure 33 A-D). 
 
 
Figure 33. Expression of sox9a and sox9b is mostly normal in Trap230 loss-of-function embryos. 
Expression of sox9a (A-D, I, J) in wild type and tpd embryos at tailbud stage (animal pole to the top) 
and 24hpf (lateral view). Expression of sox9b (E-H, K, L) in wild type an Trap230 morphant embryos 
at 3 somites (dorsal view) and 24hpf (lateral view). Expression of sox9a and sox9b in the pectoral fin 
buds is lost in tpd or Trap230 morphant embryos at 24hpf (I-L, dorsal view). Arrows indicate fin bud 
expression, asterisks its absence. 
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The exceptions to this are the pectoral fin buds, in which Sox9a expression fails to be 
activated (Figure 33 C, D, I, J), and the presumptive otic placodes, in which Sox9a 
expression is activated, but at reduced levels compared to wild type siblings (Figure 
31 A and B). Sox9b expression is also largely normal in Trap230 morphants (Figure 
33 E-H), although there is a weak reduction in the neural crest region at 3 somites 
(Figures 31 C, D and 33 E, F) and a loss of pectoral fin bud expression at 24hpf 
(Figure 33 G, H, K, L). The weak reduction of Sox9a in the otic placode region and 
Sox9b in neural crest might be due to the fact that Sox9a and Sox9b activate each 
other's expression (Yan et al., 2005), and thus reflects a stimulatory effect of Sox9 
activity on its own transcription in these cells. 
2.3.2 Sox9 overexpression cannot rescue tpd mutants 
Since failure to activate Sox9a or Sox9b expression does not appear to be the cause 
of the tpd phenotype, the ability of Sox9b mRNA to trigger downstream target gene 
activation in the absence of Trap230 activity was examined next. Since snai1b 
expression is reduced in Sox9b mutants, but is upregulated and/or its expression 
expanded rostrally in wild type embryos injected with Sox9b mRNA injection (Yan 
et al., 2005), Sox9b mRNA was injected into 1-cell stage wild type and tpd embryos, 
and its ability to up-regulate snai1b transcription in the presence or absence of 
Trap230 activity compared. While Sox9b mRNA injection leads to strong 
upregulation of snai1b expression in wild type embryos, no effect was detected on 
tpd embryos, which still show reduced snai1b expression (Figure 34). 
Similar results were obtained with foxd3 and Sox10, which also fail to respond to 
Sox9b overexpression in the absence of Trap230, although the effect observed is not 
as strong (Figure 34). Interestingly, the overexpression of Sox9b mRNA seems to 
lead to an expansion of neural plate tissue (between the two neural crest expression 
domains). However, such a function has so far not been described for Sox9 and the 
presumptively expanded tissue of Sox9b-mRNA-injected embryos in this study has 
not yet been analysed for expression of neural plate markers to confirm this 
observation. 
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Figure 34. Overexpression of sox9b-mRNA fails to rescue neural crest marker expression in tpd 
embryos. 
Expression of snai1b, foxD3 and sox10 is strongly activated in wild type embryos injected with 
sox9b-mRNA, but not in sox9b-mRNA-injected tpd embryos. Expression of these markers is reduced 
in tpd embryos. Embryos at 3 somites, dorsal view. Note concomitant expansion of neural plate in 
sox9b-mRNA injected embryos. 
Taken together, these results show that Trap230 activity is not necessary for 
transcription of Sox9 genes in most tissues, including many tissues showing a Sox9 
loss-of-function phenotype in tpd embryos. Instead, Trap230 is required for Sox9 
activity and for activation of Sox9 downstream targets. Importantly, this study not 
only confirms the data from mammalian chondrocytes, which indicated that a direct 
interaction between Trap230 and Sox9 may be required for Sox9 function (Zhou et 
al., 2002), but extends this requirement to activity of Sox9 in a large variety of 
tissues and functional contexts, moreover in a vertebrate in vivo system, showing 
genetic epistasis. 
2.4 A Sox9-independent role of Trap230 in 
forelimb development 
Since tpd mutants show a complete absence of pectoral fins in the most strongly 
affected mutants (Figure 16), it was interesting to determine how Trap230 fits into 
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the cascade of genes involved in limb induction. It is well established that both tbx5 
mutants (Ahn et al., 2002; Garrity et al., 2002; Ng et al., 2002) and fgf24 mutants 
(Fischer et al., 2003) show a similar absence of pectoral fins. Therefore the 
expression of these two genes, as well as other genes known to be regulated by them, 
in tpd mutants were examined. 
 
Figure 35. The pectoral fin phenotype of tpd mutants. 
All embryos shown are 24 hpf, dorsal views, anterior to the top. (A-D, I-L) WT; (E-H, M-P) tpd 
mutant embryos. (A, E) wnt2b expression. (B, F) tbx5.1 expression. (C, G) fgf24 expression. (D, H) 
msx-c expression. (I, M) dlx2a expression. (J, N) shh expression. (K, O) erm1 expression. (L, P) pea3 
expression. 
tbx5 expression (Tamura et al., 1999) is activated in tpd mutants, but tbx5-expressing 
cells fail to congregate towards the fin bud and stay dispersed in the lateral plate 
mesoderm (Figure 35 B, F), as in both tbx5 and fgf24 mutants (Ahn et al., 2002; 
Fischer et al., 2003; Garrity et al., 2002). fgf24 expression, in contrast, fails to be 
activated at all in tpd mutants (Figure 35 C, G). Consistent with this result, Fgf24- 
and Tbx5-dependent expression of dlx2a in the fin bud ectoderm (Akimenko et al., 
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1994; Fischer et al., 2003), and of shh in the fin bud mesenchyme (Ahn et al., 2002; 
Fischer et al., 2003; Krauss et al., 1993; Roelink et al., 1994), are not detectable in 
tpd mutants (Figure 35 I, J, M, N). Similarly, pectoral fin activation of erm1, pea3 
(Raible and Brand, 2001; Roehl and Nusslein-Volhard, 2001), and msx-c (Akimenko 
et al., 1995) fails to occur, or is strongly reduced, in tpd mutants (Figure 35 D, H, K, 
L, O, P). Since these three genes are normally activated in the absence of fgf24 
activity (Fischer et al., 2003), these results indicate that Trap230 functions upstream 
of Fgf24 activation, but downstream of Tbx5 during limb development. This is 
further confirmed by the absence of a cleithrum, a feature of tbx5 but not fgf24 loss-
of-function (Fischer et al., 2003; Garrity et al., 2002). Consistent with this proposal, 
wnt2b, which in zebrafish functions upstream of Tbx5 (Ng et al., 2002), is expressed 
normally in tpd mutants (Figure 35 A, E). 
While Sox9 activity is important for development of the fin cartilage elements, the 
initial induction, patterning, and outgrowth of pectoral fin buds is normal in 
Sox9a/Sox9b double mutants (Yan et al., 2005), indicating that the tpd fin phenotype 
cannot be attributed to loss of Sox9 activity, and that Trap230 regulates a Sox9-
independent mechanism in forelimb development. 
2.5 Other Phenotypes 
The tpd mutant has a number of interesting phenotypes, as would be expected from a 
component of the Mediator complex. However, a mutation in Trap230 is not 
immediately lethal in zebrafish, similar to what has been found in yeast, C. elegans 
and Drosophila. Homozygotes survive up to one week and many structures develop 
rather normally considering and show surprisingly specific defects. 
For completeness and with regard to possible involvement of the Sox9 pathway or 
genes/functions affected in development of the pectoral fin, the other phenotypes 
displayed by tpd mutants shall be reported here. They have not been analysed in 
detail yet, but may raise some interesting aspects. 
Beside the described neural crest, cartilage, otic placode, curled body and pectoral 
fin phenotypes, tpd mutants have defects in brain, eye formation and axon guidance 
defects as well as heart problems, slightly U-shaped somites and edemae at the 
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colon/cloaca. Whole mount in situ hybridisation studies also revealed an overall 
reduction in the expression of several fibroblast growth factors (Fgfs). 
2.5.1 Brain phenotype 
The earliest phenotype by which tpd mutants can easily be distinguished while alive 
(from around 28hpf), is when midbrain-hindbrain boundary (MHB) formation is 
retarded (Figure 36 A, B). 
Figure 36. Defective formation of 
the MHB in tpd embryos. 
(A, B) Lateral view of embryos at 
28hpf. Arrow indicates MHB, note 
impaired formation in tpd embryos. 
(C-F) Expression of fgf3 in the 
MHB is reduced in tpd embryos at 
24hpf (C, D lateral views, E, F 
dorsoposterior views). 
 
Concomittantly, expression of fgf3 in the MHB (Raible and Brand, 2001) is strongly 
reduced in tpd embryos at 24hpf (Figure 36 C-F). 
The forebrain also appears to be smaller (cf. Figures 17, 19, 36, 37) and the midbrain 
ventricle fails to inflate (Figure 37). 
Figure 37. Midbrain ventricle 
inflation. 
Brackets indicate size of the 
midbrain ventricle at 24hpf. Note 
failure to inflate and reduced size in 
tpd embryos (right panel, dorsal 
views). 
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Together with the lack of cartilage, this leads to an overall smaller head. An almost 
complete lack of touch response and hence hatching problems suggest either further 
neural disorders or muscular problems (cf. 2.5.4). 
2.5.2 Eye and axon guidance phenotypes 
The second most prominent phenotype visible in tpd embryos beside the pectoral fin 
defect is a defect in eye formation. As well as having slightly fused eyes (cyclopia), 
they are reduced in size and misshapen (Figure 38). Moreover, methylene blue 
staining of transverse cryosections reveals that lamination of the tpd retina is not 
entirely intact, i.e. the different layers cannot be distinguished properly and a 
reduction of the lens is visible (Figure 38 B, C). 
 
Figure 38. Eye phenotype of tpd 
embryos. 
(A) The eyes of tpd embryos at 4dpf 
(bottom) are smaller than in wild 
type embryos (top) and misshapen. 
Embryos are also slightly cyclopic. 
(B, C) Methylene blue stained 
transverse sections across eyes of 
embryos at 3dpf. Note the shape of 
the tpd eye, small lens and problems 
with proper lamination. GCL: 
ganglion cell layer, INL: inner 
nuclear layer, IPL: inner plexiform 
layer, L: lens, ONL: outer nuclear 
layer, OPL: outer plexiform layer, 
RPE: retinal pigmented epithelium. 
 
Seven major cell types compose the zebrafish retina. They are arranged in three 
major layers of neural retina, interconnected by two plexiform layers (Figure 38 B). 
From outer to inner layer, these are: the outer nuclear layer (ONL) containing cone 
and rod photoreceptors (Malicki, 2000); the outer plexiform layer (OPL), made up 
from synaptic connections between the photoreceptors and bipolar and horizontal 
cells (Bilotta and Saszik, 2001); the inner nuclear layer (INL) with amacrine, bipolar 
and horizontal interneurons and Mueller glia cells (Hogan, 1963); the inner 
plexiform layer (IPL) formed by dendrites of retinal ganglion cells and processes of 
bipolar and amacrine cells (Bilotta and Saszik, 2001); and finally the retinal ganglion 
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cell layer (GCL) containing retinal ganglion cells (RGCs), which transmit the visual 
signals to the brain and are the first neurons to be born in the retina (Malicki, 2000). 
 
Figure 39. Eye morphology of tpd embryos at 2 and 3dpf visualised by antibody staining. 
Sections through the eye, dorsal view. All embryos counterstained with F-actin (red) to visualise 
membranes. (A-C) zn5 antibody staining (green) at 2dpf labels ganglion cells (asterisk). Note failure 
of tpd embryos to form a proper ganglion cell layer (B, C), though some retinal ganglion cells can be 
identified in the posterior part of the retina (asterisk in B). Note also the defasciculated optic nerve 
(yellow arrow in C) exiting the retina (compare with D, G). (D-F) zpr1 antibody staining (green) at 
3dpf labels red/green double cone photoreceptors. tpd embryos form a partial outer nuclear layer (E, F 
in green) at the back of the eye, but misplaced groups of cone photoreceptors are found, especially in 
the posterior half of the eye (light blue arrows in E and F), which form rosettes (arrows an close-ups 
in F and I) and disrupt the inner plexiform layer (bright red). Note also the small lens in tpd embryos 
(compare D, E). (G-I) zpr3 antibody staining (green) at 3dpf labels rod photoreceptors. A similar 
phenotype to cone photoreceptors is seen. Note misplaced and rosette-forming groups of 
photoreceptors in H and I (light blue arrows), also disrupting the inner plexiform layer (bright red, 
compare G and I). 
To further analyse the lamination defect seen in tpd embryos, antibody stainings on 
transverse sections of the eye were performed at 2 and 3dpf. Inner surfaces of plasma 
membranes were visualised by F-actin staining with phalloidin. This confirmed the 
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reduced size of the lens and defective shape of the tpd eye (Figure 39, in red). 
Moreover, the IPL can thus be detected, since phalloidin strongly stains it at 3dpf due 
to its high plasma membrane density (Figure 39 D, G, in red). In the tpd retina, the 
IPL forms, but it does not appear as smooth and gets disrupted, especially in the 
ventroposterior half of the eye (Figure 39 E, F, H, I, in red, arrows). 
To detect whether ganglion cells are present in the tpd retina at 2dpf, zn5 antibody 
staining was performed. This shows that the GCL is strongly affected in tpd mutants 
and not formed correctly (Figure 39 A-C, in green, asterisks). RGCs are either not 
visible at all or occur as a small disorganised group in the ventroposterior retina 
(Figure 39 B-C, in green), where they normally start to form (Hu and Easter, 1999). 
The ONL was visualised by labelling of either red/green cone photoreceptors with 
zpr1 antibody or rod photoreceptors with zpr3 antibody at 3dpf (Figure 39 D-I, in 
green). Similar to the IPL, the ONL in tpd embryos does form, however, is not as 
smooth in shape as in wild type embryos and again the defects occur mainly in the 
ventroposterior part of the retina (compare Figure 39 D and G with E, F, H and I, in 
green). Notably, photoreceptor cells are found ectopically throughout the 
ventroposterior half of the tpd eye, disrupting the IPL, among other layers (Figure 
39, E, F, H and I, in green, arrows). Most interestingly, these photoreceptors seem to 
aggregate in small groups and form rosettes (Figure 39 F, I, arrows and close-ups), 
seemingly around a strongly F-actin expressing centre, reminiscent of the n-cadherin 
mutant retina phenotype in zebrafish (Malicki et al., 2003; Pujic and Malicki, 2001). 
Another phenotype visible in retinal sections is the defasciculation of the optic nerve 
exiting the tpd retina in comparison to wild type embryos (compare Figure 39 D, G 
with C, yellow arrow). This is further confirmed by anti-acetylated tubulin antibody 
stainings of the axons (Devine and Key, 2003) in 2dpf old embryos (Figure 40, 
asterisks), which moreover reveal a defect in guidance of the retinotectal axons, 
which misproject anteriorly towards the anterior commissure in tpd embryos (Figure 
40, arrow). Whether this is accompanied by a misprojection within the optic tectum, 
remains to be seen. 
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Figure 40. Axons stained with anti-acetylated tubulin antibody at 2dpf. 
In tpd embryos, retinotectal axons misproject anteriorly (arrow) and optic nerves do not form orderly 
fascicles (asterisks). 
As retinotectal axons are guided to the diencephalon along the optic stalk, a 
transitory structure, which is lost in wild type embryos by 3dpf (Figure 41 D), it was 
interesting to look at this in tpd embryos. Indeed, the optic stalk in tpd embryos fails 
to degenerate (Figure 41 E, arrows) and persists at 3dpf instead, disrupting the RPE, 
so that the choroid fissure in the ventral eye does not close, leading to a coloboma 
phenotype in tpd embryos, which is even stronger in Trap230 morphants (Figure 40 
A-C). 
 
Figure 41. Loss of Trap230 leads to formation of a coloboma in the eye. 
(A-C) Eyes at 4dpf (MO: Trap230 morphants). Note failure of the choroid fissure (ventrally) to close. 
(D, E) Methylene blue stained sections of embryos at 3dpf at the level of the eye. The optic stalk 
(arrows) fails to degenerate in tpd embryos. 
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Concomittantly, expression of pax2a, a marker for the optic stalk, which is also 
required for its development (Macdonald et al., 1997), is still present in tpd embryos 
at 52hpf, while it is absent from the optic stalk expression domain of wild type 
embryos at that age (Figure 42). 
Figure 42. Expression of 
pax2a in the optic stalk. 
At 52hpf, pax2a expression 
in the optic stalk persists in 
tpd embryos, while it is gone 
in wild types (ventral view). 
 
Expression of fgf3 is downregulated in the tpd optic stalk at 28hpf (Figure 43), a 
feature that has been reported to concur with expansion of the optic stalk tissue 
(Walshe and Mason, 2003). 
Since the ventral eye in tpd embryos appears to be most strongly affected, judging 
from the severe coloboma and the disorganised lamination in the ventroposterior 
retina, fgfs which are expressed in the ventral eye were analysed by wholemount in 
situ hybridisation. This revealed that expression fgf24 and fgf10 in the tpd ventral 
retina is lost (Figure 43). Of note, expression of fgf10 in the tpd nasal placode at 
24hpf is also lost. 
 
Figure 43. Expression of fgfs in the eye of tpd embryos. 
At 24hpf, expression of fgf24 (lateral view) and fgf10 (dorsal view) in the retina (ret, arrow) is 
reduced. Expression of fgf3 at 28hpf is lost in the optic stalk (os) of tpd embryos (lateral view). 
Reduced expression of fgf10 in the posterior retina of tpd embryos (arrow) at 30hpf (lateral view). 
Note also loss of fgf10 expression in the tpd nasal placodes (topmost expression domain). 
RESULTS  
 
 
63
Since the reduced expression of markers for the ventral retina suggested a possible 
dorsoventral patterning defect, expression of tbx5, which is a known dorsal marker in 
the retina (Lupo et al., 2005), was studied in tpd embryos. There, it was found to be 
strongly reduced at 24hpf (Figure 44), indicating that there is no additional 
expansion of dorsal fates beside the optic stalk persistence at the expense of ventral 
tissues. 
Figure 44. Expression of 
tbx5 in the eye. 
At 24hpf, tbx5 expression in 
the eye of tpd embryos is 
reduced (dorsal view). Note 
also the reduced expression 
in the heart domain (below 
the left eye) of tpd embryos. 
 
2.5.3 Heart and circulation phenotype 
The tpd embryos show a heart phenotype reminiscent of tbx5 mutants (Garrity et al., 
2002), with variably small/dysmorphic ventricle, as (Deborah Yelon, personal 
communication, Figure 45 B). The heart forms severe edemae, the tube fails to loop 
and forms a thin string instead (Figure 45 A). As seen in Figure 44, expression of 
tbx5 in the tpd heart domain seems to be reduced at 24hpf. 
 
Figure 45. Heart phenotype of 
tpd embryos. 
(A) The heart of tpd embryos at 
3dpf has a string-like shape 
(arrow) and shows a severe 
edema (lateral view). (B) 
Staining of the heart courtesy of 
Deborah Yelon. tpd embryos 
show a variably 
small/dysmorphic ventricle (v, 
frontal view). a: atrium. 
 
The heart rate of tpd embryos at 3dpf is reduced compared by 37% (n=32) in tpd24970 
and by 55% (n=25) in tpd25870 compared to wild type embryos (150-160 beats per 
minute, n=20). Bradycardia is another feature of Tbx5 loss-of-function (Garrity et 
al., 2002). Moreover, blood islands form in the embryo (not shown). 
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2.5.4 Somite phenotype 
A lack of touch response and motility was observed in tpd embryos, indicating a 
possible neuromuscular problem. Somites in tpd mutants appear slightly U-shaped 
instead of having the wild type V-shape (not shown). This is a classical feature of 
defects in the Hedgehog pathway (Ingham and Kim, 2005; van Eeden et al., 1996) 
and has been related to function of the repressive transcription factor Prdm1 
(Baxendale et al., 2004; Roy et al., 2001). Alternatively, since sox9a is expressed in 
the somites, its function there may relate to the tpd muscle phenotype. 
2.5.5 Overall downregulation of Fgf signalling and gut 
phenotype 
The tpd mutant shows reduced expression of fgfs and downstream genes (erm1, 
pea3) (Roehl and Nusslein-Volhard, 2001) not only in the pectoral fin buds (Figures 
35 C, G, K, L, O, P and 46), but also in other structures including the eye (Figure 
43), midbrain-hindbrain-boundary (Figure 36 C-F), branchial arches (Figure 47), 
nasal placodes (Figure 43) and midgut (Figure 48 A, B). Especially fgf24 is absent in 
all expression domains (Figures 35 C, G, 43, 47, 48 A, B). This suggests that further 
investigation of the role of Trap230 in Fgf regulation may be interesting. 
Figure 46. Expression of 
fgf10 is reduced in the fin 
bud of 30hpf tpd embryos 
(dorsal view). 
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Figure 47. Expression of fgfs 
in tpd branchial arches. 
Expression of fgf24 at 24hpf, 
fgf3 at 28hpf and fgf10 at 
30hpf is reduced in branchial 
arches of tpd embryos 
(dorsal views). 
 
Figure 48. Gut phenotype of 
tpd embryos. 
(A, B) Expression of fgf24 in 
the gut (black arrow, dorsal 
view) is reduced in tpd 
embryos at 24hpf. (C) An 
edema can be found at the 
colon/cloaca of many tpd 
embryos at 3dpf (lateral view, 
red arrow). 
 
Apart from the lack of fgf24 expression (Figure 48 A, B) in the midgut, tpd embryos 
show another gut phenotype, namely the development of a strong edema at the 
colon/cloaca. 
  
3 DISCUSSION 
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3.1 tpd encodes a mutation in the Mediator 
complex component Trap230 
The tpd mutant was found to encode a splice-site mutation in a zebrafish homologue 
of the conserved Mediator complex component Trap230. The Mediator complex is a 
general coactivator for most RNA pol II driven transcription in eukaryotes 
(Bjorklund and Gustafsson, 2004). While some of its up to 30 components are 
conserved from yeast to human, others have so far been identified in only some of 
the organisms (Sato et al., 2004). The Trap230 subunit is one of the conserved 
components, indicating an important function. The zebrafish Trap230 protein is 
presumably 2155 amino acids long. This is an estimation, since the sequence of the 
first three exons of the gene is so far only predicted and cannot be identified in any 
of the zebrafish sequence databases nor has been possible to clone so far. 
Considering the high degree of conservation between the gene structures and protein 
sequences of Fugu rubripes and Homo sapiens, however (cf. appendix Figures 51, 
52, 56), a high similarity of the zebrafish sequence and gene structure can be 
postulated for the N terminus encoded by the first three exons. 
Similar to C. elegans and Drosophila Trap230, the expression in zebrafish is found 
to be maternal and ubiquitous (Treisman, 2001; Wang et al., 2004a; Zhang and 
Emmons, 2000). In zebrafish, the only Mediator components cloned so far are cdk8 
and part of cycC (Brabazon et al., 2002), and they appear to be expressed similarly, 
although, of note, the published pictures seem to show no expression of cdk8 in the 
pectoral fin buds. 
The Trap230 protein consists of four domains: a leucine-rich domain (L) comprising 
the first 450 amino acids of the N terminus, followed by a leucine-and-serine-rich 
domain (LS) up to amino acid 1590, a proline-, glutamine-, and leucine-rich domain 
(PQL) of 424 amino acids length and finally a C-terminal glutamine-rich domain 
(OPA) starting at amino acid 2015. 
The OPA (opposite paired) domain was originally identified in Drosophila proteins. 
It consists of (CAX)n repeats in the cDNA encoding poly-glutamine (Q) stretches, 
where X stands for either G or A and n is ≤30. They occur in developmentally 
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regulated genes, e.g. in Notch, also in mice, where the first description was actually 
that of the Trap230 OPA domain (Duboule et al., 1987). Yet there, in contrast to the 
fly, they are not apparent in homeobox transcription factors. They have been 
speculated to function as hinges/spacers or protein-interaction domains. (Duboule et 
al., 1987; Wharton et al., 1985) 
The conserved Trap230 OPA domain (Ito et al., 1999) has been described as 
essential for Wnt-dependent but not Ras-dependent activity in C. elegans (Moghal 
and Sternberg, 2003). In human cells, the domain has shown activation functions in 
Gal4-protein fusion assays. However, it was not reported which genes were tested 
(Ito et al., 1999). 
Such CAG repeats as in Trap230 have been associated with many hereditary 
diseases, most notably neuropsychiatric disorders (Ito et al., 1999). Susceptibility to 
several neuropsychiatric disorders including autism, depression, schizophrenia, X-
linked dementia and hypothyroidism in humans has controversially been attributed to 
a dodecamer insertion in the Trap230 OPA domain (Beyer et al., 2002; DeLisi et al., 
2000; Friez et al., 2000; Hung et al., 2003; Kirov et al., 2003; Michaelis et al., 2000; 
Philibert et al., 2002; Philibert et al., 2001; Sandhu et al., 2003; Spinks et al., 2004). 
Of note, a possible use for zebrafish in studying the causes of autism has been 
proposeded, and Trap230 may be suitable as a possible object for such studies 
(Tropepe and Sive, 2003). 
The link to hypothyroidism is especially interesting, since other Mediator 
components including Med1 - which in C. elegans has a similar Wnt-dependent 
repressor phenotype to Trap230 (Zhang and Emmons, 2000; Zhang and Emmons, 
2001) - are known to mediate ligand-dependent nuclear hormone receptor signalling 
including that through thyroid hormones (Ito et al., 2000). Moerover, maternal 
thyroid deficiency during pregnancy can have an adverse effect on the subsequent 
neuropsychological functioning of the offspring (Haddow et al., 1999). 
The Trap230 protein contains two overlapping LXXLL motifs (Ito et al., 1999) near 
the N-terminus, known as nuclear receptor recognition motifs (Voegel et al., 1998) in 
various coactivators including Med1. This motif interacts with nuclear receptors in 
vitro, but has only a modest effect on nuclear receptor function in cells (Ito et al., 
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2002). Fittingly, Trap230 has been described to be associated with androgen receptor 
in the presence of testosterone (Wang et al., 2002). 
Unlike for Sox9, no subfunction partitioning appears to have occurred for the 
members of the Mediator kinase subcomplex in zebrafish. In the Zv5 genome 
assembly, only one homologue each for Trap230, Trap240, Cdk8 and CycC could be 
identified. However, this also means that Med12L and Med13L still remain to be 
found, since they should have come up in such a homology search. Nevertheless, the 
fact that it took several years to identify homologues for Mediator subunits in several 
species shows that this will not always be easy, as structure may be conserved rather 
than sequence. 
Still, the severe phenotype of tpd mutants makes it unlikely that there should be 
redundancy, although the even stronger morphant phenotype might hint to another 
Trap230-like gene being targeted and knocked down. Yet, morpholino 
oligonucleotides are known to be highly sequence specific, with a 2 or 3bp mismatch 
already abolishing their function – so another target sequence would perchance have 
to be essentially identical to the here targeted exon26-intron26 boundary of Trap230. 
Considering the high level of polymorphism in the zebrafish genome, this is highly 
unlikely. 
However, the strong Trap230 phenotype may be argued not to be sufficient proof of 
no other Trap230-like gene in zebrafish, since loss of one may be enough to abrogate 
the function of another, as is seen in the case of Trap230 and Trap240 in Drosophila 
and C. elegans. In these two organisms, one might also suspect at least homologues 
of Med12L and Med13L, but still the strong phenotypes visible for Trap230 or 
Trap240 mutants are there, suggesting the two novel subunits will have non-
redundant functions. This may also be the case for any Trap230-like gene still out 
there in the zebrafish genome – which, as has to be remembered, is not in a good 
enough state yet anyway to entirely exclude sequence homologues to be found 
eventually. 
Possibly, a comparative microarray analysis of invertebrate and vertebrate Trap230 
mutants may elucidate whether the functions are entirely similar or whether essential 
invertebrate Trap230 functions are still intact in tpd mutants. Yet, already the fact 
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that vertebrate-specific structures as neural crest and epithelial placodes are affected 
in tpd embryos, makes the comparison more difficult. 
Interestingly, The N-terminus of Trap230 has been found to interact with the 
BEACH domain of the lysosomal trafficking regulator protein (LYST), whose 
mutation causes Chediak-Higashi syndrome, an inherited immunodeficiency disease, 
characterised by giant lysosomes and impaired leukocyte degranulation (Tchernev et 
al., 2002). Unexpectedly, this may suggest a so far undescribed prevalence of 
Trap230 in the cytoplasm, since LYST is a cytosomal protein. 
3.2 Interaction of Sox9 + Trap230 
3.2.1 The trapped mutation shares many phenotypes 
with Sox9 mutants 
Although the Mediator complex functions as a general coactivator for most RNA Pol 
II driven transcription in eukaryotes, it seems that different parts of Mediator 
regulate distinct sets of genes by interacting with specific DNA-binding 
transcriptional activators. In this study, zebrafish Trap230 was shown to be required 
for Sox9 activity. trapped, a novel Trap230 mutant, was isolated, and the 
characterisation of this mutant shows that it strongly resembles the Sox9a/Sox9b 
double mutant in many different tissues. 
The phenotypes shared between tpd and Sox9a/Sox9b mutants include the complete 
absence of craniofacial cartilages, the absence or strong reduction of otic placodes, 
the absence of iridophores, the presence of expanded melanophores, and the presence 
of a curly-down body axis and heart edema. The absence of craniofacial cartilages 
correlates with strongly reduced col2a1 expression in this region. col2a1 is a direct 
target of transcriptional activation by Sox9 (Bell et al., 1997; Lefebvre et al., 1997; 
Ng et al., 1997; Zhou et al., 1998) and is strongly reduced in Sox9a/Sox9b mutants 
(Yan et al., 2005), therefore raising the possibility that Trap230 functions as a 
transcriptional coactivator participating in the regulation of Sox9 targets such as 
col2a1. 
In trunk neural crest, tpd mutants show reduced expression of snai1b, foxd3 and 
sox10, which is also observed in zebrafish Sox9b mutants (Yan et al., 2005). 
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Expression of the postmigratory neural crest marker dlx2a in tpd and Sox9a/Sox9b 
mutants is only slightly reduced, especially in the posterior branchial arches. This 
indicates that cranial neural crest cells are specified correctly, although the 
population of dlx2a expressing cells is smaller than usual. Migration of cranial neural 
crest cells also starts normally, as is the case in Sox9a/Sox9b double mutants and 
Sox9 mutants in chicken, frog or mouse. 
However, Sox9 in mouse and Sox9b in zebrafish are known to act as survival factors 
for neural crest cells. Accordingly, both zebrafish Sox9b and Sox9a/Sox9b double 
mutants and mouse Sox9 mutants show elevated apoptosis in pre-and post-migratory 
neural crest cells, which is also observed in tpd mutants. 
This eventually leads to a loss of neural crest derived structures in Sox9 mutants. One 
instance of this is the absence of DRG neurons, which has been previously described 
in mouse Sox9 mutants (Cheung et al., 2005) and was again confirmed in tpd 
mutants. 
Otic placodes are also Sox9-dependently induced. Therefore, it is not surprising to 
find that loss of either Sox9a/Sox9b or Trap230 function leads to smaller otic 
vesicles and otoliths, which in the strongest cases are entirely absent. Interestingly, 
tpd mutants show three otoliths instead of two in some cases. The only instance 
where to my knowledge occurrence of three otoliths has been described, is a 
zebrafish knockdown of the runx1 gene (Kalev-Zylinska et al., 2002). Otherwise, 
Runx1 has been mainly described as a hematopoietic factor. Besides, a role in 
neurogenesis has been suggested. 
Expression of fgf3 and fgf8 during late gastrula stages cooperatively induces otic 
placode formation and is required for expression of pax8 and pax2.1 in preplacode 
tissue (Phillips et al., 2001). Also, loss of Sox9 has been correlated with loss of pax8 
expression in the presumptive otic placodes (Saint-Germain et al., 2004). Indeed, tpd 
mutants show a similar loss of pax8 and reduced pax2.1 expression. 
While some of the phenotypes can be explained by loss of Sox9b activity only, 
especially the cartilage and ear phenotypes observed in tpd are as strong as otherwise 
only found in Sox9a/Sox9b double mutants (Yan et al., 2005), suggesting activity of 
both genes is lost in tpd mutants. 
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These results indicate that Trap230 is crucial for Sox9 activity, and is required for 
both Sox9a and Sox9b in zebrafish, suggesting that the split of the ancestral Sox9 
gene into two teleost copies did not affect their dependence on Trap230 activity. My 
results suggest that Trap230 specifically interacts with Sox9, since most tpd 
phenotypes can be explained by disrupted Sox9 activity. However, Trap230 clearly 
also functions in Sox9-independent events, such as limb induction. It therefore 
remains to be seen how many different vertebrate transcription factors depend on 
Trap230. The present study has focused on the role of zygotically expressed trap230, 
and it may be that maternally expressed trap230 is required for distinct transcription 
factors. 
3.2.2 The role of Trap230 in Sox9 activity 
Two possible scenarios could explain the apparent similarity between the tpd and 
Sox9a/Sox9 mutant phenotypes: Trap230 could either be upstream of Sox9a and 
Sox9b and necessary for the transcriptional activation of these two genes, or else it 
could be a competence factor necessary for Sox9-dependent transcription through 
interaction with the Mediator complex. 
Since transcription of Sox9a and Sox9b is activated normally in most tissues in the 
absence of Trap230 activity, this suggests that the activity of Sox9 is disrupted in 
these mutants. The exception to this are the pectoral fin buds, where both Sox9a and 
Sox9b fail to be expressed. However, the fin development defect observed in tpd 
mutants is very early, the disruption taking place already at the bud initiation stage, 
while the role of Sox9a and Sox9b in the limb buds is a later one, namely during 
chondrogenesis. Since tpd fin buds never reach that stage, it is not surprising that in 
this case Sox9 expression should be lost and Trap230 function be upstream of Sox9. 
Consistent with the proposal that Trap230 acts as a competence factor for Sox9 
rather than as a transcriptional regulator of Sox9 expression, injection of Sox9b 
mRNA can trigger target gene activation in wild type embryos, but not in tpd 
mutants. Consequently, Sox9 activity appears to require the presence of at least part 
of the Mediator kinase subcomplex. 
Similar to the situation in Sox9a/Sox9b double mutants and mouse Sox9 mutants, 
col2a1 expression persists in some expression domains in tpd embryos (Ng et al., 
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1997; Yan et al., 2005). Since col2a1 is known to be directly activated not only by 
Sox9 but in cooperation with Sox5 and Sox6 (Ng et al., 1997; Zhou et al., 1998), this 
may explain the residual expression of col2a1 in both Sox9a/Sox9b and tpd mutants. 
A similar cooperation has been observed for the aggrecan gene, suggesting that Sox 
genes coordinately affect the composition of the extracellular matrix (Wegner, 1999). 
Importantly, the residual col2a1 expression in tpd embryos indicates the specificity 
of the interaction between Sox9 and Trap230, since the tpd mutant does apparently 
not affect the activities of Sox5 and Sox6 in this context, but specifically that of 
Sox9. 
These results are in agreement with the finding that the transactivating domain of 
human SOX9 protein binds directly to TRAP230 in vitro, both in a yeast two-hybrid 
assay, and in a GST pull-down assay (Zhou et al., 2002). Furthermore, Zhou et al. 
also showed that TRAP230 co-immunoprecipitates with SOX9 from a human cell 
line, thus demonstrating that this binding also occurs in vivo. The PQL domain of 
TRAP230 is both necessary and sufficient for this interaction with SOX9. The PQL 
domain, which is located near the C-terminus, is deleted both in tpd mutants and in 
Trap230 morphants, and therefore suggests these truncated forms are unable to bind 
Sox9. The in vivo results of this study thus confirm and extend the significance of 
the regulatory interaction between Trap230 and Sox9. 
Other regions of Sox9 could also contact the TRAP complex. The PQA motif 
(Wagner et al., 1994) adjacent to the Sox9 TA domain is known to contribute to its 
function. Nevertheless, this region is poorly conserved in Sox9 between different 
species and because of its PQA-rich sequence may only work as a flexible hinge for 
the TA-domain (Zhou et al., 2002). 
The study of (Zhou et al., 2002) also found the PQL domain of TRAP230 to interact 
with the transactivating domains of human SOX8 and SOX10, the two other 
members of the E group of SOX transcription factors. This may indicate a similar 
function of Trap230 for the activities of Sox8 and Sox10 and remains to be tested. 
A general Trap230 function for Sox10 activity can however be excluded, since 
zebrafish Sox10 mutants lack all melanophores, as tpd embryos clearly do not 
(Dutton et al., 2001). 
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Interestingly, both Sox9 and Trap230 have been suggested to be regulated by Wnt 
and through PKA phosphorylation (Harley et al., 2003), suggesting they might be 
regulated in parallel on top of Trap230 being required for the activity of Sox9. 
Moreover, Sox9 is involved in the induction of migratory neural crest through 
modulating cadherin expression (Cheung and Briscoe, 2003), indicating a possible 
involvement in the cell affinity defects observed in tpd mutants, like failure of 
pectoral fin bud cells to migrate into a coherent patch, or the axon guidance and 
photoreceptor defects. 
C. elegans Trap230 has been described as modulator of β-catenin stimulated Wnt 
pathway activity (Zhang and Emmons, 2000). This could reinforce the capacity of 
different Sox proteins to interfere with TCF/LEF binding to β-catenin and modulate 
Wnt signalling (Zorn, Williams 1999 XSox3; Takash, Poulat, Mattei 2001 Sox7). 
The binding of Sox9 at enhancers and concurrent bending of the DNA may facilitate 
the interaction of Sox9 with the promoter-bound Mediator and allow context-
dependent coregulation by bringing other enhancer-bound factors close to the 
Mediator machinery (Pevny and Lovell-Badge, 1997). 
Importantly, my findings not only support the previous data suggesting an interaction 
of Trap230 and Sox9 but extend it, indicating that Trap230 and Sox9 in vivo not only 
interact in chondrogenesis but also in all other tissues, reflecting in vivo Sox9 
activity. Besides, the fact that some of the phenotypes seen in tpd reflect interference 
with the Sox9a/Sox9b double activity rather than that of only one of them (eg the 
chondrogenesis defect), indicates that this interaction has survived the division and 
subfunctionalisation into two Sox9 proteins. Moreover, the fact that the C-terminal 
sequences containing the transactivating domain of Sox9a and Sox9b are reasonably 
different (Chiang et al., 2001), nevertheless not abolishing the functional interaction 
with Trap230, supports the idea that this interaction is structure rather than sequence 
specific, a possibility that has also been postulated by (Zhou et al., 2002) in view of 
the fact that the TA domains of human SOX8 and SOX10, the other two E box 
transcription factors, also show in vitro interaction with the Trap230 PQL domain, 
despite their sequence dissimilarities. Sox genes from other groups, which 
presumably will have different 3D structures, show no such interactions (Zhou et al., 
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2002). Unfortunately, Sox5 and Sox6, the two prime candidates for interaction with 
Sox9 in chondrogenic regulation, have not been tested. 
One possible scenario for the function of Trap230-Sox9 interaction in transcriptional 
activation (at least in the case of Col2a1, my study has demonstrated Trap230 to be a 
direct coactivator rather than a corepressor) could be similar to the scenario observed 
in activation of the retinoic acid pathway, where PARP-1 interacts with Cdk8 (Pavri 
et al., 2005) to mediate RA-induced activity – which actually comes about through 
uncoupling the kinase module from the core complex and hereby sterically allowing 
for RNA Pol II binding, resulting in constitutively active RA signalling activity if 
Cdk8 – and through this presumably the integrity of the kinase subcomplex – is lost. 
This would also be in accordance with the dominant-negative activity of an 
ectopically supplied Trap230 PQL/OPA domain for Sox9 (Zhou et al., 2002). If this 
truncated protein cannot interact properly with endogenous members of the kinase 
subcomplex, only endogenous Trap230 will be part of the complex and binding of 
Sox9 to the ectopic Trap230 will not disrupt endogenous Mediator structure, 
resulting in its dominant negative activity. 
Another possibility would be that the interaction of Sox9 with Trap230 leads to a 
conformational change, but without detaching the kinase subcomplex from the rest of 
Mediator. This seems to be the case, as it was possible to purify an entire Mediator 
complex (including core components) through a Sox9 interaction. Nevertheless, 
there are two caveats in the approach used – one is the fact that thyroid hormone 
receptor (TR) is still bound to the purified Mediator complex, which could positively 
be viewed as steric non-inhibition of Sox9 and TR binding together to the Mediator 
complex, or negatively as TR holding together the complex artificially and 
overriding a possible disengagement of parts that could be the normal result of Sox9 
interaction. The other possibility that cannot be ruled out is that Sox9 can also bind 
to other parts of the Mediator complex, possibly also of the core, and it is this 
interaction that has actually been monitored by this assay. 
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3.2.3 Trap230 as a transcriptional co-regulator during 
vertebrate development 
The Trap230/Med12 and Trap240/Med13 subunits are part of a Mediator 
subcomplex that also contains Cdk8 and CycC (reviewed in Bjorklund and 
Gustafsson, 2005; Malik and Roeder, 2005). This module is variably present in the 
Mediator complex, and its presence correlates with transcriptional repression in yeast 
(Holstege et al., 1998; Samuelsen et al., 2003; Spahr et al., 2003) and in mammalian 
cells (Naar et al., 2002; Wang et al., 2001), leading to a model in which recruitment 
of Mediator containing this module represses transcription, whereas Mediator devoid 
of this module activates transcription. The role of this module may be more complex, 
however, since Cdk8 is linked to the positive regulatory effect of Mediator on pol II 
in Drosophila (Park et al., 2001a), and activation of the Notch signaling pathway 
leads to the recruitment of Cdk8 and CycC to a Notch target promoter for Notch 
degradation and turnover (Fryer et al., 2004). Mediator containing this module may 
thus be involved both in transcriptional activation and repression. In C. elegans, 
Trap230 is required for transcriptional repression (Yoda et al., 2005), while in 
Drosophila it is not yet clear if Trap230 participates in transcriptional repression or 
activation (Janody et al., 2003). 
My results are consistent with a role for Trap230 in transcriptional activation by 
Sox9. Thus col2a1, a direct transcriptional target of Sox9 activation (Bell et al., 
1997; Lefebvre et al., 1997; Ng et al., 1997; Zhou et al., 1998), shows strongly 
reduced expression in tpd mutants, and the same is true of genes known to be 
downstream of Sox9 signaling in neural crest and otic placodes. Furthermore, 
injection of Sox9b mRNA can upregulate snai1b, foxd3 and sox10 expression in wild 
type, but not in tpd mutant embryos. Consistent with this proposal, overexpression of 
a Trap230 subfragment, which only contains the Sox9-binding domain, acts as a 
dominant negative and blocks the ability of Sox9 to activate target gene expression 
in vitro, suggesting that binding of full-length Trap230 is crucial for transcriptional 
activation by Sox9 (Zhou et al., 2002). Alternatively, for targets that are not known 
to be direct, Sox9 may achieve some of its activation effects indirectly, by repressing 
the transcription of a repressor. In that case, Trap230 might mediate such an effect as 
a corepressor while in the case of col2a1 it must surely act as a coactivator. 
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3.3 The role of Trap230 in forelimb initiation 
This study has shown that tpd mutants fail to form pectoral fin buds, and lack all 
pectoral fin structures. Since Sox9 signaling is not involved in the early steps of limb 
development (Yan et al., 2005), this is a clear example of Trap230 involvement in a 
Sox9-independent pathway. 
The data indicate that Trap230 functions upstream of Fgf24 during limb 
development. fgf24 expression fails to be activated in tpd mutants, as do the fgf24-
dependent genes dlx2 and shh. Also, several genes that are activated independently 
of Fgf24 in the limb bud mesenchyme, including msx-c, erm1, and pea3 (Fischer et 
al., 2003), are strongly reduced or absent in tpd embryos, thus further indicating an 
event upstream of Fgf24 is blocked in the absence of Trap230 activity. 
fgf24, dlx2 and shh are all downstream of Tbx5 in the limb signalling cascade 
(Fischer et al., 2003). Since tbx5 expression is activated in tpd mutants, the data of 
this study suggest that Trap230 is required for an event between Tbx5 and Fgf24 
activation. Similarly, the heart and eye phenotypes observed in tpd embryos may also 
be related to loss of Tbx5 activity during their development. In the simplest scenario, 
Trap230 might bind directly to Tbx5, and function as a coregulator, similar to its 
interaction with Sox9. Alternatively, it could bind to a transcription factor acting 
downstream of Tbx5. Future experiments will help to distinguish between these 
possibilities. 
Tbx5 has been proposed to act directly on the promoters of human and mouse fgf10 
(Ng et al., 2002). In zebrafish, however, fgf24, a member of the fibroblast growth 
factor family for which a mammalian ortholog still waits to be identified (Draper et 
al., 2003), has been placed in the early limb outgrowth signalling cascade between 
Tbx5 and Fgf10 (Fischer et al., 2003; Norton et al., 2005), suggesting that the fgf24 
promoter is a worthwhile candidate for Tbx5 binding site analysis. A direct role for 
zebrafish Trap230 mediating Tbx5 function on this promoter seems plausible. 
Depending on whether a mammalian fgf24 ortholog can be identified, this may point 
to a specialised role of Trap230 in zebrafish and thus to the versatility of a highly 
conserved pan-eukaryotic complex such as Mediator. 
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While tbx5-expressing cells in zebrafish tpd and tbx5 mutants fail to migrate towards 
the mesenchymal core of the developing limb bud, they nevertheless occasionally 
turn perpendicular to the basement membrane, but do not proliferate further (Garrity 
et al., 2002) and this study). This effect of missing Tbx5 activity has not been 
confirmed in the mouse, though (Agarwal et al., 2003; Ahn et al., 2002). It is likely 
mediated through Fgf24, as the same effect is observed in fgf24 mutants (Fischer et 
al., 2003). A general role has been proposed for T-box family genes in cell-
autonomously mediating cell migration, possibly through changes in adhesive 
properties (Griffin et al., 1998; Ho and Kane, 1990; Russ et al., 2000; Wilson et al., 
1995). Trap230 has also been implicated in cell affinity changes in Drosophila, C. 
elegans and yeast, suggesting a possible cooperation. 
T-box genes, like Hox genes, have been proposed to often work within gene 
networks comprised of related family members (Goering et al., 2003). Moreover, 
Tbx5 in the heart has been shown to interact with the Nkx2.5 homeodomain for 
direct transcriptional activation of targets like atrial natriuretic factor and Connexin 
40 (Cx40, (Fan et al., 2003). Cx40 is a gap junction component that has recently also 
been reported as a direct target of Tbx5 in the mouse limb (Pizard et al., 2005). 
There, it is required at a later stage, during bone formation. Interestingly, this is 
mediated through modulating Sox9 expression (Pizard et al., 2005). Whether there is 
another function of Cx40 in early zebrafish pectoral fin development, possibly 
mediating Tbx5 dependent cell migration in parallel to or downstream of Fgf24, 
remains to be seen. A modulation of gap junctions could well be implicated in this 
process. 
The connection of tbx5 to bone formation indicates a possible pathway by which 
formation of the cleithrum in the pectoral girdle of both tpd and tbx5 mutant embryos 
is lost (or significantly reduced) in contrast to mutations in sox9a/sox9b or fgf24 
(Fischer et al., 2003; Yan et al., 2005). 
Cooperation with other transcription factors is a common theme for both Sox9 and 
Tbx5. Thus, should Trap230 prove to be directly required for Tbx5 function, 
Trap230-Mediator may be envisaged as an integrating platform for combined 
transcription factor activity. Whether transcription factors bound to Sox9 and Tbx5 
would then also interact directly with the Mediator complex, and with which 
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component, remains speculative. The size of Trap230 as the second-largest 
component of the complex may already permit simultaneous binding of several 
transcription factors. Protein-protein interaction sites outside the Sox9-interacting 
PQL domain remain still to be identified. 
In tpd embryos, expression of wnt2b upstream of Tbx5 in pectoral fin induction is 
normal. While this requirement for Wnt signalling in zebrafish is well established 
(Ng et al., 2002), experiments in mouse failed to confirm it (Agarwal et al., 2003; 
Galceran et al., 2001; Yamaguchi et al., 1999). In chick, on the other hand, a 
dominant negative form of Tbx5 lead to reduced wnt2b expression, while inhibition 
of canonical Wnt signalling did not affect Tbx5. This suggests a role for Tbx5 in 
maintenance of Wnt signalling (Takeuchi et al., 2003). Nevertheless, the lack of 
Tbx5 activity in tpd pectoral fins constitutes a modulation of a Wnt signalling 
downstream effect. This is consistent with a role for Trap230 as Wnt signalling 
modulator reported in Drosophila and C. elegans. 
3.4 Other phenotypes 
3.4.1 Brain and muscle phenotypes 
The brain of tpd embryos shows several defects: the forebrain is reduced, the 
midbrain ventricle fails to inflate and the MHB is not specified properly. 
These defects may, at least in part, again be mediated by loss of Sox9 activity, since 
sox9a is expressed in the MHB and forebrain (both diencephalons and 
telencephalon), sox9b in the ventral midbrain, and both sox9a and sox9b are 
expressed in the epiphysis and hindbrain at 24hpf (Chiang et al., 2001; Yan et al., 
2005). Moreover, patients suffering from campomelic dysplasia due to a defect in 
Sox9, have also been described to display brain abnormalities (Houston et al., 1983). 
Wnt signalling is necessary for proper MHB specification in zebrafish. This is a 
function conserved among vertebrates (Buckles et al., 2004). With regard to the 
proposed and known functions of Sox9 and Trap230 in Wnt signalling mentioned 
above, this may add to explanation of the phenotype. 
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3.4.2 Eye and axon guidance phenotypes 
The eye phenotype of tpd embryos is the most prominent one beside that in the 
pectoral fins. They are overall reduced in size and misshapen, plus they are closer 
together than normal anteriorly (slight cyclopia), which may correlate with the 
observed reduction of forebrain tissue (cf. 3.4.1). 
Derivatives of the eye premordium (optic stalk, neural retina, retinal pigmented 
epithelium) and patterning events responsible for their formation are determined 
along the dorsoventral axis of the eye (Chow and Lang, 2001). tpd mutant embryos 
show severe defects in dorsoventral patterning. Specifically, ventral, and to some 
extent also dorsal retina tissue is reduced, while the optic stalk fails to degenerate 
and is therefore expanded relative to the rest of the eye. This can not only be visually 
assessed by the coloboma which tpd embryos show, but also molecularly, by in situ 
hybridisation. While expression of tbx5 as a marker for the dorsal retina prior to 
retinal lamination (Begemann and Ingham, 2000; Lupo et al., 2005) and fgf24 and 
fgf10 as markers for the ventral retina are lost, expression of pax2a in the optic stalk 
(Lupo et al., 2005) persists overly long, while expression of fgf3 in the same domain 
(Walshe and Mason, 2003) is prematurely lost. All this is consistent with the 
observed tpd phenotype. Strong expansion of optic stalk tissue at the expense of 
mainly ventral retina as in tpd has been described as a function of strong retinoic 
acid, Hedgehog or Fgf receptor signalling or their combination (Lupo et al., 2005). 
However, expression of at least fgf3, fgf10 and fgf24 in the eye is entirely lost rather 
than enhanced. Fgf3 and Fgf10 both act mainly through Fgf receptor 2 (Fgfr2IIIB) 
(Herzog et al., 2004), therefore, enhanced signalling through this Fgf receptor is 
possibly not expected to be the trigger. 
Moreover, lamination defects are seen in the tpd retina later on. While the ganglion 
cell layer fails to develop to more than a few disorganised cells at 2dpf, both the 
outer nuclear and inner plexiform layers do form at 3dpf, although with a less 
smooth appearance than usual and strong disruptions in the ventroposterior part of 
the retina, which is strongly affected in tpd embryos. This disruption is seen mostly 
in form of displaced photoreceptor cells, both rods and cones, mainly in the inner 
plexiform layer. There, they form rosettes around an expression centre of F-actin. 
Intriguingly, this is a specific phenotype observed also in zebrafish n-cadherin 
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mutants (Malicki et al., 2003; Pujic and Malicki, 2001), suggestive of a cell affinity 
specification defect in tpd embyos. 
Here, zebrafish tpd mutants are clearly different from mutants in Drosophila 
Trap230, which have been reported to lack photoreceptor differentiation (Janody et 
al., 2004). Still, another Trap230 Drosophila allele has been described, which shows 
no overt eye defect (Boube et al., 2000). 
Guidance of retinal ganglion cell axons along the optic stalk is also defective. They 
are not fasciculated into an orderly optic nerve as in wild type embryos (Culverwell 
and Karlstrom, 2002), and misproject anteriorly to the anterior commissure along 
their way. The lack of melanophore condensation displayed by tpd embryos 
furthermore suggests they are blind and therefore unable to detect light. With regard 
to the disorganised retina and optic nerve, this seems likely. 
Different types of retinotectal axon pathfinding mutants are known in zebrafish 
(Karlstrom et al., 1997). The defects seen in tpd resemble the no-isthmus phenotype 
seen in pax2a mutants, which fail to close the choroid fissure and have 
defasciculated retinotectal axons extending rostrally inappropriately (Macdonald et 
al., 1997). Intriguingly, however, expression of pax2a in tpd embryos is upregulated 
rather than downregulated, suggesting that possibly pax2a may be another 
transcription factor for whose activity Trap230 is necessary. Its transcription may 
then be upregulated due to the failure to activate a negative feedback loop. 
Alternatively, pax2a misregulation may lead to a similar phenotype, no matter 
whether its transcription is up- or downregulated, and Trap230 may play a role in 
finetuning the transcriptional level of pax2a, normally repressing it either directly or 
indirectly. 
As obvious candidates for transcription factors requiring Trap230 as a competence 
factor, expression of tbx5, Sox9a and Sox9b in the tpd eye were considered. 
Expression of tbx5 in the eye of tpd embryos appears to be reduced by 24hpf (Figure 
44). However, zebrafish tbx5 mutants do not have an overt eye phenotype (Garrity et 
al., 2002), suggesting that tbx5 is anyway not a prime candidate in this context. 
Sox9a does not seem to be expressed in the zebrafish eye (Chiang et al., 2001; Yan et 
al., 2005) and this study, and Sox9b expression in the tpd eye at 24hpf did not seem 
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altered (Figure 33 G, H). This is in agreement with my other findings concerning the 
interaction of Sox9 and Trap230. As the role of Sox9 in the eye has not been 
reported yet, it remains to be seen whether the defects described in tpd embryos can 
be attributed to a lack of Sox9, in this case Sox9b activity. Although this has not 
actually been reported, Sox9b mutant embryos appear to have a coloboma of the eye, 
as well (Yan et al., 2005), suggesting that a closer analysis is certainly worthwhile. 
Once again, loss of Trap230 function seems to be implicated in altered cell adhesion 
properties and migration defects, in this case defined by retinal cells which do not 
form smooth layers, and, in the case of photoreceptors, even aggregate ectopically as 
rosettes of cells, a phenotype that has been related to defects in N-cadherin, a cell 
adhesion molecule. Moreover, retinotectal axons fail to form fascicles and are 
misguided, phenotypes that also suggest defective cell affinity properties. 
Mutations in Trap230 have been reported to alter cell affinity already in Drosophila 
eye, antennal and wing discs, where mutant clones disrupt expression boundaries 
and/or have smooth borders (Janody et al., 2003; Treisman, 2001). A possible link to 
E-cadherin has been drawn (Dahmann and Basler, 2000), interestingly correlating 
with the n-cadherin-like photoreceptor phenotype of tpd eyes. Moreover, Trap230 in 
Drosophila has been implicated in the RTK/Ras pathway (Maixner et al., 1998), 
which through phosphorylation of Trap240 in yeast stimulates a flocculation 
phenotype of cell aggregation, therefore also a change in cell affinity (Chang et al., 
2004). 
3.4.3 Heart and circulation phenotype 
Tbx5 deficiency in humans leads to Holt-Oram syndrome, a defect in heart and limb 
development (Basson et al., 1994; Newbury-Ecob et al., 1996). Zebrafish tbx5 
mutants exhibit not only a similar limb but also heart phenotype as tpd embryos 
(Garrity et al., 2002) and Tbx5 function is involved in heart formation (Begemann 
and Ingham, 2000; Fan et al., 2003). With regard to this, a direct role for Trap230 in 
Tbx5 activity similar to that it has with Sox9, seems plausible not only in the context 
of pectoral fin induction, as discussed above, but also of heart development. 
Sox9 expression in the heart during development has also been reported (Ng et al., 
1997). Therefore, Sox9 loss of activity may explain the tpd heart phenotype. Since 
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regulation of Sox9 by Tbx5 through Connexin 40 in limb bone development has 
recently been reported (Pizard et al., 2005), a similar cascade may function in the 
heart, involving Trap230 at multiple steps. 
3.4.4 Somite phenotype 
In tpd mutants, a motility problem and slightly U-shaped somites were observed. As 
sox9a is expressed in the somites, a requirement for Trap230 in this context may 
explain the tpd muscle phenotype. However, the phenotype described for sox9a 
mutants consists of shorter and thicker muscles (Yan et al., 2002) and it is not clear 
whether this is identical with the phenotype displayed by tpd embryos. Alternatively, 
Prdm1, a zinc finger and SET domain transcription factor with histone methyl 
transferase activity, which has been implicated in this process (Baxendale et al., 
2004; Roy et al., 2001) and is known to function mainly as a repressor (Wilm and 
Solnica-Krezel, 2005), may recruit Trap230 for its function – especially since 
Trap230 is thought to act mainly as a corepressor rather than a coactivator. 
Strikingly, loss of Prdm1 function also leads to a failure of fin bud induction and the 
gene is expressed in the photoreceptor cell layer (Wilm and Solnica-Krezel, 2005) 
(cf. tpd eye phenotype in 2.5.2). 
3.4.5 Overall downregulation of Fgf signalling and gut 
phenotype 
Zebrafish tpd mutants show a downregulation of fgf and Fgf-downstream-target 
expression in several tissues apart from pectoral fin buds, namely in branchial arches, 
midbrain hindbrain boundary, ventral eyes, nasal placodes and the midgut. 
fgf-expression in the nasal placodes may be reduced due to lack of Sox9 activity, 
caused by the function of Sox9 in epidermal placode formation, not only for the otic 
but also the nasal placodes (Yan et al., 2005). 
Genetic interactions between Fgf signalling pathways and T-box transcription 
factors, where the latter are required for their induction and maintenance, have 
started to become a common theme in vertebrate development (Draper et al., 2003; 
Ng et al., 2002). Should the possibility of a rule for Trap230 in mediating T-box 
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transcription factor activity, firstly in the case of Tbx5, hold true, this may provide an 
explanation for reduced expression of Fgfs in tpd embryos to be proven. 
Another hint may come from cloning the gene affected in the zebrafish aussicht 
mutant, which shows a general fgf overexpression (Heisenberg et al., 1999) and may 
point to a universal Fgf-regulatory mechanism which could possibly also be 
conversely affected and lead to general downregulation of fgfs. 
A combined effect of deficient Sox9 and Tbx5 activity with disruption of a general 
Fgf-regulatory mechanism and indirect components attributable to misregulated 
targets of other major signalling pathways as the Wnt pathway, which is known to 
intersect with the Fgf pathway on several levels and in many instances, appears 
plausible though complex. Possibly, a simpler and more specific explanation may 
turn out to hold true. 
In addition to fgf24 downregulation in the midgut, tpd embryos also show an edema 
at the colon/cloaca. This may be a secondary effect due to osmotic problems caused 
by renal failure, as Sox9 is also known to have a function in the kidney (Morais da 
Silva et al., 1996). However, it also seems feasible that this should hint to a possible 
interaction of Trap230 with Sox10, since a mouse Sox10 mutant, DOM (dominant 
megacolon) shows exactly this phenotype (Herbarth et al., 1998). On the other hand, 
zebrafish Sox10 mutants have an intrinsic lack of melanophores (Dutton et al., 2001), 
which tpd embryos certainly do not have (Figure 48 C). Therefore, Trap230 could 
only be required for some functions of Sox10, but not all. Interestingly, an 
expression of Sox9 in the gut has also recently been reported (Blache et al., 2004), 
suggesting that there may be a function of Sox9 whose loss could lead to the tpd gut 
phenotype. Yet, Sox9a/Sox9b double mutants have not been reported to show such 
edemae, making this explanation less likely. The Sox9 function in the gut, 
interestingly, appears to involve maintenance of an undifferentiated cell state through 
Wnt signalling regulation (Blache et al., 2004), relating back to loss of 
Trap230/Mediator kinase subcomplex being involved in entry of cells into a 
G0/stationary phase/differentiated state (Spahr et al., 2003). 
A regulator of Fgf24 in the gut has unfortunately also not been reported yet. So the 
cause of this tpd phenotype remains elusive. 
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3.4.6 Outlook 
Certainly, one recurrent theme for Trap230 and the Mediator kinase subcomplex is 
its involvement in the control of differentiation. Intriguingly, as seems to be the case 
for HDAC1 (Stadler et al., 2005), which is generally thought to be a repressor and 
has been proposed as an opponent of the Mediator complex (Kwon and Lee, 2001), 
although they share some phenotypes, the Mediator kinase subcomplex appears to be 
involved in activation as well as in its canonical repression of genes, and has been 
implicated in both maintaining an undifferentiated cell state and promoting cell 
differentiation, depending on the context. Its cdk and cyclin components link it to the 
cell cycle, making this role more feasible. Apparently, phosphorylation of Trap240 
and possibly also Trap230 through a Ras/cAMP pathway seems to be recurrently 
involved in this function. Moreover, the proposed chromatin remodelling activity in 
the subunit may come to aid there, and complex differential regulation of the 
Mediator kinase submodule through other Mediator components, co- and 
transcription factors as well as directly through secondary modifications like 
phosphorylation or possibly sumoylation explain the fact that Trap230 and Trap240 
have been identified in Drosophila as members of both the Trithorax and Polycomb 
group, maintaining either an active or repressed transcriptional state. Indeed, 
Trap230/Trap240 are involved in regulating the activity or expression of a number of 
homeobox transcription factors in various organisms. 
Differentiation is inhibited - respective an undifferentiated state maintained - in 
presence of the kinase complex in case of yeast cells, where it represses entry into 
G0/stationary phase. This is also the case for much of the Sox9 functions, which 
through Wnt signalling have been implicated in maintaining undifferentiated cell 
states and require Trap230 to be relayed. On the other hand, in C. elegans vulval 
development, Drosophila eye development and Dictyostelium spore formation, 
Trap230 appears to promote differentiation. 
Moreover, another (or possibly the same) connection exists between Trap230/the 
Mediator kinase subcomplex and regulation of cell affinity in yeast, mammalian 
cells, Drosophila and zebrafish. Whether this is an indirect effect, eg. through 
modulating Wnt/Sox9 signalling and thereby the composition of the ECM, the actin 
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cytoskeleton bound to β-catenin or the planar cell polarity pathway, or a more direct 
function, remains to be seen. 
Clearly, the emerging picture of Mediator is that of an all-integrative platform for 
transcriptional regulation as well as other DNA-related activities, at which signalling 
pathways and transcription factor activities converge and cross-talk. It is a complex 
and versatile machinery with manifold regulatory features. Different proteins may 
bind to different subunits, modify them, eg. by phosphorylation, sterically inhibit 
each other or be brought in contact with one another. The chromatin structure is 
altered to bring enhancer- and promoter-bound proteins in contact with one another, 
nucleosomes are removed and acetylated, individual Mediator components may 
modify each other and regulate each other, submodules may be recruited depending 
on the context – and ultimately, structure and state of the entire complex are thus 
modified to intricately regulate the activity of pol II for transcribing the gene close to 
which Mediator is bound. 
Such a complex system is probably more than the sum of its components, yet, 
understanding the function of individual subunits will promote the understanding of 
the whole. Therefore, it is essential to analyse a component like Trap230 and study 
its function. Again, analysing individual instances of Trap230 activity will help to 
get an idea, like its interaction with Sox9 or a possible interaction with Tbx5 and 
resulting effects. Nevertheless, it will be most important to understand the general 
idea behind it and find the rules that this piece in the whole framework obeys to. One 
may think of Trap230 as a protein which randomly interacts with some transcription 
factor or other as a competence factor for its activity, yet I believe the emerging 
picture to be more specific. A number of possibilities present themselves for now, 
which may not encompass the whole scope yet and can also include the truth in a 
combination of them. Trap230 may be specific for relaying transcription factor 
activity downstream of certain signalling pathways and not others – so far, the Wnt, 
Ras, Notch, Hedgehog and JNK pathways have been proposed. It may be specific for 
certain tissues, although its ubiquitous expression suggests otherwise. Its specificity 
may lie in a role for regulating cell cycle and proliferation, as has been implicated at 
several points also for other components of the Mediator kinase subunit. 
Alternatively, it may serve to regulate cell-cell or cell-matrix affinity as a general 
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rule, as some data suggest. Or, it may be specific for a set of transcription factors 
with common structural or other features, like those which need to synergise with 
others for their function, as Sox and T-box proteins do. Moreover, unknown 
functions of Trap230 may remain to be found, like enzymatic activities or a role in 
the cytoplasm. These possible functions may also differ from one species or phylum 
to the other – or be conserved. It remains to be seen. 
Another important point are the possible implications of Trap230 and Mediator 
defects for human diseases. They have been linked to neurodegenerative and 
neuropsychiatric diseases, as well as to congenital defects of many organs and 
cancer. 
In summary, both a detailed analysis of specific Trap230-interactions and a broader 
analysis, eg. by microarray studies, should help to provide us with a clearer picture 
of its function within the Mediator complex. The same holds true for its other 
components, and comparative analysis of the clockwork components will be 
important to understand how the Mediator clock ticks. 
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4.1 Fish stocks 
The trapped alleles used were t25870 and t24970. Embryos were cultured in E3 medium, 
with or without the addition of 0.003% 1-Phenyl-2-thiourea (PTU, Sigma) to inhibit 
pigmentation. Embryos were staged according to hours post fertilisation (hpf) or 
days post fertilisation (dpf;(Westerfield, 1995). 
4.2 Chemicals and solutions 
The following overview comprises general buffers and solutions. Special solutions 
and reagents are mentioned together with the methods. All chemicals, if not noted 
otherwise, were purchased from the companies Applichem, Merck, Roth and Sigma. 
Agarose was purchased from Pharmacia, Bromophenol blue and Xylene cyanol from 
Serva. 
60x stock solution E3 saline 34,8g NaCl 
1,6g KCl 
5,8g CaCl2 x 2H2O 
9,78g MgSO4 x 6H2O 
H2O ad 2l 
pH 7.2 with NaOH 
autoclave 
for 1x use 16ml/l + 100µl methylene blue solution 
 
10x loading buffer: 50% glycerol 
1x TE 
0.25% bromophenol blue 
0.25% xylene cyanol 
 
TE: 10 mM Tris/HCl pH 7.4 
1mM EDTA pH 8.0 
  
50xTAE 242 gm Tris base 
57.1 ml glacial acetic acid 
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100ml 0.5M EDTA 
Add ddH2O to 1 liter and adjust pH to 8.5. 
 
10xPBS 70g NaCL; 62.4g Na2HPO4.2h2O; 3.4g KH2PO4 
pH7.4 
4.3 Linkage analysis and genetic mapping 
4.3.1 Quick lysis of embryos 
• Fix embryos in 100% MetOH 
• Place at -20°C for at least 30min 
• Place embryos individually into a 96-well-plate 
• Mix 250µl proteinase K (20mg/ml) and 2250µl TE 
• Pipet 25µl into each well (multipipet) 
• Close plate firmly with lids 
• Digest 4h-O/N at 50-70°C 
• Boil 5min at 96°C to destroy proteinase K 
• Dilute with 75µl H2O per well 
• Store at -20°C 
• Use 1-5µl per PCR 
4.3.2 Finclipping 
Anesthetise the fish in 100ml H2O + 4ml 0.4% Triacin (MS222, Sigma). After 30-
60sec, the fish will be anesthetised. Scoop the fish out with a tea-strainer, cut off a 
tiny bit of tail fin using a sharp sterile blade and let the fish recover in fresh water. 
Finclip solution: 
400mM Tris 
5mM EDTA 
150mM NaCl 
0.1% SDS 
pH8.0 
• Digest finclip in 100µl finclip solution + 5µl proteinase K (20mg/ml) for 
several hours at 60°C or O/N at 50°C 
• Boil 5min to destroy proteinase K 
• Purify and concentrate DNA using a Qiagen PCR Purification Kit, elute with 
10-50µl 
4.3.3 SSLP markers used 
Primer sequences for all markers used from the meiotic MGH panel can be found in 
the ZFIN database (http://www.zfin.org). 
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For fine mapping of tpd, SSLPs were generated using the Sanger genome database. 
The closest SSLP marker to the tpd mutation, P1, uses the primer pair 
GCATCCACCCAAACATGAGG (forward) and GCAGTGCGATTGATGTTGGG 
(reverse), at a distance of <0.08cM south of the mutation. 
4.3.4 Bulked segregant analysis 
For bulked segregant analysis, 5µl each of quick lysis extracted DNA from 48 
mutant or wild type embryos (cf. 4.3.2) were pooled. 
PCR using SSLP primers was performed as follows: 
PCR MIX 
5µl DNA 
2µl 10x PCR Buffer 
1.6µl DNTPs (2.5µmol each) 
0.08µl each primer at 100pmol/µl 
0.4µl Taq polymerase 
ad 20µl H20 
PROGRAM 
2min 94°C 
35 – 40 cycles: 
 30sec 94°C 
 30sec 58°C 
 1min 72°C 
5min 72°C 
 
For initial linkage analysis of the 192 marker set, PCRs were performed in 96-well-
plates, for analysis of single markers, 8-strip or single PCR tubes. 
4.3.5 Fine mapping 
Individual embryo PCR was performed essentially as described for bulked segregant 
analysis, but using 2-5µl of DNA from individually lysed embryos (cf. 4.3.2) and 
doing the PCRs in 96-well-plates. 
4.3.6 Websites 
http://www.zfin.org Zebrafish database 
http://www.repeatmasker.org Program to find CA 
repeats 
http://www.sanger.ac.uk/Projects/D_rerio/WebFPC/zebrafish/small.shtml Zebrafish BAC-FPC map 
http://ensembl.org/Danio_rerio/ Zebrafish genome 
http://vega.sanger.ac.uk/Danio_rerio/ Zebrafish BAC/PAC 
sequence assembly 
http://zebrafish.mgh.harvard.edu/ Zebrafish meiotic MGH 
mapping panel 
http://helix.wustl.edu/dcaps/dcaps.html Program to find SNPs 
http://www.ebi.ac.uk/clustalw/ Sequence alignment 
program 
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4.4 Histochemical methods 
4.4.1 Whole mount in situ hybridization (WMISH) 
4.4.1.1 WMISH probes 
col2a1 (Yan et al., 1995) 
dlx2 (Akimenko et al., 1994) 
erm1 (Roehl and Nusslein-Volhard, 2001) 
fgf3 (courtesy of Michael Tsang) (Kiefer et al., 1996) 
fgf10 (Ng et al., 2002) 
fgf24 (Fischer et al., 2003) 
foxd3 (courtesy of Darren Gilmour) (Odenthal and Nusslein-Volhard, 1998) 
msx-c (Akimenko et al., 1995) 
pax2a (Krauss et al., 1991) 
pax8 (Pfeffer et al., 1998) 
pea3 (Roehl and Nusslein-Volhard, 2001) 
shh (Krauss et al., 1993) 
snai1b (courtesy of Stephen Wilson) (Thisse et al., 1995) 
sox9a (courtesy of Stephen Wilson) (Chiang et al., 2001) 
sox9b (Chiang et al., 2001) 
sox10 (courtesy of Darren Gilmour) (Dutton et al., 2001) 
tbx5 (Begemann and Ingham, 2000) 
wnt2b (Ng et al., 2002) 
The trap230 in situ probe was synthesized using the following primers: 
forward primer GGTGGGTGGGATGTTTGAC 
reverse primer TTCACAGAACAACGCCAGTATG. 
4.4.1.2 IN SITU PROBE SYNTHESIS 
Preparation of DNA template: 
• Digest 4-5µg plasmid DNA in 100µl volume 2h at 37°C 
• Purify DNA with Qiagen PCR purification kit 
o Add 5 vol. buffer PB to 1 vol. PCR sample, mix 
o Apply sample on Qiaquick spin column on 2ml tube, spin 30-60s, 
discard flow-through 
o Wash with 750µl Buffer PE, spin 30-60s, discard flow-through, spin 
1min max. speed 
o Place column on clean 1.5ml tube 
o Add with 30µl Buffer EB, let stand for 1min, spin 1min max. speed 
• Measure concentration 
Transcription reaction (20µl final): 
• 1µg linearised DNA in 9µl H2O 
• 4µl  5x trascription Buffer (Promega DIG kit no. 8) 
• 2µl 100mM DTT (shelf 5 in box) 
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• 2µl 10x DIG-labelled nucleotide mix (DIG kit no. 7) 
• 1µl RNAse inhibitor (DIG kit no. 10) 
• 2µl RNA polymerase (DIG kit no. 12, shelf 7) 
• incubate 2h 37°C 
Nucleotide removal: 
• use Qiagen RNeasy kit 
o use maximum of 100µg RNA for Mini kit 
o Buffer RLT should be redissolved by warming if precipitated, then at 
RT 
o Adjust sample to 100µl with RNase-free water 
o Add 350µl Buffer RLT, mix thoroughly (β-ME should be in Buffer!) 
o Add 250µl EtOH, mix thoroughly by pipetting, don’t spin 
o Apply to RNeasy column in 2ml tube, spin 15s at max. speed 
(≥8000g), discard flow-through 
o Place column on new tube 
o Add 500µl Buffer RPE, spin 15s at max. speed, discard flow-through 
o Add 500µl Buffer RPE, spin 2min at max. speed, discard flow-
through 
o Optional: place column in new tube, spin 1min at max. speed 
o Place column on new 1.5ml tube 
o Add 30µl H2O, spin 1min at max. speed 
• Check RNA concentration (should be ~100ng/µl) 
• Add 30µl formamide 
• Store at –20°C 
4.4.1.3 WMISH protocol 
BUFFERS: 
20xSSC: 
175.3 g NaCl 
88.2 g NatriumCitrat 
in 1l H2O pH 7.0/NaOH 
Hyb-: 
50% formamide 
5x SSC 
0.1% Tween-20 
(store at -20°C) 
Hyb+: 
Hyb- 
50µg/ml Heparin 
50mg/ml torula (yeast) RNA 
(store at -20°C) 
Staining buffer: 
100mM Tris pH 9.5 (50ml 1M stock for 500ml) 
50mM MgCl2 (25ml 1M stock for 500ml) 
100mM NaCl (16.7ml 3M stock for 500ml) 
0.1% Tween-20 (add shortly before use!) 
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2x malate buffer: 
200mM Malate pH 7.5 (50ml 2M stock for 500ml – adjust pH in stock!!) 
300mM NaCl (50ml 3M stock for 500ml) 
0.1% Tween-20 (add shortly before use!) 
blocking buffer: 
for 300ml: 
6g blocking reagent (Roche Cat. No. 1096176) to make 2% solution 
150ml H2O 
150ml 2x malate buffer with 0.1% Tween 
(store at –20°C) 
EMBRYO FIXATION AND STORAGE 
• Fix embryos in 4% PFA (paraformaldehyde) in PBS at RT 1-4h or O/N at 
4°C 
• Wash 2-3x in PBS 
• Dechorionate in small petridish with forceps in PBS 
• Wash in PBS 
• Replace PBS by 50% methanol (in PBS) 
• Replace by 100% methanol 
• Wash 1-2x in 100% methanol 
• Store at -20°C 30min - storage 
WMISH 
DAY 1 
• 5min 50% MetOH in PBS at RT 
• 5min 30% MetOH in PBS at RT 
• 2-4x 5min PBST (0.1% Tween 20 in PBS) at RT 
• digest with 5µg/ml Proteinase K (2ml PBST + 0.5µl 20mg/ml stock) at RT, 
time depends on embryo stage 
o 10h 3min 
o 3s 5min 
o 14s 7min 
o 16s 8min 
o 20s 10min 
o 24h 12min 
o 52h 15min 
o 68h 15min 
• wash 2-3x in PBST 
• transfer to 0.5ml tube (20-30 embryos per tube) 
• prehybridise in 200µl Hyb- (RT liquid) 5min at 67°C (may be left out) 
• may be stored in Hyb- up to 24h at -20°C 
• prehybridise in 200µl Hyb+ (RT liquid) at least 1-2h at 67°C 
• take off 100-120µl Hyb+ (don’t let embryos touch air) 
• add 1-2µl RNA probe 
• hybridise at 65-68°C O/N – 48h 
DAY2 
• take off probe, store at -20°C and reuse 
• wash 2x 30min in 50% formamide / 50% 2xSSCT (0.1% Tween) at 67°C 
• wash 15min with 2xSSCT at 67°C 
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• wash 2x 30min with 0.2x SSCT at 67°C 
• wash 2x with 1x malate buffer 
• block at least 1h with blocking buffer at RT 
• incubate in 500µl alkaline phosphatase coupled Fab antibody (0.5µl in 2ml 
blocking buffer) for 4h at RT or 4°C O/N 
DAY3 
• wash 4x 25min with 1x malate buffer at RT (make fresh!!) 
• (leave in PBST at 4°C O/N) 
• wash 3x 5min with staining buffer at RT (make fresh) 
• stain in 500µl BM Purple AP substrate solution (Roche Cat. No. 1442074) 
(warm & shake before use) in 24-well-plates at 37°C in the dark, check every 
10-15min 
• wash 3x with PBST 
• fix in 4% PFA, store at 4°C 
• replace by 75% glycerol/PBS, store at 4°C 
4.4.2 Cryosections 
• Fix dechorionated embryos in 4% PFA/PBS for 1h at RT or O/N at 4°C 
• Wash with PBS 
• 2h at RT (O/N – a few days at 4°C) in 20% sucrose/PBS 
• take embryos out from sucrose and place in plastic moulds (Polysciences) 
• take off sucrose as well as possible 
• cover embryos with Tissu Tek (Plano) 
• align embryos in required position (ventral to the mold bottom) under the 
microscope 
• place molds on dry ice so tissue-tek hardens (about 20min) 
• detach blocks by pressing hard with the thumb against the mold bottom 
• place blocks on holders 
• place a holder in the cryostat and start to cut 
• try to find the plane containing embryos by trimming 30-50µm sections 
• cut embryos in 12µm sections 
• transfer sections in a line to slide (super frost slides, Roth), 5-7 sections per 
line are optimal 
• leave to dry at RT at least 1h 
4.4.3 Antibody stainings 
4.4.3.1 Antibodies 
The following primary antibodies were used: 
mouse anti-acetylated tubulin antibody (Santa Cruz; 1:1000) 
mouse anti-Hu (Marusich et al., 1994), kindly provided by Darren Gilmour; 1:200) 
mouse anti-Islet1 (Developmental Studies Hybridoma Bank; 1:50) 
mouse anti-Zn5 (University of Oregon; 1:500) 
mouse anti-Zpr1 (University of Oregon; 1:200) 
mouse anti-Zpr3 (University of Oregon; 1:200) 
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Secondary antibodies: 
anti-mouse antibody used was either coupled with AlexaFluor488 (green) or 
AlexaFluor 549 (red) (Molecular Probes, 1:500) 
Alexa Fluor 568-conjugated phalloidin (Molecular Probes; 1:40) 
4.4.3.2 Hu staining protocol 
• Fix embryos in 4% PFA (PBS) for 3h at RT or O/N at 4°C 
• Rinse once + wash 3x with PBST (0.1% Tween 20) 
• Dehydrate in MetOH series (33%, 66%, 2x100%, 5min each, place at -20°C 
for at least 1h). Important for penetration of later stage samples. 
• Permeabilise in 1ml Proteinase K solution (30µg/ml in H2O). Time depends 
on stage of embryos – 10min should be enough for most later stages. 
• Rinse once + wash 3x with PBST (0.1% Tween 20) 
• Block 1h in GS-PDT (10% goat serum in 0.1% Tween 20, 1% DMSO in 
PBS) 
• Dilute primary antibody in GS-PBST (no DMSO), add 100-200µl to the 
samples and incubate O/N at 4°C or 4h at RT 
• Wash 4-6x 30min in GS-PBST 
• Incubate with secondary antibody (anti-mouse AlexaFluor 488; 1:500) in GS-
PBST 4h at RT or O/N at 4°C 
• Rinse once + wash 2x 30min in GS-PDT 
• Rinse once + wash 2x 30min in PDT 
4.4.3.3 Islet1 staining protocol 
This is a tedious but worthwhile protocol, since embryos have to be digested in every 
possible way to let the antibody through to the dorsal root ganglia. 
• Dechorionate embryos 
• Fix in 4% PFA 0.1% Tween 1h at RT 
• Wash embryos 2x 5min in PBSTw (0.1% Tween/PBS) 
• Wash 5min in H2O, then 1h in H2O, then through a series of 25%, 50%, 75% 
into 100% MetOH in H2O to keep at -20°C O/N 
• Rehydrate through a MetOH series into PBS 0.1% Tween20 0.5% Triton 
• Pass embryos into a glass tube (acetone will dissolve plastic) 
• Short wash with H2O 
• Permeabilise with cold (-20°C) acetone for 20min at -20°C 
• Short wash with H2O 
• Wash 3x 5min with PBS 0.1% Tween20 0.5% Triton 
• Short wash in 2% goat serum, 1% BSA, 1% DMSO, 0.5% Triton in PBS 
(PBDST) 
• Transfer embryos back into Eppendorff tubes 
• Block 1h in PBDST 
• Primary antibody incubation: Islet-1 1:30 in PBDST O/N at 4°C or 4h at RT 
• 4x 30min wash in PBDT (no goat serum) 
• secondary antibody incubation: (anti-mouse AlexaFluor 488; 1:500) In PBDT 
O/N at 4°C or 4h at RT 
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• 4x 30min wash in PBDT 
4.4.3.4 Acetylated tubulin staining protocol 
SOLUTIONS 
TCA: 10% trichloroacetic acid stock in distilled water, stored at 4°C, dilute to 2% in 
PBS 
PBT: 0.5% Triton X-100 in PBS, 10% Triton, stored at RT 
Trypsin: from Gibco-BRL (2.5% solution), stored at -20°C in aliquots (200µl), dilute 
to 0.25% in PBT before use 
Primary and secondary antibodies, goat serum and DAB stocks are stored at -20°C in 
aliquots. 
PROTOCOL 
• Fix embryos in 2% TCA (trichloroacetid acid) in PBS for 3h exactly at RT 
• Wash 3x 5min in PBS 
• Store at 4°C in PBTx (0.5% Triton in PBS) until use 
Careful: TCA fixed fish are quite fragile 
DAY1 
• Wash 2x 10min in PBS after several rinses 
• Trypsin treatment (to permeabilise the embryos) 
o Prechill trypsin solution (dilute frozen stock 10x in PBTx 100µl 
stock) on ice 
o Prechill aliquot of PBTx (for stop solution) 
o Incubate the embryos in trypsin solution on ice 
4min for 44hpf, 8min for 58hpf, 12min for 72hpf embryos 
• Rinse in prechilled PBTx 
• Wash 5x 5min in PBTx at RT 
• Blocking: incubate in 10% goat serum, 1% DMSO in PBTx for at least 1h at 
RT 
• Replace with primary antibody diluted in 10% goat serum, 1% DMSO in 
PBTx 
• Incubate O/N at 4°C 
DAY2 
• Remove primary antibody solution and keep in fresh tube at 4°C for reuse 
• Rinse embryos 2x with PBTx 
• Wash 6x 30min in PBTx on a shaker at RT 
• Wash in PBTx for 30min 
• Incubate in secondary antibody (anti-mouse AlexaFluor 488; 1:200) diluted 
in 1% goat serum in PBT O/N at 4°C 
DAY3 
• Remove secondary antibody (and discard) 
• Rinse 3x with PBTx 
• Wash 6x 30min in PBTx on shaker at RT 
• Final wash in PBS after several rinses 
• Transfer to 70% glycerol / 30% PBS and store at 4°C to view 
4.4.3.5 Eye sections double labelling protocol 
Cryosections of 2 and 3dpf old embryos were used. 
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• Wash 2x 5min in PBST (0.1% Tween) 
• Block 1h at RT in 1% BSA/PBS in a wet chamber, cover sections with 
parafilm, 150µl per slide 
• Primary antibody: 
o Zn5 1:500; or Zpr1 or Zpr3: 1:100 
o 4°C O/N incubation 
• Wash 3x 5min in PBST 
• Secondary antibody: 
o Anti-mouse AlexaFlour 488 (1:500) and Alexa-conjugated phalloidin 
(1:40) 
o 150µl per slide in blocking buffer 
o 1h at RT in wet chamber, slides covered with parafilm 
• wash 3x 10min with PBST 
• mount with Moviol 
4.4.4 Methylene blue staining 
Methylene blue solution: 
• Add 25ml of 4% NaOH solution to 100ml of 1% silver nitrate solution 
• Allow the precipitated silver oxide to sediment and decant supernatant 
• Dissolve 1g methylene blue in 100ml distilled water, heat and add to the 
washed silver oxide 
• Heat for a further 5min 
• Allow to cool and filter 
Staining procedure: 
• Wash cryosections 2x in PBS 
• Wash sections with distilled water 
• Stain for 15sec – 2min in methylene blue 
• Wash in running tap water around 10min (dependent on section thickness and 
age of staining solution) 
• Wash 30sec in 70% EtOH 
• Wash 2x 30sec in 100% EtOH 
• Place 5min in xylene 
• Check staining quality under microscope 
• Mount with Entellan 
4.4.5 Alcian blue staining 
H2OT: tap water with 0.1% Tween 20 
• Fix embryos O/N at 4°C in 4% PFA (PBS) 
• Place embryos in 70% EtOH for 10min (can be stored at 4°C for about a 
week) 
• For storage (optional): take through a MetOH series and store in 100% 
MetOH at -20°C 
• Stain O/N in 0.1g Alcian Blue in 0.1N HCl pH1 at 37°C 
• Rinse 2x 5min in H20T 
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• Bleach and defat 30min at 37°C in: 
10µl 30% H2O2 
100µl 10% KOH 
890µl H2OT 
(freshly made, invert tube 2x to mix) 
• Rinse 2x 5min in H2OT 
• Rinse 10min in: 
300µl saturated Borate (Borax) 
600µl H2OT 
• Digest: replace with the same solution including 0.25mg/ml Trypsin, digest 
30min at 37°C (invert tube 2x to mix) 
• Rinse 2x 5min in H2OT 
• Rinse in 25% glycerol/75% H2O for 30min 
• Transfer to 50% glycerol / 50% H2O 
• Transfer to 75% glycerol / 25% H2O for long term storage at RT/4°C 
4.4.6 TUNEL staining 
TUNEL staining was performed on whole mount embryos using the in situ cell death 
TMR red kit (Roche). 
4.5 Total RNA isolation from embryos 
• Collect 30-50 embryos at 3dpf and shock-freeze with liquid nitrogen 
• place at -80°C for a few hours 
• resuspend in 400µl TES solution: 
o 10mM TrisCl pH 7.5 
o 10mM EDTA 
o 0.5% SDS 
• add 400µl acid phenol, vortex vigorously 10sec 
• incubate 60min at 65°C with occasional, brief vortexing 
• place on ice 5min, centrifuge 5min at top speed, 4°C 
• transfer aqueous (top) phase (400µl) to a clean 1.5ml tube, add 400µl acid 
phenol, vortex vigorously, place on ice 5min, centrifuge at top speed, 4°C 
• repeat 
• transfer aqueous phase to a new tube, add 40µl of 3M sodium acetate, pH 
5.3 and 1ml of ice-cold 100% EtOH 
• precipitate 1h at -80°C 
• centrifuge 5min at top speed, 4°C 
• take off EtOH 
• wash RNA pellet by vortexing briefly in ice-cold 70% EtOH 
• centrifuge as before to pellet RNA 
• take off EtOH 
• resuspend pellet in 50µl H2O, determine OD (1:100), store at -20°C 
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4.6 cDNA synthesis 
cDNA first strand synthesis (for cloning) was performed with SuperScriptII Reverse 
transcriptase (Gibco) according to the manufacturer´s protocol. 
4.7 General gene cloning procedure 
Programs and PCR mixtures used depended on the aim of amplification and primers. 
If not noted otherwise, 1000bps/ min were used as standard to calculate the extension 
time. Promega Tfl polymerase was used. 
PCR products were separated electrophoretically on agarose gels, cut out and 
extracted using a Qiagen MinElute Kit. 
Redo TA overhangs: 
5.6µl DNA 
2µl    Promega Tfl 5x buffer 
1µl    dATP 0.2mM (1:50dilution of stock from stores) 
1µl    Promega Tfl polymerase from RT kit (Promega) 
0.4µl MgSO4 25mM 
30min 70°C 
Ligation TopoTA Kit:  Ligation pGEMT Kit: 
(Invitrogen)    (Promega) 
2µl DNA    2µl DNA 
1µl salt solution   5µl buffer 
0.5µl vector    1µl vector 
2.5µl water    1µl water 
     1µl ligase 
5-15min RT    1h RT 
Ligated plasmids were chemically transformed into Top10 cells (Invitrogen) 
according to product sheet, grown O/N on agar plates. Individual clones were picked 
and a bacterial mini preparation performed. Restriction digests using EcoRI were 
done to check insert size on agarose gel. Clones containing inserts of correct size 
were then sequenced in house. 
4.7.1 Trap230 primers 
Primer name forward primer(s) reverse primer(s)  
Trap-1 GTTCCCATCTTCAGCAAGAAAG TCTCTGCTGTACTCTTGCGG 
Trap-1b ACACGAGTTCCTCACCTGG CAGAAGTGGCAGAAGCAAACG 
Trap-1c GTGTTGTGTTGCCCCAGC GTTAAAGGTGCTGTTGCCCC 
Trap-1d GTCAGAAGTTGTAGATGAGAAAGG GAAACTGCAGCAGGACATCC 
Trap-2 GAGGAGAGTGCAAGTCATGAG TGCTGGCACTGTTGCTATTGG 
Trap-3 GCTGTATTCTCTTCTGGAGAAC ACTGGAGAGCTGCTGCTG 
Trap-3b  GTCAAACATCCCACCCACC 
Trap-4(a) GGTGGGTGGGATGTTTGAC TTCACAGAACAACGCCAGTATG 
Trap-4b CATGTCTCTCCTGAGCCAG CCT CTT CTC TCA GAA AGG TCC 
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Primer name forward primer(s) reverse primer(s)  
Trap-5'UTR AAGAGTGTGCATTTGTGTGTGC  
Trap-5'RACE CACTGGCACAGAGTACTTGGCAAGGTA
GCC 
nested: GCC AAA CAC TTC CTC TTT CTT 
GCT GAA GAT GGG AAC 
 
T1-I4A w1 GGTCCAGGTGGGCATCAG GAGGCCAGGTCCCCACGG 
T2-I2-J2 w1 TGTTCTGCGGAGATACCA CAGCATCTCCCAGCATG 
T4 w1 TGGACCTGCTGTTGCA TCCTGGGGCTGGTTCG 
J4 w1 CTGGGGCTGGTTCGGA TCCAAAAACTGGACCCT 
Trap-MO-
Test 
gaaacagccagtctggtgg CAAATTGTGTTCCAGTAGTTGGG 
Trap-MO-
Test-Ex24 
 CAG GAT GCG TTT GAT GCG C 
Trap-MO-
Check-Ex24 
 ACAGAGACTTCAGACAGCGC 
Trap-5'deg ATGAARCARWSNATGCC  
Trap-5' spec  ATCTTGTTTTCAGTTATGGCAGCG 
Trap-5'-Tet-
deg 
ATGGGCKGCYTTCGGGATC  
Trap-Ex10-
rev 
 ACTCGCTCACTCTCGTTCC 
Trap-Int9-rev  gaatgccacttcactgtatcc 
Figure 49. Sequences of Trap230 primers used in this study. 
4.8 Sequencing 
DNA sequencing was performed by the EMBL internal service unit of Vladimir 
Benes. 
4.9 Sequence alignments 
DNA sequences were analysed and aligned using the DNAMAN program. DNA and 
protein sequences of a selected number of species were obtained from the database 
and aligned using the online CLUSTALW algorithm at the EBI, Cambridge. 
4.10 Microinjection of morpholino 
oligonucleotides and mRNA 
TRAP230 splice morpholino oligonucleotide (MO) was purchased from GeneTools 
LLC. The MO, designed to target the exon26-intron26 splice junction, has the 
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sequence CAGATCCTCTAAAAATCATCACCTG. A MO stock solution was 
formed by dilution in water and was stored at –20°C prior to use. Embryos were 
injected at the single cell stage with 0.25 mM MO. 
sox9b-mRNA was synthesized using the SP6 mMessage mMachine kit (Ambion) 
from a full-length clone obtained at RZPD (IMAGp998A0514858Q) and injected at 
single cell stage with a concentration of 90ng/µl. 
4.11 Further molecular standard techniques 
DNA restriction digests and agarose gel electrophoresis (1-2% agarose, TAE buffer) 
were performed according to standard protocols (Sambrook, 1989). Ethidium 
bromide was added in a 1:10000 dilution directly to the gels prior to solidifying. Gels 
were used for gel extraction or photography on a gel documentation station. 
Bacterial mini preparations were done using an Eppendorff FastPlasmid Mini kit. 
DNA was eluted from agarose gels by cutting the respective piece out of gel under 
long-wave UV conditions (λ=366nm) and subsequently purifying it using a Qiagen 
MinElute kit and eluted in a final volume of 10µl. 
 5 REFERENCES 
REFERENCES  
 
 
104
 
Agarwal, P., Wylie, J. N., Galceran, J., Arkhitko, O., Li, C., Deng, C., 
Grosschedl, R. and Bruneau, B. G. (2003). Tbx5 is essential for forelimb bud 
initiation following patterning of the limb field in the mouse embryo. Development 
130, 623-33. 
Ahn, D. G., Kourakis, M. J., Rohde, L. A., Silver, L. M. and Ho, R. K. (2002). T-
box gene tbx5 is essential for formation of the pectoral limb bud. Nature 417, 754-8. 
Akimenko, M. A., Ekker, M., Wegner, J., Lin, W. and Westerfield, M. (1994). 
Combinatorial expression of three zebrafish genes related to distal-less: part of a 
homeobox gene code for the head. J Neurosci 14, 3475-86. 
Akimenko, M. A., Johnson, S. L., Westerfield, M. and Ekker, M. (1995). 
Differential induction of four msx homeobox genes during fin development and 
regeneration in zebrafish. Development 121, 347-57. 
Akoulitchev, S., Chuikov, S. and Reinberg, D. (2000). TFIIH is negatively 
regulated by cdk8-containing mediator complexes. Nature 407, 102-6. 
Aldhous, P. (2000). 'Saturation screen' lets zebrafish show their stripes. Nature 404, 
910. 
Amores, A., Force, A., Yan, Y. L., Joly, L., Amemiya, C., Fritz, A., Ho, R. K., 
Langeland, J., Prince, V., Wang, Y. L. et al. (1998). Zebrafish hox clusters and 
vertebrate genome evolution. Science 282, 1711-4. 
Anderson, K. V. and Ingham, P. W. (2003). The transformation of the model 
organism: a decade of developmental genetics. Nat Genet 33 Suppl, 285-93. 
Ansari, A. Z., Koh, S. S., Zaman, Z., Bongards, C., Lehming, N., Young, R. A. 
and Ptashne, M. (2002). Transcriptional activating regions target a cyclin-dependent 
kinase. Proc Natl Acad Sci U S A 99, 14706-9. 
Ansari, A. Z., Ogirala, A. and Ptashne, M. (2005). Transcriptional activating 
regions target attached substrates to a cyclin-dependent kinase. Proc Natl Acad Sci U 
S A 102, 2346-9. 
Asada, S., Choi, Y., Yamada, M., Wang, S. C., Hung, M. C., Qin, J. and Uesugi, 
M. (2002). External control of Her2 expression and cancer cell growth by targeting a 
Ras-linked coactivator. Proc Natl Acad Sci U S A 99, 12747-52. 
Asturias, F. J., Jiang, Y. W., Myers, L. C., Gustafsson, C. M. and Kornberg, R. 
D. (1999). Conserved structures of mediator and RNA polymerase II holoenzyme. 
Science 283, 985-7. 
Atkins, G. B., Hu, X., Guenther, M. G., Rachez, C., Freedman, L. P. and Lazar, 
M. A. (1999). Coactivators for the orphan nuclear receptor RORalpha. Mol 
Endocrinol 13, 1550-7. 
Bach, E. A., Vincent, S., Zeidler, M. P. and Perrimon, N. (2003). A sensitized 
genetic screen to identify novel regulators and components of the Drosophila janus 
kinase/signal transducer and activator of transcription pathway. Genetics 165, 1149-
66. 
REFERENCES  
 
 
105
Baek, H. J., Malik, S., Qin, J. and Roeder, R. G. (2002). Requirement of 
TRAP/mediator for both activator-independent and activator-dependent transcription 
in conjunction with TFIID-associated TAF(II)s. Mol Cell Biol 22, 2842-52. 
Bajusz, I., Sipos, L., Gyorgypal, Z., Carrington, E. A., Jones, R. S., Gausz, J. 
and Gyurkovics, H. (2001). The Trithorax-mimic allele of Enhancer of zeste 
renders active domains of target genes accessible to polycomb-group-dependent 
silencing in Drosophila melanogaster. Genetics 159, 1135-50. 
Balciunas, D., Galman, C., Ronne, H. and Bjorklund, S. (1999). The Med1 
subunit of the yeast mediator complex is involved in both transcriptional activation 
and repression. Proc Natl Acad Sci U S A 96, 376-81. 
Balciunas, D. and Ronne, H. (1995). Three subunits of the RNA polymerase II 
mediator complex are involved in glucose repression. Nucleic Acids Res 23, 4421-5. 
Barembaum, M. and Bronner-Fraser, M. (2005). Early steps in neural crest 
specification. Semin Cell Dev Biol. 
Basson, C. T., Cowley, G. S., Solomon, S. D., Weissman, B., Poznanski, A. K., 
Traill, T. A., Seidman, J. G. and Seidman, C. E. (1994). The clinical and genetic 
spectrum of the Holt-Oram syndrome (heart-hand syndrome). N Engl J Med 330, 
885-91. 
Baxendale, S., Davison, C., Muxworthy, C., Wolff, C., Ingham, P. W. and Roy, 
S. (2004). The B-cell maturation factor Blimp-1 specifies vertebrate slow-twitch 
muscle fiber identity in response to Hedgehog signaling. Nat Genet 36, 88-93. 
Baxter, S. M., Rosenblum, J. S., Knutson, S., Nelson, M. R., Montimurro, J. S., 
Di Gennaro, J. A., Speir, J. A., Burbaum, J. J. and Fetrow, J. S. (2004). 
Synergistic computational and experimental proteomics approaches for more 
accurate detection of active serine hydrolases in yeast. Mol Cell Proteomics 3, 209-
25. 
Begemann, G. and Ingham, P. W. (2000). Developmental regulation of Tbx5 in 
zebrafish embryogenesis. Mech Dev 90, 299-304. 
Begemann, G., Schilling, T. F., Rauch, G. J., Geisler, R. and Ingham, P. W. 
(2001). The zebrafish neckless mutation reveals a requirement for raldh2 in 
mesodermal signals that pattern the hindbrain. Development 128, 3081-94. 
Beier, D. R. (1998). Zebrafish: genomics on the fast track. Genome Res 8, 9-17. 
Bell, D. M., Leung, K. K., Wheatley, S. C., Ng, L. J., Zhou, S., Ling, K. W., 
Sham, M. H., Koopman, P., Tam, P. P. and Cheah, K. S. (1997). SOX9 directly 
regulates the type-II collagen gene. Nat Genet 16, 174-8. 
Beyer, K. S., Klauck, S. M., Benner, A., Poustka, F. and Poustka, A. (2002). 
Association studies of the HOPA dodecamer duplication variant in different subtypes 
of autism. Am J Med Genet 114, 110-5. 
Bilotta, J. and Saszik, S. (2001). The zebrafish as a model visual system. Int J Dev 
Neurosci 19, 621-9. 
Bjorklund, S., Buzaite, O. and Hallberg, M. (2001). The yeast mediator. Mol Cells 
11, 129-36. 
REFERENCES  
 
 
106
Bjorklund, S. and Gustafsson, C. M. (2004). The mediator complex. Adv Protein 
Chem 67, 43-65. 
Bjorklund, S. and Gustafsson, C. M. (2005). The yeast Mediator complex and its 
regulation. Trends Biochem Sci 30, 240-4. 
Bjorklund, S. and Kim, Y. J. (1996). Mediator of transcriptional regulation. Trends 
Biochem Sci 21, 335-7. 
Blache, P., van de Wetering, M., Duluc, I., Domon, C., Berta, P., Freund, J. N., 
Clevers, H. and Jay, P. (2004). SOX9 is an intestine crypt transcription factor, is 
regulated by the Wnt pathway, and represses the CDX2 and MUC2 genes. J Cell 
Biol 166, 37-47. 
Blazek, E., Mittler, G. and Meisterernst, M. (2005). The mediator of RNA 
polymerase II. Chromosoma 113, 399-408. 
Borggrefe, T., Davis, R., Erdjument-Bromage, H., Tempst, P. and Kornberg, R. 
D. (2002). A complex of the Srb8, -9, -10, and -11 transcriptional regulatory proteins 
from yeast. J Biol Chem 277, 44202-7. 
Boube, M., Faucher, C., Joulia, L., Cribbs, D. L. and Bourbon, H. M. (2000). 
Drosophila homologs of transcriptional mediator complex subunits are required for 
adult cell and segment identity specification. Genes Dev 14, 2906-17. 
Boube, M., Joulia, L., Cribbs, D. L. and Bourbon, H. M. (2002). Evidence for a 
mediator of RNA polymerase II transcriptional regulation conserved from yeast to 
man. Cell 110, 143-51. 
Bourbon, H. M., Aguilera, A., Ansari, A. Z., Asturias, F. J., Berk, A. J., 
Bjorklund, S., Blackwell, T. K., Borggrefe, T., Carey, M., Carlson, M. et al. 
(2004). A unified nomenclature for protein subunits of mediator complexes linking 
transcriptional regulators to RNA polymerase II. Mol Cell 14, 553-7. 
Boyer, T. G., Martin, M. E., Lees, E., Ricciardi, R. P. and Berk, A. J. (1999). 
Mammalian Srb/Mediator complex is targeted by adenovirus E1A protein. Nature 
399, 276-9. 
Brabazon, E. D., Bree, R. T., Carton, M. W., Grealy, M. and Byrnes, L. (2002). 
Cyclin-dependent kinase 8 is expressed both maternally and zygotically during 
zebrafish embryo development. Biochim Biophys Acta 1576, 203-8. 
Bregman, D. B., Pestell, R. G. and Kidd, V. J. (2000). Cell cycle regulation and 
RNA polymerase II. Front Biosci 5, D244-57. 
Bronner-Fraser, M. (1986). Analysis of the early stages of trunk neural crest 
migration in avian embryos using monoclonal antibody HNK-1. Dev Biol 115, 44-
55. 
Brumby, A. M., Zraly, C. B., Horsfield, J. A., Secombe, J., Saint, R., Dingwall, 
A. K. and Richardson, H. (2002). Drosophila cyclin E interacts with components of 
the Brahma complex. Embo J 21, 3377-89. 
Buckles, G. R., Thorpe, C. J., Ramel, M. C. and Lekven, A. C. (2004). 
Combinatorial Wnt control of zebrafish midbrain-hindbrain boundary formation. 
Mech Dev 121, 437-47. 
REFERENCES  
 
 
107
Burakov, D., Wong, C. W., Rachez, C., Cheskis, B. J. and Freedman, L. P. 
(2000). Functional interactions between the estrogen receptor and DRIP205, a 
subunit of the heteromeric DRIP coactivator complex. J Biol Chem 275, 20928-34. 
Capdevila, J. and Izpisua Belmonte, J. C. (2001). Patterning mechanisms 
controlling vertebrate limb development. Annu Rev Cell Dev Biol 17, 87-132. 
Carlson, M. (1997). Genetics of transcriptional regulation in yeast: connections to 
the RNA polymerase II CTD. Annu Rev Cell Dev Biol 13, 1-23. 
Carrera, I., Janody, F., Martirosyan, Z., Treisman, J. (2003). Two subunits of the 
mediator complex act as adaptors for Notch and Wingless signaling. In 44th Annual 
Drosophila Research Conference, (ed., pp. 346A. Chicago: The Genetics Society of 
America. 
Chang, Y. W., Howard, S. C., Budovskaya, Y. V., Rine, J. and Herman, P. K. 
(2001). The rye mutants identify a role for Ssn/Srb proteins of the RNA polymerase 
II holoenzyme during stationary phase entry in Saccharomyces cerevisiae. Genetics 
157, 17-26. 
Chang, Y. W., Howard, S. C. and Herman, P. K. (2004). The Ras/PKA signaling 
pathway directly targets the Srb9 protein, a component of the general RNA 
polymerase II transcription apparatus. Mol Cell 15, 107-16. 
Chen, Z. and Han, M. (2001). Role of C. elegans lin-40 MTA in vulval fate 
specification and morphogenesis. Development 128, 4911-21. 
Cheng, Y., Cheung, M., Abu-Elmagd, M. M., Orme, A. and Scotting, P. J. 
(2000). Chick sox10, a transcription factor expressed in both early neural crest cells 
and central nervous system. Brain Res Dev Brain Res 121, 233-41. 
Cheung, M. and Briscoe, J. (2003). Neural crest development is regulated by the 
transcription factor Sox9. Development 130, 5681-93. 
Cheung, M., Chaboissier, M. C., Mynett, A., Hirst, E., Schedl, A. and Briscoe, J. 
(2005). The transcriptional control of trunk neural crest induction, survival, and 
delamination. Dev Cell 8, 179-92. 
Chi, Y., Huddleston, M. J., Zhang, X., Young, R. A., Annan, R. S., Carr, S. A. 
and Deshaies, R. J. (2001). Negative regulation of Gcn4 and Msn2 transcription 
factors by Srb10 cyclin-dependent kinase. Genes Dev 15, 1078-92. 
Chiang, E. F., Pai, C. I., Wyatt, M., Yan, Y. L., Postlethwait, J. and Chung, B. 
(2001). Two sox9 genes on duplicated zebrafish chromosomes: expression of similar 
transcription activators in distinct sites. Dev Biol 231, 149-63. 
Cho, H., Orphanides, G., Sun, X., Yang, X. J., Ogryzko, V., Lees, E., Nakatani, 
Y. and Reinberg, D. (1998). A human RNA polymerase II complex containing 
factors that modify chromatin structure. Mol Cell Biol 18, 5355-63. 
Chow, R. L. and Lang, R. A. (2001). Early eye development in vertebrates. Annu 
Rev Cell Dev Biol 17, 255-96. 
Christiansen, J. H., Coles, E. G. and Wilkinson, D. G. (2000). Molecular control 
of neural crest formation, migration and differentiation. Curr Opin Cell Biol 12, 719-
24. 
REFERENCES  
 
 
108
Conaway, R. C., Sato, S., Tomomori-Sato, C., Yao, T. and Conaway, J. W. 
(2005). The mammalian Mediator complex and its role in transcriptional regulation. 
Trends Biochem Sci 30, 250-5. 
Cooper, K. F., Mallory, M. J., Smith, J. B. and Strich, R. (1997). Stress and 
developmental regulation of the yeast C-type cyclin Ume3p (Srb11p/Ssn8p). Embo J 
16, 4665-75. 
Cresko, W. A., Yan, Y. L., Baltrus, D. A., Amores, A., Singer, A., Rodriguez-
Mari, A. and Postlethwait, J. H. (2003). Genome duplication, subfunction 
partitioning, and lineage divergence: Sox9 in stickleback and zebrafish. Dev Dyn 
228, 480-9. 
Culverwell, J. and Karlstrom, R. O. (2002). Making the connection: retinal axon 
guidance in the zebrafish. Semin Cell Dev Biol 13, 497-506. 
Dahmann, C. and Basler, K. (2000). Opposing transcriptional outputs of Hedgehog 
signaling and engrailed control compartmental cell sorting at the Drosophila A/P 
boundary. Cell 100, 411-22. 
DeFalco, T. J., Verney, G., Jenkins, A. B., McCaffery, J. M., Russell, S. and Van 
Doren, M. (2003). Sex-specific apoptosis regulates sexual dimorphism in the 
Drosophila embryonic gonad. Dev Cell 5, 205-16. 
DeLisi, L. E., Smith, A. B., Razi, K., Stewart, J., Wang, Z., Sandhu, H. K. and 
Philibert, R. A. (2000). Investigation of a candidate gene for schizophrenia on Xq13 
previously associated with mental retardation and hypothyroidism. Am J Med Genet 
96, 398-403. 
Detrich, H. W., 3rd, Westerfield, M. and Zon, L. I. (1999). Overview of the 
Zebrafish system. Methods Cell Biol 59, 3-10. 
Devine, C. A. and Key, B. (2003). Identifying axon guidance defects in the 
embryonic zebrafish brain. Methods Cell Sci 25, 33-7. 
Dorsky, R. I., Moon, R. T. and Raible, D. W. (1998). Control of neural crest cell 
fate by the Wnt signalling pathway. Nature 396, 370-3. 
Dorsky, R. I., Raible, D. W. and Moon, R. T. (2000). Direct regulation of nacre, a 
zebrafish MITF homolog required for pigment cell formation, by the Wnt pathway. 
Genes Dev 14, 158-62. 
Drane, P., Barel, M., Balbo, M. and Frade, R. (1997). Identification of RB18A, a 
205 kDa new p53 regulatory protein which shares antigenic and functional properties 
with p53. Oncogene 15, 3013-24. 
Draper, B. W., Stock, D. W. and Kimmel, C. B. (2003). Zebrafish fgf24 functions 
with fgf8 to promote posterior mesodermal development. Development 130, 4639-
54. 
Duboule, D. (2002). Making progress with limb models. Nature 418, 492-3. 
Duboule, D., Haenlin, M., Galliot, B. and Mohier, E. (1987). DNA sequences 
homologous to the Drosophila opa repeat are present in murine mRNAs that are 
differentially expressed in fetuses and adult tissues. Mol Cell Biol 7, 2003-6. 
REFERENCES  
 
 
109
Dudley, A. T., Ros, M. A. and Tabin, C. J. (2002). A re-examination of 
proximodistal patterning during vertebrate limb development. Nature 418, 539-44. 
Duret, L., Gasteiger, E. and Perriere, G. (1996). LALNVIEW: a graphical viewer 
for pairwise sequence alignments. Comput Appl Biosci 12, 507-10. 
Dutton, K. A., Pauliny, A., Lopes, S. S., Elworthy, S., Carney, T. J., Rauch, J., 
Geisler, R., Haffter, P. and Kelsh, R. N. (2001). Zebrafish colourless encodes 
sox10 and specifies non-ectomesenchymal neural crest fates. Development 128, 
4113-25. 
Eberhardy, S. R. and Farnham, P. J. (2002). Myc recruits P-TEFb to mediate the 
final step in the transcriptional activation of the cad promoter. J Biol Chem 277, 
40156-62. 
Eisen, J. S. (1996). Zebrafish make a big splash. Cell 87, 969-77. 
Eisenmann, D. M., Maloof, J. N., Simske, J. S., Kenyon, C. and Kim, S. K. 
(1998). The beta-catenin homolog BAR-1 and LET-60 Ras coordinately regulate the 
Hox gene lin-39 during Caenorhabditis elegans vulval development. Development 
125, 3667-80. 
Ellies, D. L., Langille, R. M., Martin, C. C., Akimenko, M. A. and Ekker, M. 
(1997). Specific craniofacial cartilage dysmorphogenesis coincides with a loss of dlx 
gene expression in retinoic acid-treated zebrafish embryos. Mech Dev 61, 23-36. 
Evans, T., Rosenthal, E. T., Youngblom, J., Distel, D. and Hunt, T. (1983). 
Cyclin: a protein specified by maternal mRNA in sea urchin eggs that is destroyed at 
each cleavage division. Cell 33, 389-96. 
Fan, C., Liu, M. and Wang, Q. (2003). Functional analysis of TBX5 missense 
mutations associated with Holt-Oram syndrome. J Biol Chem 278, 8780-5. 
Ferrari, D. and Kosher, R. A. (2002). Dlx5 is a positive regulator of chondrocyte 
differentiation during endochondral ossification. Dev Biol 252, 257-70. 
Fischer, S., Draper, B. W. and Neumann, C. J. (2003). The zebrafish fgf24 mutant 
identifies an additional level of Fgf signaling involved in vertebrate forelimb 
initiation. Development 130, 3515-24. 
Fishman, M. C. (1999). Zebrafish genetics: the enigma of arrival. Proc Natl Acad 
Sci U S A 96, 10554-6. 
Fondell, J. D., Guermah, M., Malik, S. and Roeder, R. G. (1999). Thyroid 
hormone receptor-associated proteins and general positive cofactors mediate thyroid 
hormone receptor function in the absence of the TATA box-binding protein-
associated factors of TFIID. Proc Natl Acad Sci U S A 96, 1959-64. 
Force, A., Lynch, M., Pickett, F. B., Amores, A., Yan, Y. L. and Postlethwait, J. 
(1999). Preservation of duplicate genes by complementary, degenerative mutations. 
Genetics 151, 1531-45. 
Frade, R., Balbo, M. and Barel, M. (2000). RB18A, whose gene is localized on 
chromosome 17q12-q21.1, regulates in vivo p53 transactivating activity. Cancer Res 
60, 6585-9. 
REFERENCES  
 
 
110
Friez, M. J., Essop, F. B., Krause, A., Castiglia, L., Ragusa, A., Sossey-Alaoui, 
K., Nelson, R. L., May, M. M., Michaelis, R. C., Srivastava, A. K. et al. (2000). 
Evidence that a dodecamer duplication in the gene HOPA in Xq13 is not associated 
with mental retardation. Hum Genet 106, 36-9. 
Fryer, C. J., White, J. B. and Jones, K. A. (2004). Mastermind recruits 
CycC:CDK8 to phosphorylate the Notch ICD and coordinate activation with 
turnover. Mol Cell 16, 509-20. 
Galceran, J., Hsu, S. C. and Grosschedl, R. (2001). Rescue of a Wnt mutation by 
an activated form of LEF-1: regulation of maintenance but not initiation of 
Brachyury expression. Proc Natl Acad Sci U S A 98, 8668-73. 
Gammill, L. S. and Bronner-Fraser, M. (2003). Neural crest specification: 
migrating into genomics. Nat Rev Neurosci 4, 795-805. 
Garrity, D. M., Childs, S. and Fishman, M. C. (2002). The heartstrings mutation 
in zebrafish causes heart/fin Tbx5 deficiency syndrome. Development 129, 4635-45. 
Ge, K., Guermah, M., Yuan, C. X., Ito, M., Wallberg, A. E., Spiegelman, B. M. 
and Roeder, R. G. (2002). Transcription coactivator TRAP220 is required for PPAR 
gamma 2-stimulated adipogenesis. Nature 417, 563-7. 
Geisler, R. (2002). Mapping and cloning. In Zebrafish, (ed. C. Nuesslein-Volhard 
and R. Dahm). Oxford: Oxford University Press. 
Giese, K., Cox, J. and Grosschedl, R. (1992). The HMG domain of lymphoid 
enhancer factor 1 bends DNA and facilitates assembly of functional nucleoprotein 
structures. Cell 69, 185-95. 
Gim, B. S., Park, J. M., Yoon, J. H., Kang, C. and Kim, Y. J. (2001). Drosophila 
Med6 is required for elevated expression of a large but distinct set of 
developmentally regulated genes. Mol Cell Biol 21, 5242-55. 
Gindhart, J. G., Jr. and Kaufman, T. C. (1995). Identification of Polycomb and 
trithorax group responsive elements in the regulatory region of the Drosophila 
homeotic gene Sex combs reduced. Genetics 139, 797-814. 
Goering, L. M., Hoshijima, K., Hug, B., Bisgrove, B., Kispert, A. and Grunwald, 
D. J. (2003). An interacting network of T-box genes directs gene expression and fate 
in the zebrafish mesoderm. Proc Natl Acad Sci U S A 100, 9410-5. 
Grandel, H., Draper, B. W. and Schulte-Merker, S. (2000). dackel acts in the 
ectoderm of the zebrafish pectoral fin bud to maintain AER signaling. Development 
127, 4169-78. 
Grandel, H., Lun, K., Rauch, G. J., Rhinn, M., Piotrowski, T., Houart, C., 
Sordino, P., Kuchler, A. M., Schulte-Merker, S., Geisler, R. et al. (2002). 
Retinoic acid signalling in the zebrafish embryo is necessary during pre-
segmentation stages to pattern the anterior-posterior axis of the CNS and to induce a 
pectoral fin bud. Development 129, 2851-65. 
Grandel, H. and Schulte-Merker, S. (1998). The development of the paired fins in 
the zebrafish (Danio rerio). Mech Dev 79, 99-120. 
REFERENCES  
 
 
111
Green, S. R. and Johnson, A. D. (2004). Promoter-dependent roles for the Srb10 
cyclin-dependent kinase and the Hda1 deacetylase in Tup1-mediated repression in 
Saccharomyces cerevisiae. Mol Biol Cell 15, 4191-202. 
Griffin, K. J., Amacher, S. L., Kimmel, C. B. and Kimelman, D. (1998). 
Molecular identification of spadetail: regulation of zebrafish trunk and tail mesoderm 
formation by T-box genes. Development 125, 3379-88. 
Guglielmi, B., van Berkum, N. L., Klapholz, B., Bijma, T., Boube, M., 
Boschiero, C., Bourbon, H. M., Holstege, F. C. and Werner, M. (2004). A high 
resolution protein interaction map of the yeast Mediator complex. Nucleic Acids Res 
32, 5379-91. 
Gutierrez, L., Zurita, M., Kennison, J. A. and Vazquez, M. (2003). The 
Drosophila trithorax group gene tonalli (tna) interacts genetically with the Brahma 
remodeling complex and encodes an SP-RING finger protein. Development 130, 
343-54. 
Gwack, Y., Baek, H. J., Nakamura, H., Lee, S. H., Meisterernst, M., Roeder, R. 
G. and Jung, J. U. (2003). Principal role of TRAP/mediator and SWI/SNF 
complexes in Kaposi's sarcoma-associated herpesvirus RTA-mediated lytic 
reactivation. Mol Cell Biol 23, 2055-67. 
Haddow, J. E., Palomaki, G. E., Allan, W. C., Williams, J. R., Knight, G. J., 
Gagnon, J., O'Heir, C. E., Mitchell, M. L., Hermos, R. J., Waisbren, S. E. et al. 
(1999). Maternal thyroid deficiency during pregnancy and subsequent 
neuropsychological development of the child. N Engl J Med 341, 549-55. 
Haffter, P., Granato, M., Brand, M., Mullins, M. C., Hammerschmidt, M., 
Kane, D. A., Odenthal, J., van Eeden, F. J., Jiang, Y. J., Heisenberg, C. P. et al. 
(1996). The identification of genes with unique and essential functions in the 
development of the zebrafish, Danio rerio. Development 123, 1-36. 
Haldane, J. B. S. (1956). The detection of autosomal lethals in mice induced by 
mutagenic agents. J Genet 54, 327-342. 
Hampsey, M. (1998). Molecular genetics of the RNA polymerase II general 
transcriptional machinery. Microbiol Mol Biol Rev 62, 465-503. 
Harley, V. R., Clarkson, M. J. and Argentaro, A. (2003). The molecular action 
and regulation of the testis-determining factors, SRY (sex-determining region on the 
Y chromosome) and SOX9 [SRY-related high-mobility group (HMG) box 9]. 
Endocr Rev 24, 466-87. 
Heisenberg, C. P., Brennan, C. and Wilson, S. W. (1999). Zebrafish aussicht 
mutant embryos exhibit widespread overexpression of ace (fgf8) and coincident 
defects in CNS development. Development 126, 2129-40. 
Hengartner, C. J., Myer, V. E., Liao, S. M., Wilson, C. J., Koh, S. S. and Young, 
R. A. (1998). Temporal regulation of RNA polymerase II by Srb10 and Kin28 
cyclin-dependent kinases. Mol Cell 2, 43-53. 
Hengartner, C. J., Thompson, C. M., Zhang, J., Chao, D. M., Liao, S. M., 
Koleske, A. J., Okamura, S. and Young, R. A. (1995). Association of an activator 
with an RNA polymerase II holoenzyme. Genes Dev 9, 897-910. 
REFERENCES  
 
 
112
Herbarth, B., Pingault, V., Bondurand, N., Kuhlbrodt, K., Hermans-
Borgmeyer, I., Puliti, A., Lemort, N., Goossens, M. and Wegner, M. (1998). 
Mutation of the Sry-related Sox10 gene in Dominant megacolon, a mouse model for 
human Hirschsprung disease. Proc Natl Acad Sci U S A 95, 5161-5. 
Herzog, W., Sonntag, C., von der Hardt, S., Roehl, H. H., Varga, Z. M. and 
Hammerschmidt, M. (2004). Fgf3 signaling from the ventral diencephalon is 
required for early specification and subsequent survival of the zebrafish 
adenohypophysis. Development 131, 3681-92. 
Hittelman, A. B., Burakov, D., Iniguez-Lluhi, J. A., Freedman, L. P. and 
Garabedian, M. J. (1999). Differential regulation of glucocorticoid receptor 
transcriptional activation via AF-1-associated proteins. Embo J 18, 5380-8. 
Ho, R. K. and Kane, D. A. (1990). Cell-autonomous action of zebrafish spt-1 
mutation in specific mesodermal precursors. Nature 348, 728-30. 
Hogan, M. J. (1963). The Vitreous, Its Structure, and Relation to the Ciliary Body 
and Retina. Proctor Award Lecture. Invest Ophthalmol 51, 418-45. 
Holstege, F. C., Jennings, E. G., Wyrick, J. J., Lee, T. I., Hengartner, C. J., 
Green, M. R., Golub, T. R., Lander, E. S. and Young, R. A. (1998). Dissecting 
the regulatory circuitry of a eukaryotic genome. Cell 95, 717-28. 
Hong, C. S. and Saint-Jeannet, J. P. (2005). Sox proteins and neural crest 
development. Semin Cell Dev Biol. 
Houston, C. S., Opitz, J. M., Spranger, J. W., Macpherson, R. I., Reed, M. H., 
Gilbert, E. F., Herrmann, J. and Schinzel, A. (1983). The campomelic syndrome: 
review, report of 17 cases, and follow-up on the currently 17-year-old boy first 
reported by Maroteaux et al in 1971. Am J Med Genet 15, 3-28. 
Hu, M. and Easter, S. S. (1999). Retinal neurogenesis: the formation of the initial 
central patch of postmitotic cells. Dev Biol 207, 309-21. 
Humphrey, C. D. and Pittman, F. E. (1974). A simple methylene blue-azure II-
basic fuchsin stain for epoxy-embedded tissue sections. Stain Technol 49, 9-14. 
Hung, C. C., Yeh, J. I., Fang, J. S. and Chen, C. H. (2003). No association of a 
dodecamer duplication in the human opposite paired (HOPA) gene with mental 
retardation and schizophrenia in Chinese patients from Taiwan. Psychiatry Res 119, 
163-6. 
Ingham, P. W. and Kim, H. R. (2005). Hedgehog signalling and the specification 
of muscle cell identity in the zebrafish embryo. Exp Cell Res 306, 336-42. 
Ito, M., Okano, H. J., Darnell, R. B. and Roeder, R. G. (2002). The TRAP100 
component of the TRAP/Mediator complex is essential in broad transcriptional 
events and development. Embo J 21, 3464-75. 
Ito, M., Yuan, C. X., Malik, S., Gu, W., Fondell, J. D., Yamamura, S., Fu, Z. Y., 
Zhang, X., Qin, J. and Roeder, R. G. (1999). Identity between TRAP and SMCC 
complexes indicates novel pathways for the function of nuclear receptors and diverse 
mammalian activators. Mol Cell 3, 361-70. 
REFERENCES  
 
 
113
Ito, M., Yuan, C. X., Okano, H. J., Darnell, R. B. and Roeder, R. G. (2000). 
Involvement of the TRAP220 component of the TRAP/SMCC coactivator complex 
in embryonic development and thyroid hormone action. Mol Cell 5, 683-93. 
Ito, T., Chiba, T., Ozawa, R., Yoshida, M., Hattori, M. and Sakaki, Y. (2001). A 
comprehensive two-hybrid analysis to explore the yeast protein interactome. Proc 
Natl Acad Sci U S A 98, 4569-74. 
Janody, F., Benlali, A., Martirosyan, Z., Treisman, J. (2001). blind spot (bli) and 
kohtalo (kto), the Drosophila homologs of TRAP240 and TRAP230, cause specific 
and identical developmental phenotypes., (ed. 
Janody, F., Lee, J. D., Jahren, N., Hazelett, D. J., Benlali, A., Miura, G. I., 
Draskovic, I. and Treisman, J. E. (2004). A mosaic genetic screen reveals distinct 
roles for trithorax and polycomb group genes in Drosophila eye development. 
Genetics 166, 187-200. 
Janody, F., Martirosyan, Z., Benlali, A. and Treisman, J. E. (2003). Two 
subunits of the Drosophila mediator complex act together to control cell affinity. 
Development 130, 3691-701. 
Jiang, Y. W., Veschambre, P., Erdjument-Bromage, H., Tempst, P., Conaway, 
J. W., Conaway, R. C. and Kornberg, R. D. (1998). Mammalian mediator of 
transcriptional regulation and its possible role as an end-point of signal transduction 
pathways. Proc Natl Acad Sci U S A 95, 8538-43. 
Johnson, S. L., Gates, M. A., Johnson, M., Talbot, W. S., Horne, S., Baik, K., 
Rude, S., Wong, J. R. and Postlethwait, J. H. (1996). Centromere-linkage analysis 
and consolidation of the zebrafish genetic map. Genetics 142, 1277-88. 
Kalev-Zylinska, M. L., Horsfield, J. A., Flores, M. V., Postlethwait, J. H., Vitas, 
M. R., Baas, A. M., Crosier, P. S. and Crosier, K. E. (2002). Runx1 is required for 
zebrafish blood and vessel development and expression of a human RUNX1-
CBF2T1 transgene advances a model for studies of leukemogenesis. Development 
129, 2015-30. 
Kang, J. S., Kim, S. H., Hwang, M. S., Han, S. J., Lee, Y. C. and Kim, Y. J. 
(2001). The structural and functional organization of the yeast mediator complex. J 
Biol Chem 276, 42003-10. 
Kang, Y. K., Guermah, M., Yuan, C. X. and Roeder, R. G. (2002). The 
TRAP/Mediator coactivator complex interacts directly with estrogen receptors alpha 
and beta through the TRAP220 subunit and directly enhances estrogen receptor 
function in vitro. Proc Natl Acad Sci U S A 99, 2642-7. 
Karlstrom, R. O., Trowe, T. and Bonhoeffer, F. (1997). Genetic analysis of axon 
guidance and mapping in the zebrafish. Trends Neurosci 20, 3-8. 
Kato, Y., Habas, R., Katsuyama, Y., Naar, A. M. and He, X. (2002). A 
component of the ARC/Mediator complex required for TGF beta/Nodal signalling. 
Nature 418, 641-6. 
Kawakami, Y., Capdevila, J., Buscher, D., Itoh, T., Rodriguez Esteban, C. and 
Izpisua Belmonte, J. C. (2001). WNT signals control FGF-dependent limb initiation 
and AER induction in the chick embryo. Cell 104, 891-900. 
REFERENCES  
 
 
114
Kennison, J. A. and Tamkun, J. W. (1988). Dosage-dependent modifiers of 
polycomb and antennapedia mutations in Drosophila. Proc Natl Acad Sci U S A 85, 
8136-40. 
Kent, J., Wheatley, S. C., Andrews, J. E., Sinclair, A. H. and Koopman, P. 
(1996). A male-specific role for SOX9 in vertebrate sex determination. Development 
122, 2813-22. 
Kettenberger, H., Armache, K. J. and Cramer, P. (2003). Architecture of the 
RNA polymerase II-TFIIS complex and implications for mRNA cleavage. Cell 114, 
347-57. 
Kiefer, P., Strahle, U. and Dickson, C. (1996). The zebrafish Fgf-3 gene: cDNA 
sequence, transcript structure and genomic organization. Gene 168, 211-5. 
Kim, Y. J. and Lis, J. T. (2005). Interactions between subunits of Drosophila 
Mediator and activator proteins. Trends Biochem Sci 30, 245-9. 
Kim, Y. O., Park, S. J., Balaban, R. S., Nirenberg, M. and Kim, Y. (2004). A 
functional genomic screen for cardiogenic genes using RNA interference in 
developing Drosophila embryos. Proc Natl Acad Sci U S A 101, 159-64. 
Kirov, G., Georgieva, L., Nikolov, I., Zammit, S., Jones, G., Poriazova, N., 
Tolev, T., Owen, R., Jones, S. and Owen, M. J. (2003). Association analysis of the 
HOPA12bp polymorphism in schizophrenia and manic depressive illness. Am J Med 
Genet B Neuropsychiatr Genet 118, 16-9. 
Knapik, E. W. (2000). ENU mutagenesis in zebrafish--from genes to complex 
diseases. Mamm Genome 11, 511-9. 
Knapik, E. W., Goodman, A., Atkinson, O. S., Roberts, C. T., Shiozawa, M., 
Sim, C. U., Weksler-Zangen, S., Trolliet, M. R., Futrell, C., Innes, B. A. et al. 
(1996). A reference cross DNA panel for zebrafish (Danio rerio) anchored with 
simple sequence length polymorphisms. Development 123, 451-60. 
Koh, S. S., Ansari, A. Z., Ptashne, M. and Young, R. A. (1998). An activator 
target in the RNA polymerase II holoenzyme. Mol Cell 1, 895-904. 
Kon, T., Adachi, H. and Sutoh, K. (2000). amiB, a novel gene required for the 
growth/differentiation transition in Dictyostelium. Genes Cells 5, 43-55. 
Krauss, S., Concordet, J. P. and Ingham, P. W. (1993). A functionally conserved 
homolog of the Drosophila segment polarity gene hh is expressed in tissues with 
polarizing activity in zebrafish embryos. Cell 75, 1431-44. 
Krauss, S., Johansen, T., Korzh, V. and Fjose, A. (1991). Expression of the 
zebrafish paired box gene pax[zf-b] during early neurogenesis. Development 113, 
1193-206. 
Kuchin, S., Yeghiayan, P. and Carlson, M. (1995). Cyclin-dependent protein 
kinase and cyclin homologs SSN3 and SSN8 contribute to transcriptional control in 
yeast. Proc Natl Acad Sci U S A 92, 4006-10. 
Kwon, J. Y. and Lee, J. (2001). Biological significance of a universally conserved 
transcription mediator in metazoan developmental signaling pathways. Development 
128, 3095-104. 
REFERENCES  
 
 
115
Kwon, J. Y., Park, J. M., Gim, B. S., Han, S. J., Lee, J. and Kim, Y. J. (1999). 
Caenorhabditis elegans mediator complexes are required for developmental-specific 
transcriptional activation. Proc Natl Acad Sci U S A 96, 14990-5. 
Lahue, E. E., Smith, A. V. and Orr-Weaver, T. L. (1991). A novel cyclin gene 
from Drosophila complements CLN function in yeast. Genes Dev 5, 2166-75. 
Larschan, E. and Winston, F. (2005). The Saccharomyces cerevisiae Srb8-Srb11 
complex functions with the SAGA complex during Gal4-activated transcription. Mol 
Cell Biol 25, 114-23. 
Lau, J. F., Nusinzon, I., Burakov, D., Freedman, L. P. and Horvath, C. M. 
(2003). Role of metazoan mediator proteins in interferon-responsive transcription. 
Mol Cell Biol 23, 620-8. 
Laudet, V., Stehelin, D. and Clevers, H. (1993). Ancestry and diversity of the 
HMG box superfamily. Nucleic Acids Res 21, 2493-501. 
Lee, J. S., von der Hardt, S., Rusch, M. A., Stringer, S. E., Stickney, H. L., 
Talbot, W. S., Geisler, R., Nusslein-Volhard, C., Selleck, S. B., Chien, C. B. et al. 
(2004). Axon sorting in the optic tract requires HSPG synthesis by ext2 (dackel) and 
extl3 (boxer). Neuron 44, 947-60. 
Lee, M., Chatterjee, S. and Struhl, K. (2000). Genetic analysis of the role of Pol II 
holoenzyme components in repression by the Cyc8-Tup1 corepressor in yeast. 
Genetics 155, 1535-42. 
Lee, T. I., Wyrick, J. J., Koh, S. S., Jennings, E. G., Gadbois, E. L. and Young, 
R. A. (1998). Interplay of positive and negative regulators in transcription initiation 
by RNA polymerase II holoenzyme. Mol Cell Biol 18, 4455-62. 
Lefebvre, V., Huang, W., Harley, V. R., Goodfellow, P. N. and de Crombrugghe, 
B. (1997). SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro 
alpha1(II) collagen gene. Mol Cell Biol 17, 2336-46. 
Lemon, B. and Tjian, R. (2000). Orchestrated response: a symphony of 
transcription factors for gene control. Genes Dev 14, 2551-69. 
Lew, D. J., Dulic, V. and Reed, S. I. (1991). Isolation of three novel human cyclins 
by rescue of G1 cyclin (Cln) function in yeast. Cell 66, 1197-206. 
Li, H., Lahti, J. M. and Kidd, V. J. (1996). Alternatively spliced cyclin C mRNA is 
widely expressed, cell cycle regulated, and encodes a truncated cyclin box. 
Oncogene 13, 705-12. 
Liem, K. F., Jr., Tremml, G., Roelink, H. and Jessell, T. M. (1995). Dorsal 
differentiation of neural plate cells induced by BMP-mediated signals from 
epidermal ectoderm. Cell 82, 969-79. 
Lin, H. H., Khosla, M., Huang, H. J., Hsu, D. W., Michaelis, C., Weeks, G. and 
Pears, C. (2004). A homologue of Cdk8 is required for spore cell differentiation in 
Dictyostelium. Dev Biol 271, 49-58. 
Lister, J. A., Robertson, C. P., Lepage, T., Johnson, S. L. and Raible, D. W. 
(1999). nacre encodes a zebrafish microphthalmia-related protein that regulates 
neural-crest-derived pigment cell fate. Development 126, 3757-67. 
REFERENCES  
 
 
116
Liu, Z. J., Tanaka, Y., Mine, S., Morinobu, A., Yagita, H., Okumura, K., 
Taniguchi, T., Yamamura, H. and Minami, Y. (1998a). Functional cooperation of 
cyclin C and c-Myc in mediating homotypic cell adhesion via very late antigen-4 
activation and vascular cell adhesion molecule-1 induction. Blood 92, 4700-11. 
Liu, Z. J., Ueda, T., Miyazaki, T., Tanaka, N., Mine, S., Tanaka, Y., Taniguchi, 
T., Yamamura, H. and Minami, Y. (1998b). A critical role for cyclin C in 
promotion of the hematopoietic cell cycle by cooperation with c-Myc. Mol Cell Biol 
18, 3445-54. 
Loyer, P., Trembley, J. H., Katona, R., Kidd, V. J. and Lahti, J. M. (2005). Role 
of CDK/cyclin complexes in transcription and RNA splicing. Cell Signal 17, 1033-
51. 
Lu, X. and Horvitz, H. R. (1998). lin-35 and lin-53, two genes that antagonize a C. 
elegans Ras pathway, encode proteins similar to Rb and its binding protein RbAp48. 
Cell 95, 981-91. 
Lupo, G., Liu, Y., Qiu, R., Chandraratna, R. A., Barsacchi, G., He, R. Q. and 
Harris, W. A. (2005). Dorsoventral patterning of the Xenopus eye: a collaboration 
of Retinoid, Hedgehog and FGF receptor signaling. Development 132, 1737-48. 
Macdonald, R., Scholes, J., Strahle, U., Brennan, C., Holder, N., Brand, M. and 
Wilson, S. W. (1997). The Pax protein Noi is required for commissural axon 
pathway formation in the rostral forebrain. Development 124, 2397-408. 
Maixner, A., Hecker, T. P., Phan, Q. N. and Wassarman, D. A. (1998). A screen 
for mutations that prevent lethality caused by expression of activated sevenless and 
Ras1 in the Drosophila embryo. Dev Genet 23, 347-61. 
Malicki, J. (2000). Genetic analysis of eye development in zebrafish. Results Probl 
Cell Differ 31, 257-82. 
Malicki, J., Jo, H. and Pujic, Z. (2003). Zebrafish N-cadherin, encoded by the glass 
onion locus, plays an essential role in retinal patterning. Dev Biol 259, 95-108. 
Malik, S. and Roeder, R. G. (2000). Transcriptional regulation through Mediator-
like coactivators in yeast and metazoan cells. Trends Biochem Sci 25, 277-83. 
Malik, S. and Roeder, R. G. (2005). Dynamic regulation of pol II transcription by 
the mammalian Mediator complex. Trends Biochem Sci 30, 256-63. 
Malik, S., Wallberg, A. E., Kang, Y. K. and Roeder, R. G. (2002). 
TRAP/SMCC/mediator-dependent transcriptional activation from DNA and 
chromatin templates by orphan nuclear receptor hepatocyte nuclear factor 4. Mol 
Cell Biol 22, 5626-37. 
Maloof, J. N. and Kenyon, C. (1998). The Hox gene lin-39 is required during C. 
elegans vulval induction to select the outcome of Ras signaling. Development 125, 
181-90. 
Marusich, M. F., Furneaux, H. M., Henion, P. D. and Weston, J. A. (1994). Hu 
neuronal proteins are expressed in proliferating neurogenic cells. J Neurobiol 25, 
143-55. 
REFERENCES  
 
 
117
Meyer, A. and Schartl, M. (1999). Gene and genome duplications in vertebrates: 
the one-to-four (-to-eight in fish) rule and the evolution of novel gene functions. 
Curr Opin Cell Biol 11, 699-704. 
Michaelis, R. C., Copeland-Yates, S. A., Sossey-Alaoui, K., Skinner, C., Friez, 
M. J., Longshore, J. W., Simensen, R. J., Schroer, R. J. and Stevenson, R. E. 
(2000). The HOPA gene dodecamer duplication is not a significant etiological factor 
in autism. J Autism Dev Disord 30, 355-8. 
Michelmore, R. W., Paran, I. and Kesseli, R. V. (1991). Identification of markers 
linked to disease-resistance genes by bulked segregant analysis: a rapid method to 
detect markers in specific genomic regions by using segregating populations. Proc 
Natl Acad Sci U S A 88, 9828-32. 
Mittler, G., Stuhler, T., Santolin, L., Uhlmann, T., Kremmer, E., Lottspeich, F., 
Berti, L. and Meisterernst, M. (2003). A novel docking site on Mediator is critical 
for activation by VP16 in mammalian cells. Embo J 22, 6494-504. 
Mo, X., Kowenz-Leutz, E., Xu, H. and Leutz, A. (2004). Ras induces mediator 
complex exchange on C/EBP beta. Mol Cell 13, 241-50. 
Moghal, N. and Sternberg, P. W. (2003). A component of the transcriptional 
mediator complex inhibits RAS-dependent vulval fate specification in C. elegans. 
Development 130, 57-69. 
Morais da Silva, S., Hacker, A., Harley, V., Goodfellow, P., Swain, A. and 
Lovell-Badge, R. (1996). Sox9 expression during gonadal development implies a 
conserved role for the gene in testis differentiation in mammals and birds. Nat Genet 
14, 62-8. 
Mullins, M. C., Hammerschmidt, M., Haffter, P. and Nusslein-Volhard, C. 
(1994). Large-scale mutagenesis in the zebrafish: in search of genes controlling 
development in a vertebrate. Curr Biol 4, 189-202. 
Musante, L., Bartsch, O., Ropers, H. H. and Kalscheuer, V. M. (2004). cDNA 
cloning and characterization of the human THRAP2 gene which maps to 
chromosome 12q24, and its mouse ortholog Thrap2. Gene 332, 119-27. 
Myer, V. E. and Young, R. A. (1998). RNA polymerase II holoenzymes and 
subcomplexes. J Biol Chem 273, 27757-60. 
Myers, L. C., Gustafsson, C. M., Bushnell, D. A., Lui, M., Erdjument-Bromage, 
H., Tempst, P. and Kornberg, R. D. (1998). The Med proteins of yeast and their 
function through the RNA polymerase II carboxy-terminal domain. Genes Dev 12, 
45-54. 
Naar, A. M., Beaurang, P. A., Zhou, S., Abraham, S., Solomon, W. and Tjian, 
R. (1999). Composite co-activator ARC mediates chromatin-directed transcriptional 
activation. Nature 398, 828-32. 
Naar, A. M., Taatjes, D. J., Zhai, W., Nogales, E. and Tjian, R. (2002). Human 
CRSP interacts with RNA polymerase II CTD and adopts a specific CTD-bound 
conformation. Genes Dev 16, 1339-44. 
REFERENCES  
 
 
118
Nair, D., Kim, Y. and Myers, L. C. (2005). Mediator and TFIIH Govern Carboxyl-
terminal Domain-dependent Transcription in Yeast Extracts. J Biol Chem 280, 
33739-48. 
Nakagawa, S. and Takeichi, M. (1998). Neural crest emigration from the neural 
tube depends on regulated cadherin expression. Development 125, 2963-71. 
Ner, S. S. (1992). HMGs everywhere. Curr Biol 2, 208-10. 
Neumann, C. J. (2002). Vertebrate development: a view from the zebrafish. Semin 
Cell Dev Biol 13, 469. 
Neumann, C. J., Grandel, H., Gaffield, W., Schulte-Merker, S. and Nusslein-
Volhard, C. (1999). Transient establishment of anteroposterior polarity in the 
zebrafish pectoral fin bud in the absence of sonic hedgehog activity. Development 
126, 4817-26. 
Nevado, J., Tenbaum, S. P. and Aranda, A. (2004). hSrb7, an essential human 
Mediator component, acts as a coactivator for the thyroid hormone receptor. Mol 
Cell Endocrinol 222, 41-51. 
Newbury-Ecob, R. A., Leanage, R., Raeburn, J. A. and Young, I. D. (1996). 
Holt-Oram syndrome: a clinical genetic study. J Med Genet 33, 300-7. 
Ng, J. K., Kawakami, Y., Buscher, D., Raya, A., Itoh, T., Koth, C. M., 
Rodriguez Esteban, C., Rodriguez-Leon, J., Garrity, D. M., Fishman, M. C. et 
al. (2002). The limb identity gene Tbx5 promotes limb initiation by interacting with 
Wnt2b and Fgf10. Development 129, 5161-70. 
Ng, J. K., Tamura, K., Buscher, D. and Izpisua-Belmonte, J. C. (1999). 
Molecular and cellular basis of pattern formation during vertebrate limb 
development. Curr Top Dev Biol 41, 37-66. 
Ng, L. J., Wheatley, S., Muscat, G. E., Conway-Campbell, J., Bowles, J., 
Wright, E., Bell, D. M., Tam, P. P., Cheah, K. S. and Koopman, P. (1997). SOX9 
binds DNA, activates transcription, and coexpresses with type II collagen during 
chondrogenesis in the mouse. Dev Biol 183, 108-21. 
Nieto, M. A., Sargent, M. G., Wilkinson, D. G. and Cooke, J. (1994). Control of 
cell behavior during vertebrate development by Slug, a zinc finger gene. Science 
264, 835-9. 
Niswander, L. (2003). Pattern formation: old models out on a limb. Nat Rev Genet 
4, 133-43. 
Norton, W. H., Ledin, J., Grandel, H. and Neumann, C. J. (2005). HSPG 
synthesis by zebrafish Ext2 and Extl3 is required for Fgf10 signalling during limb 
development. Development 132, 4963-73. 
Odenthal, J. and Nusslein-Volhard, C. (1998). fork head domain genes in 
zebrafish. Dev Genes Evol 208, 245-58. 
Panman, L. and Zeller, R. (2003). Patterning the limb before and after SHH 
signalling. J Anat 202, 3-12. 
Papoulas, O., Beek, S. J., Moseley, S. L., McCallum, C. M., Sarte, M., Shearn, 
A. and Tamkun, J. W. (1998). The Drosophila trithorax group proteins BRM, 
REFERENCES  
 
 
119
ASH1 and ASH2 are subunits of distinct protein complexes. Development 125, 
3955-66. 
Park, J. M., Gim, B. S., Kim, J. M., Yoon, J. H., Kim, H. S., Kang, J. G. and 
Kim, Y. J. (2001a). Drosophila Mediator complex is broadly utilized by diverse 
gene-specific transcription factors at different types of core promoters. Mol Cell Biol 
21, 2312-23. 
Park, J. M., Kim, J. M., Kim, L. K., Kim, S. N., Kim-Ha, J., Kim, J. H. and 
Kim, Y. J. (2003). Signal-induced transcriptional activation by Dif requires the 
dTRAP80 mediator module. Mol Cell Biol 23, 1358-67. 
Park, J. M., Werner, J., Kim, J. M., Lis, J. T. and Kim, Y. J. (2001b). Mediator, 
not holoenzyme, is directly recruited to the heat shock promoter by HSF upon heat 
shock. Mol Cell 8, 9-19. 
Pavri, R., Lewis, B., Kim, T. K., Dilworth, F. J., Erdjument-Bromage, H., 
Tempst, P., de Murcia, G., Evans, R., Chambon, P. and Reinberg, D. (2005). 
PARP-1 determines specificity in a retinoid signaling pathway via direct modulation 
of mediator. Mol Cell 18, 83-96. 
Pevny, L. H. and Lovell-Badge, R. (1997). Sox genes find their feet. Curr Opin 
Genet Dev 7, 338-44. 
Pfeffer, P. L., Gerster, T., Lun, K., Brand, M. and Busslinger, M. (1998). 
Characterization of three novel members of the zebrafish Pax2/5/8 family: 
dependency of Pax5 and Pax8 expression on the Pax2.1 (noi) function. Development 
125, 3063-74. 
Philibert, R., Caspers, K., Langbehn, D., Troughton, E. P., Yucuis, R., Sandhu, 
H. K. and Cadoret, R. J. (2002). The association of a HOPA polymorphism with 
major depression and phobia. Compr Psychiatry 43, 404-10. 
Philibert, R. A., Sandhu, H. K., Hutton, A. M., Wang, Z., Arndt, S., Andreasen, 
N. C., Crowe, R. and Wassink, T. H. (2001). Population-based association analyses 
of the HOPA12bp polymorphism for schizophrenia and hypothyroidism. Am J Med 
Genet 105, 130-4. 
Phillips, B. T., Bolding, K. and Riley, B. B. (2001). Zebrafish fgf3 and fgf8 encode 
redundant functions required for otic placode induction. Dev Biol 235, 351-65. 
Pineda Torra, I., Freedman, L. P. and Garabedian, M. J. (2004). Identification of 
DRIP205 as a coactivator for the Farnesoid X receptor. J Biol Chem 279, 36184-91. 
Pizard, A., Burgon, P. G., Paul, D. L., Bruneau, B. G., Seidman, C. E. and 
Seidman, J. G. (2005). Connexin 40, a target of transcription factor Tbx5, patterns 
wrist, digits, and sternum. Mol Cell Biol 25, 5073-83. 
Postlethwait, J. H., Johnson, S. L., Midson, C. N., Talbot, W. S., Gates, M., 
Ballinger, E. W., Africa, D., Andrews, R., Carl, T., Eisen, J. S. et al. (1994). A 
genetic linkage map for the zebrafish. Science 264, 699-703. 
Postlethwait, J. H. and Talbot, W. S. (1997). Zebrafish genomics: from mutants to 
genes. Trends Genet 13, 183-90. 
REFERENCES  
 
 
120
Postlethwait, J. H., Woods, I. G., Ngo-Hazelett, P., Yan, Y. L., Kelly, P. D., Chu, 
F., Huang, H., Hill-Force, A. and Talbot, W. S. (2000). Zebrafish comparative 
genomics and the origins of vertebrate chromosomes. Genome Res 10, 1890-902. 
Postlethwait, J. H., Yan, Y. L., Gates, M. A., Horne, S., Amores, A., Brownlie, 
A., Donovan, A., Egan, E. S., Force, A., Gong, Z. et al. (1998). Vertebrate genome 
evolution and the zebrafish gene map. Nat Genet 18, 345-9. 
Ptashne, M. and Gann, A. (1997). Transcriptional activation by recruitment. Nature 
386, 569-77. 
Pujic, Z. and Malicki, J. (2001). Mutation of the zebrafish glass onion locus causes 
early cell-nonautonomous loss of neuroepithelial integrity followed by severe 
neuronal patterning defects in the retina. Dev Biol 234, 454-69. 
Rachez, C. and Freedman, L. P. (2001). Mediator complexes and transcription. 
Curr Opin Cell Biol 13, 274-80. 
Rachez, C., Lemon, B. D., Suldan, Z., Bromleigh, V., Gamble, M., Naar, A. M., 
Erdjument-Bromage, H., Tempst, P. and Freedman, L. P. (1999). Ligand-
dependent transcription activation by nuclear receptors requires the DRIP complex. 
Nature 398, 824-8. 
Raible, F. and Brand, M. (2001). Tight transcriptional control of the ETS domain 
factors Erm and Pea3 by Fgf signaling during early zebrafish development. Mech 
Dev 107, 105-17. 
Rauch, G. J., Granato, M., Haffter, P. (1997). A polymorphic line for genetic 
mapping using SSLPs on high-percentage agarose gels. Tech Tips Online T01, 208. 
Rehberg, S., Lischka, P., Glaser, G., Stamminger, T., Wegner, M. and Rosorius, 
O. (2002). Sox10 is an active nucleocytoplasmic shuttle protein, and shuttling is 
crucial for Sox10-mediated transactivation. Mol Cell Biol 22, 5826-34. 
Roehl, H. and Nusslein-Volhard, C. (2001). Zebrafish pea3 and erm are general 
targets of FGF8 signaling. Curr Biol 11, 503-7. 
Roelink, H., Augsburger, A., Heemskerk, J., Korzh, V., Norlin, S., Ruiz i 
Altaba, A., Tanabe, Y., Placzek, M., Edlund, T., Jessell, T. M. et al. (1994). Floor 
plate and motor neuron induction by vhh-1, a vertebrate homolog of hedgehog 
expressed by the notochord. Cell 76, 761-75. 
Roy, S., Wolff, C. and Ingham, P. W. (2001). The u-boot mutation identifies a 
Hedgehog-regulated myogenic switch for fiber-type diversification in the zebrafish 
embryo. Genes Dev 15, 1563-76. 
Russ, A. P., Wattler, S., Colledge, W. H., Aparicio, S. A., Carlton, M. B., Pearce, 
J. J., Barton, S. C., Surani, M. A., Ryan, K., Nehls, M. C. et al. (2000). 
Eomesodermin is required for mouse trophoblast development and mesoderm 
formation. Nature 404, 95-9. 
Ryu, S., Zhou, S., Ladurner, A. G. and Tjian, R. (1999). The transcriptional 
cofactor complex CRSP is required for activity of the enhancer-binding protein Sp1. 
Nature 397, 446-50. 
REFERENCES  
 
 
121
Saint-Germain, N., Lee, Y. H., Zhang, Y., Sargent, T. D. and Saint-Jeannet, J. 
P. (2004). Specification of the otic placode depends on Sox9 function in Xenopus. 
Development 131, 1755-63. 
Sambrook, J., Fritsch, E. F., Maniatis, T. (1989). Molecular Cloning, A 
Laboratory Manual: Cold Spring Harbor Laboratory Press. 
Samuelsen, C. O., Baraznenok, V., Khorosjutina, O., Spahr, H., Kieselbach, T., 
Holmberg, S. and Gustafsson, C. M. (2003). TRAP230/ARC240 and 
TRAP240/ARC250 Mediator subunits are functionally conserved through evolution. 
Proc Natl Acad Sci U S A 100, 6422-7. 
Sandhu, H. K., Sarkar, M., Turner, B. M., Wassink, T. H. and Philibert, R. A. 
(2003). Polymorphism analysis of HOPA: a candidate gene for schizophrenia. Am J 
Med Genet B Neuropsychiatr Genet 123, 33-8. 
Sato, S., Tomomori-Sato, C., Banks, C. A., Parmely, T. J., Sorokina, I., Brower, 
C. S., Conaway, R. C. and Conaway, J. W. (2003a). A mammalian homolog of 
Drosophila melanogaster transcriptional coactivator intersex is a subunit of the 
mammalian Mediator complex. J Biol Chem 278, 49671-4. 
Sato, S., Tomomori-Sato, C., Banks, C. A., Sorokina, I., Parmely, T. J., Kong, S. 
E., Jin, J., Cai, Y., Lane, W. S., Brower, C. S. et al. (2003b). Identification of 
mammalian Mediator subunits with similarities to yeast Mediator subunits Srb5, 
Srb6, Med11, and Rox3. J Biol Chem 278, 15123-7. 
Sato, S., Tomomori-Sato, C., Parmely, T. J., Florens, L., Zybailov, B., Swanson, 
S. K., Banks, C. A., Jin, J., Cai, Y., Washburn, M. P. et al. (2004). A set of 
consensus mammalian mediator subunits identified by multidimensional protein 
identification technology. Mol Cell 14, 685-91. 
Saunders, J. W., Jr. (2002). Is the progress zone model a victim of progress? Cell 
110, 541-3. 
Searls, R. L. and Janners, M. Y. (1971). The initiation of limb bud outgrowth in 
the embryonic chick. Dev Biol 24, 198-213. 
Sefton, M., Sanchez, S. and Nieto, M. A. (1998). Conserved and divergent roles for 
members of the Snail family of transcription factors in the chick and mouse embryo. 
Development 125, 3111-21. 
Selleck, M. A. and Bronner-Fraser, M. (1995). Origins of the avian neural crest: 
the role of neural plate-epidermal interactions. Development 121, 525-38. 
Shao, W., Rosenauer, A., Mann, K., Chang, C. P., Rachez, C., Freedman, L. P. 
and Miller, W. H., Jr. (2000). Ligand-inducible interaction of the DRIP/TRAP 
coactivator complex with retinoid receptors in retinoic acid-sensitive and -resistant 
acute promyelocytic leukemia cells. Blood 96, 2233-9. 
Shim, E. Y., Walker, A. K. and Blackwell, T. K. (2002). Broad requirement for the 
mediator subunit RGR-1 for transcription in the Caenorhabditis elegans embryo. J 
Biol Chem 277, 30413-6. 
Shimogawa, H., Kwon, Y., Mao, Q., Kawazoe, Y., Choi, Y., Asada, S., Kigoshi, 
H. and Uesugi, M. (2004). A wrench-shaped synthetic molecule that modulates a 
transcription factor-coactivator interaction. J Am Chem Soc 126, 3461-71. 
REFERENCES  
 
 
122
Shin, J. T. and Fishman, M. C. (2002). From Zebrafish to human: modular medical 
models. Annu Rev Genomics Hum Genet 3, 311-40. 
Singh, N. and Han, M. (1995). sur-2, a novel gene, functions late in the let-60 ras-
mediated signaling pathway during Caenorhabditis elegans vulval induction. Genes 
Dev 9, 2251-65. 
Solari, F. and Ahringer, J. (2000). NURD-complex genes antagonise Ras-induced 
vulval development in Caenorhabditis elegans. Curr Biol 10, 223-6. 
Song, A., Wang, Q., Goebl, M. G. and Harrington, M. A. (1998). Phosphorylation 
of nuclear MyoD is required for its rapid degradation. Mol Cell Biol 18, 4994-9. 
Song, W., Treich, I., Qian, N., Kuchin, S. and Carlson, M. (1996). SSN genes that 
affect transcriptional repression in Saccharomyces cerevisiae encode SIN4, ROX3, 
and SRB proteins associated with RNA polymerase II. Mol Cell Biol 16, 115-20. 
Sordino, P., van der Hoeven, F. and Duboule, D. (1995). Hox gene expression in 
teleost fins and the origin of vertebrate digits. Nature 375, 678-81. 
Spahr, H., Khorosjutina, O., Baraznenok, V., Linder, T., Samuelsen, C. O., 
Hermand, D., Makela, T. P., Holmberg, S. and Gustafsson, C. M. (2003). 
Mediator influences Schizosaccharomyces pombe RNA polymerase II-dependent 
transcription in vitro. J Biol Chem 278, 51301-6. 
Spinks, R., Sandhu, H. K., Andreasen, N. C. and Philibert, R. A. (2004). 
Association of the HOPA12bp allele with a large X-chromosome haplotype and 
positive symptom schizophrenia. Am J Med Genet B Neuropsychiatr Genet 127, 20-
7. 
Spokony, R. F., Aoki, Y., Saint-Germain, N., Magner-Fink, E. and Saint-
Jeannet, J. P. (2002). The transcription factor Sox9 is required for cranial neural 
crest development in Xenopus. Development 129, 421-32. 
Stevens, J. L., Cantin, G. T., Wang, G., Shevchenko, A. and Berk, A. J. (2002). 
Transcription control by E1A and MAP kinase pathway via Sur2 mediator subunit. 
Science 296, 755-8. 
Stoltzfus, A. (1999). On the possibility of constructive neutral evolution. J Mol Evol 
49, 169-81. 
Streisinger, G., Walker, C., Dower, N., Knauber, D. and Singer, F. (1981). 
Production of clones of homozygous diploid zebra fish (Brachydanio rerio). Nature 
291, 293-6. 
Sun, X., Mariani, F. V. and Martin, G. R. (2002). Functions of FGF signalling 
from the apical ectodermal ridge in limb development. Nature 418, 501-8. 
Sun, X., Zhang, Y., Cho, H., Rickert, P., Lees, E., Lane, W. and Reinberg, D. 
(1998). NAT, a human complex containing Srb polypeptides that functions as a 
negative regulator of activated transcription. Mol Cell 2, 213-22. 
Taatjes, D. J., Naar, A. M., Andel, F., 3rd, Nogales, E. and Tjian, R. (2002). 
Structure, function, and activator-induced conformations of the CRSP coactivator. 
Science 295, 1058-62. 
REFERENCES  
 
 
123
Takeuchi, J. K., Koshiba-Takeuchi, K., Suzuki, T., Kamimura, M., Ogura, K. 
and Ogura, T. (2003). Tbx5 and Tbx4 trigger limb initiation through activation of 
the Wnt/Fgf signaling cascade. Development 130, 2729-39. 
Tamura, K., Yonei-Tamura, S. and Belmonte, J. C. (1999). Differential 
expression of Tbx4 and Tbx5 in Zebrafish fin buds. Mech Dev 87, 181-4. 
Tassan, J. P., Jaquenoud, M., Leopold, P., Schultz, S. J. and Nigg, E. A. (1995). 
Identification of human cyclin-dependent kinase 8, a putative protein kinase partner 
for cyclin C. Proc Natl Acad Sci U S A 92, 8871-5. 
Taylor, J. S., Van de Peer, Y., Braasch, I. and Meyer, A. (2001). Comparative 
genomics provides evidence for an ancient genome duplication event in fish. Philos 
Trans R Soc Lond B Biol Sci 356, 1661-79. 
Tchernev, V. T., Mansfield, T. A., Giot, L., Kumar, A. M., Nandabalan, K., Li, 
Y., Mishra, V. S., Detter, J. C., Rothberg, J. M., Wallace, M. R. et al. (2002). The 
Chediak-Higashi protein interacts with SNARE complex and signal transduction 
proteins. Mol Med 8, 56-64. 
Thisse, C., Thisse, B. and Postlethwait, J. H. (1995). Expression of snail2, a 
second member of the zebrafish snail family, in cephalic mesendoderm and 
presumptive neural crest of wild-type and spadetail mutant embryos. Dev Biol 172, 
86-99. 
Thompson, C. M., Koleske, A. J., Chao, D. M. and Young, R. A. (1993). A 
multisubunit complex associated with the RNA polymerase II CTD and TATA-
binding protein in yeast. Cell 73, 1361-75. 
Tickle, C. (2003). Patterning systems--from one end of the limb to the other. Dev 
Cell 4, 449-58. 
Toth, J. I., Datta, S., Athanikar, J. N., Freedman, L. P. and Osborne, T. F. 
(2004). Selective coactivator interactions in gene activation by SREBP-1a and -1c. 
Mol Cell Biol 24, 8288-300. 
Treisman, J. (2001). Drosophila homologues of the transcriptional coactivation 
complex subunits TRAP240 and TRAP230 are required for identical processes in 
eye-antennal disc development. Development 128, 603-15. 
Tropepe, V. and Sive, H. L. (2003). Can zebrafish be used as a model to study the 
neurodevelopmental causes of autism? Genes Brain Behav 2, 268-81. 
Trowe, T., Klostermann, S., Baier, H., Granato, M., Crawford, A. D., 
Grunewald, B., Hoffmann, H., Karlstrom, R. O., Meyer, S. U., Muller, B. et al. 
(1996). Mutations disrupting the ordering and topographic mapping of axons in the 
retinotectal projection of the zebrafish, Danio rerio. Development 123, 439-50. 
Tudor, M., Murray, P. J., Onufryk, C., Jaenisch, R. and Young, R. A. (1999). 
Ubiquitous expression and embryonic requirement for RNA polymerase II 
coactivator subunit Srb7 in mice. Genes Dev 13, 2365-8. 
Uetz, P., Giot, L., Cagney, G., Mansfield, T. A., Judson, R. S., Knight, J. R., 
Lockshon, D., Narayan, V., Srinivasan, M., Pochart, P. et al. (2000). A 
comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae. 
Nature 403, 623-7. 
REFERENCES  
 
 
124
Van de Peer, Y., Taylor, J. S., Joseph, J. and Meyer, A. (2002). Wanda: a 
database of duplicated fish genes. Nucleic Acids Res 30, 109-12. 
van Eeden, F. J., Granato, M., Schach, U., Brand, M., Furutani-Seiki, M., 
Haffter, P., Hammerschmidt, M., Heisenberg, C. P., Jiang, Y. J., Kane, D. A. et 
al. (1996). Mutations affecting somite formation and patterning in the zebrafish, 
Danio rerio. Development 123, 153-64. 
Voegel, J. J., Heine, M. J., Tini, M., Vivat, V., Chambon, P. and Gronemeyer, H. 
(1998). The coactivator TIF2 contains three nuclear receptor-binding motifs and 
mediates transactivation through CBP binding-dependent and -independent 
pathways. Embo J 17, 507-19. 
Wada, O., Oishi, H., Takada, I., Yanagisawa, J., Yano, T. and Kato, S. (2004). 
BRCA1 function mediates a TRAP/DRIP complex through direct interaction with 
TRAP220. Oncogene 23, 6000-5. 
Wagner, T., Wirth, J., Meyer, J., Zabel, B., Held, M., Zimmer, J., Pasantes, J., 
Bricarelli, F. D., Keutel, J., Hustert, E. et al. (1994). Autosomal sex reversal and 
campomelic dysplasia are caused by mutations in and around the SRY-related gene 
SOX9. Cell 79, 1111-20. 
Walshe, J. and Mason, I. (2003). Unique and combinatorial functions of Fgf3 and 
Fgf8 during zebrafish forebrain development. Development 130, 4337-49. 
Wang, G. and Berk, A. J. (2002). In vivo association of adenovirus large E1A 
protein with the human mediator complex in adenovirus-infected and -transformed 
cells. J Virol 76, 9186-93. 
Wang, G., Cantin, G. T., Stevens, J. L. and Berk, A. J. (2001). Characterization of 
mediator complexes from HeLa cell nuclear extract. Mol Cell Biol 21, 4604-13. 
Wang, J. C., Walker, A., Blackwell, T. K. and Yamamoto, K. R. (2004a). The 
Caenorhabditis elegans ortholog of TRAP240, CeTRAP240/let-19, selectively 
modulates gene expression and is essential for embryogenesis. J Biol Chem 279, 
29270-7. 
Wang, Q., Sharma, D., Ren, Y. and Fondell, J. D. (2002). A coregulatory role for 
the TRAP-mediator complex in androgen receptor-mediated gene expression. J Biol 
Chem 277, 42852-8. 
Wang, S., Ge, K., Roeder, R. G. and Hankinson, O. (2004b). Role of mediator in 
transcriptional activation by the aryl hydrocarbon receptor. J Biol Chem 279, 13593-
600. 
Warnmark, A., Almlof, T., Leers, J., Gustafsson, J. A. and Treuter, E. (2001). 
Differential recruitment of the mammalian mediator subunit TRAP220 by estrogen 
receptors ERalpha and ERbeta. J Biol Chem 276, 23397-404. 
Wegner, M. (1999). From head to toes: the multiple facets of Sox proteins. Nucleic 
Acids Res 27, 1409-20. 
Werner, E. A. (1919). XCIV. The constitution of carbamides. IX. The interactions 
of nitrous acid and mono-substituted ureas. The preparation of diazomethane, 
diazoethane, diazo-n-butane, and diazoisopentane from the prsopective nitrosoureas. 
J Chem Soc 115, 1093-1102. 
REFERENCES  
 
 
125
Wery, M., Shematorova, E., Van Driessche, B., Vandenhaute, J., Thuriaux, P. 
and Van Mullem, V. (2004). Members of the SAGA and Mediator complexes are 
partners of the transcription elongation factor TFIIS. Embo J 23, 4232-42. 
Westerfield, M. (1995). The zebrafish book. A guide for the laboratory use of 
zebrafish (Danio rerio). Eugene: Univ. of Oregon Press. 
Wharton, K. A., Yedvobnick, B., Finnerty, V. G. and Artavanis-Tsakonas, S. 
(1985). opa: a novel family of transcribed repeats shared by the Notch locus and 
other developmentally regulated loci in D. melanogaster. Cell 40, 55-62. 
Wilm, T. P. and Solnica-Krezel, L. (2005). Essential roles of a zebrafish 
prdm1/blimp1 homolog in embryo patterning and organogenesis. Development 132, 
393-404. 
Wilson, C. J., Chao, D. M., Imbalzano, A. N., Schnitzler, G. R., Kingston, R. E. 
and Young, R. A. (1996). RNA polymerase II holoenzyme contains SWI/SNF 
regulators involved in chromatin remodeling. Cell 84, 235-44. 
Wilson, V., Manson, L., Skarnes, W. C. and Beddington, R. S. (1995). The T 
gene is necessary for normal mesodermal morphogenetic cell movements during 
gastrulation. Development 121, 877-86. 
Wolpert, L. (2002). Limb patterning: reports of model's death exaggerated. Curr 
Biol 12, R628-30. 
Woods, A., Munday, M. R., Scott, J., Yang, X., Carlson, M. and Carling, D. 
(1994). Yeast SNF1 is functionally related to mammalian AMP-activated protein 
kinase and regulates acetyl-CoA carboxylase in vivo. J Biol Chem 269, 19509-15. 
Woychik, N. A. and Hampsey, M. (2002). The RNA polymerase II machinery: 
structure illuminates function. Cell 108, 453-63. 
Wright, E., Hargrave, M. R., Christiansen, J., Cooper, L., Kun, J., Evans, T., 
Gangadharan, U., Greenfield, A. and Koopman, P. (1995). The Sry-related gene 
Sox9 is expressed during chondrogenesis in mouse embryos. Nat Genet 9, 15-20. 
Yamaguchi, M., Yoshida, H., Hirose, F., Inoue, Y. H., Hayashi, Y., Yamagishi, 
M., Nishi, Y., Tamai, K., Sakaguchi, K. and Matsukage, A. (2001). Ectopic 
expression of BEAF32A in the Drosophila eye imaginal disc inhibits differentiation 
of photoreceptor cells and induces apoptosis. Chromosoma 110, 313-21. 
Yamaguchi, T. P., Takada, S., Yoshikawa, Y., Wu, N. and McMahon, A. P. 
(1999). T (Brachyury) is a direct target of Wnt3a during paraxial mesoderm 
specification. Genes Dev 13, 3185-90. 
Yan, Y. L., Hatta, K., Riggleman, B. and Postlethwait, J. H. (1995). Expression 
of a type II collagen gene in the zebrafish embryonic axis. Dev Dyn 203, 363-76. 
Yan, Y. L., Miller, C. T., Nissen, R. M., Singer, A., Liu, D., Kirn, A., Draper, B., 
Willoughby, J., Morcos, P. A., Amsterdam, A. et al. (2002). A zebrafish sox9 gene 
required for cartilage morphogenesis. Development 129, 5065-79. 
Yan, Y. L., Willoughby, J., Liu, D., Crump, J. G., Wilson, C., Miller, C. T., 
Singer, A., Kimmel, C., Westerfield, M. and Postlethwait, J. H. (2005). A pair of 
Sox: distinct and overlapping functions of zebrafish sox9 co-orthologs in craniofacial 
and pectoral fin development. Development 132, 1069-83. 
REFERENCES  
 
 
126
Yang, F., DeBeaumont, R., Zhou, S. and Naar, A. M. (2004). The activator-
recruited cofactor/Mediator coactivator subunit ARC92 is a functionally important 
target of the VP16 transcriptional activator. Proc Natl Acad Sci U S A 101, 2339-44. 
Yelon, D., Ticho, B., Halpern, M. E., Ruvinsky, I., Ho, R. K., Silver, L. M. and 
Stainier, D. Y. (2000). The bHLH transcription factor hand2 plays parallel roles in 
zebrafish heart and pectoral fin development. Development 127, 2573-82. 
Yoda, A., Kouike, H., Okano, H. and Sawa, H. (2005). Components of the 
transcriptional Mediator complex are required for asymmetric cell division in C. 
elegans. Development 132, 1885-93. 
Yuan, C. X., Ito, M., Fondell, J. D., Fu, Z. Y. and Roeder, R. G. (1998). The 
TRAP220 component of a thyroid hormone receptor- associated protein (TRAP) 
coactivator complex interacts directly with nuclear receptors in a ligand-dependent 
fashion. Proc Natl Acad Sci U S A 95, 7939-44. 
Zhang, H. and Emmons, S. W. (2000). A C. elegans mediator protein confers 
regulatory selectivity on lineage-specific expression of a transcription factor gene. 
Genes Dev 14, 2161-72. 
Zhang, H. and Emmons, S. W. (2001). The novel C. elegans gene sop-3 modulates 
Wnt signaling to regulate Hox gene expression. Development 128, 767-77. 
Zhao, Q., Eberspaecher, H., Lefebvre, V. and De Crombrugghe, B. (1997). 
Parallel expression of Sox9 and Col2a1 in cells undergoing chondrogenesis. Dev Dyn 
209, 377-86. 
Zhou, G., Lefebvre, V., Zhang, Z., Eberspaecher, H. and de Crombrugghe, B. 
(1998). Three high mobility group-like sequences within a 48-base pair enhancer of 
the Col2a1 gene are required for cartilage-specific expression in vivo. J Biol Chem 
273, 14989-97. 
Zhou, R., Bonneaud, N., Yuan, C. X., de Santa Barbara, P., Boizet, B., 
Schomber, T., Scherer, G., Roeder, R. G., Poulat, F. and Berta, P. (2002). SOX9 
interacts with a component of the human thyroid hormone receptor-associated 
protein complex. Nucleic Acids Res 30, 3245-52. 
Zhu, Y., Qi, C., Jain, S., Le Beau, M. M., Espinosa, R., 3rd, Atkins, G. B., 
Lazar, M. A., Yeldandi, A. V., Rao, M. S. and Reddy, J. K. (1999). Amplification 
and overexpression of peroxisome proliferator-activated receptor binding protein 
(PBP/PPARBP) gene in breast cancer. Proc Natl Acad Sci U S A 96, 10848-53. 
Zhu, Y., Qi, C., Jain, S., Rao, M. S. and Reddy, J. K. (1997). Isolation and 
characterization of PBP, a protein that interacts with peroxisome proliferator-
activated receptor. J Biol Chem 272, 25500-6. 
 
 
REFERENCES  
 
 
127
 
 
 6 APPENDIX 
APPENDIX  
 
 
129
6.1 Sequence alignments 
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Figure 50. Alignment of zebrafish Trap230 sequences. 
Trap230_WT: self-cloned wild type sequence from Tübingen strain; Trap230_tpd25870: mutant 
sequence; Trap230_prediction: sequence as predicted by zebrafish genome annotation; Note 
differences between prediction and self-cloned sequence and the actual mutation around 1360bp. 
Alignment was done using Clustalw. 
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Figure 51. Alignment of Trap230 and related proteins across species (Clustalw). 
z_Trap230: zebrafish Trap230, own cloned sequence; z_Trap230_pred: zebrafish Trap230, predicted 
sequence; d_kto: Drosophila kohtalo (Trap230 homologue); m_TNRC11: mouse TNRC11 (Trap230 
homologue); h_MED12: human MED12 (Trap230 homologue); h_MED12L: human MED12L 
(Trap230-like); c_TNRC11: chick TNRC11 (Trap230 homologue); f_Trap230: Takifugu rubripes 
Trap230; sc_srb8: Saccharomyces cerevisiae srb8 (Trap230 homologue); ss_srb8: 
Schizosaccharomyces pombe srb8 (Trap230 homologue); d_skd: Drosophila skuld (Trap240 
homologue); h_MED13: human MED13 (Trap240 homologue); h_MED13L: human MED13l 
(Trap240-like). Chick sequence part of 3086AA. 
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6.2 Phylogenetic trees 
 
Figure 52. Cladogram of Trap230 and related proteins across species (Clustalw). 
Abbreviations as in Figure 52. 
 
Figure 53. A phylogenetic tree for Sox9-related genes. 
(Cresko et al., 2003) Numbers are bootstrap values for 1,000 trials. Dre, Danio rerio, zebrafish; Gac, 
Gasterosteus aculeatus, threespine stickleback; Gga, Gallus gallus, chicken; Hsa, Homo 
sapiens, human; Mal, Monopterus albus, rice eel; Mmu, Mus musculus, mouse; Tru, Takifugu 
rubripes, pufferfish. Dre Sox8 AW153579; Dre Sox9a AY090034; Dre Sox9b AAG09815; Dre 
Sox10 AF402677; Gga Sox9 U12533; Gga Sox10 AF152356; Gga Sox8 AF228664; Hsa Sox8 
NP_055402; Hsa Sox9 NP_000337; Hsa Sox10 NP_008872; Mal Sox9a AF378150; Mal Sox9b 
AF378151; Mmu Sox8 XP_128601; Mmu Sox9 NP_035578; Mmu Sox10 XP_128139; Tru Sox9a 
AAL32172 (mayfold000587); Tru Sox9b mayfold 000421 (fugu assembly 3 at 
http://fugu.hgmp.mrc.ac.uk/).Mediator complex components 
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6.3 Mediator complex components 
 
Figure 54. Mediator subunits. New nomenclature and comparison of synonyms across species. 
(Bourbon et al., 2004) 
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Figure 55. Comparison of mammalian Mediator-like complexes. 
(Conaway et al., 2005) Mediator subunits identified in different Mediator preparations are indicated 
with blue; Mediator subunits not identified are indicated with yellow. Subunits are grouped according 
to which module they are believed to be in. On the left, composition of S.cerevisiae Mediator is 
summarised in comparison. On the right, a summary of Mediator components identified by MudPIT 
(multidimensional protein identification technology) via immunoaffinity chromatography of nuclear 
extracts prepared from extracts of HeLa cells expressing the indicated subunits with an N-terminal 
epitope tag with the amino sequence Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys (the FLAG epitope). f 
denotes the FLAG epitope; proteins identified following immunoaffinity chromatography of extracts 
from parental HeLa or 293 cells are indicated. 
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Figure 56. Location of conserved regions within human Mediator subunits. 
(Blazek et al., 2005) Extended stretches of high homology can be found in the MED23 and MED31 proteins 
and the Cdk8/Cyclin C pair. Regions that share at least 20% homology with the corresponding sequences in the 
respective Drosophila melanogaster subunits are coloured according to the degree of identity. Systematic as well 
as common names of human and corresponding yeast subunits are listed. In addition, tentative locations of 
subunits within the Head, Body and Kinase (KIN) module of the complex have been assigned. Sequences were 
aligned using the SIM program (BLOSUM62 Matrix) and visualized with the LALNVIEW (Duret et al., 1996) 
program (both available at http://www.expasy.ch). The data were extracted for further manipulation. Alignments 
of up to 20 regions per subunit were generated. Within the LALNVIEW program the “similarity score threshold” 
was set to a value above 40 to ignore insignificant alignments. 
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Factor  Mediator subunit References 
ERα and ERβ  MED1  (Zhu et al., 1999); (Burakov et al., 
2000); (Warnmark et al., 2001); (Kang 
et al., 2002) 
AR MED1  (Wang et al., 2002) 
GR MED1, MED14  (Hittelman et al., 1999) 
TRα MED1, MED21 (Yuan et al., 1998)); (Zhu et al., 1997); 
(Nevado et al., 2004) 
TRβ  MED1 (Yuan et al., 1998); (Zhu et al., 1997) 
VDR MED1 (Rachez et al., 1999) 
RARα  MED1  (Zhu et al., 1997); (Shao et al., 2000) 
RXRα  MED1  (Zhu et al., 1997); (Yuan et al., 1998) 
PPARα  MED1 (Zhu et al., 1997); (Yuan et al., 1998) 
PPARγ MED1 (Zhu et al., 1997);(Ge et al., 2002) 
HNF-4  MED1, MED14  (Malik et al., 2002) 
FXR MED1 (Pineda Torra et al., 2004) 
RORα  MED1  (Atkins et al., 1999) 
STAT2 MED14, MED17  (Lau et al., 2003) 
Elk-1 MED23  (Stevens et al., 2002) 
Esx/Elf-3  MED23  (Asada et al., 2002); (Shimogawa et al., 
2004) 
C/EBPβ  MED23 (Mo et al., 2004) 
SMAD2, SMAD3, SMAD4 MED15 (Kato et al., 2002) 
DSXF  MED29 (Sato et al., 2003a; Sato et al., 2003b); 
(Sato et al., 2003a; Sato et al., 2003b) 
SOX9 MED12 (Zhou et al., 2002) 
Dif (dmNF-κB like) MED17, MED16, MED23, MED25 (Park et al., 2003); (Kim et al., 2004) 
E1A-13S  MED23 (Stevens et al., 2002); (Wang and Berk, 
2002) 
RTA  MED12  (Gwack et al., 2003) 
VP16 MED25, MED17  (Mittler et al., 2003); (Ito et al., 1999); 
(Yang et al., 2004) 
Myc Cdk8 (Eberhardy and Farnham, 2002) 
p53 MED1, MED17 (Drane et al., 1997); (Frade et al., 
2000); (Ito et al., 1999) 
BRCA1  MED1  (Wada et al., 2004) 
HSF MED17, MED23, MED25 (Park et al., 2001b); (Kim et al., 2004) 
Aryl HC receptor  MED1  (Wang et al., 2004b) 
SREBP-1a  MED14  (Toth et al., 2004) 
Figure 57. The role of Mediator in cellular signalling. 
(Blazek et al., 2005) Transcription factors that exert their function via the Mediator complex are listed along with 
their target subunit within the Mediator complex and the corresponding reference(s) 
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6.4 Abbreviations 
SI units (système international d’unités) and symbols of standard multiples (m, µ, 
etc.) are not listed below. Additional abbreviations are introduced in the text at the 
site of their first appearance. 
AA amino acid 
AER apical ectodermal ridge 
AT adenin-thymine 
ß-ME ß-mercapto ethanol 
BAC bacterial artificial chromosome 
BAC-FPC BAC fingerprinting contig 
bHLH basic helix-loop-helix 
bp base pairs 
BSA bovine serum albumin 
CA cytosine-adenin 
cAMP cyclic Adenosine-5´monophosphate 
°C degree Celsius 
cdks cyclin-dependent kinases 
cf. Compare 
cM centiMorgan 
CNS central nervous system 
C-terminus Carboxy-terminus (of a peptide) 
Da Dalton 
DMSO dimethylsulfoxide 
DNA deoxyribonucleic acid 
dNTP deoxy-A/C/G/T-trisphosphate 
DRG dorsal root ganglion 
EtOH ethanol 
EST expressed sequence tag 
Fgf (FgfR) Fibroblast growth factor (receptor) 
g gravity constant 
GC guanine-cytosine 
GCL ganglion cell layer 
h hour(s) 
HDAC histone deacetylase 
hpf hours post fertilization 
ICD intracellular domain 
IM intermediate mesoderm 
IPL inner plexiform layer 
kB kilo bases 
LG linkage group 
LPM lateral plate mesoderm 
M mol/l 
MetOH methanol 
MHB midbrain-hindbrain boundary 
min minute(s) 
MO morpholino oligonucleotide 
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mRNA messenger RNA 
MRP multi-drug-resistence protein 
NR nuclear receptor 
N-terminus Amino-terminus (of a peptide) 
OD optical density 
O/N overnight 
ONL outer nuclear layer 
PAC P1-derived artificial chromosome 
PCR polymerase chain reaction 
PFA paraformaldehyde 
PKA protein kinase A 
PTU 1-phenyl-2-thiourea 
RA retinoic acid 
RACE rapid amplification of cDNA ends 
RGC retinal ganglion cells 
RNA ribonucleic acid 
RPE retinal pigmented epithelium 
RT room temperature 
SET (domain transcription factor) 
SNP single nucleotide polymorphism 
Shh sonic hedgehog 
SSLP single sequence length polymorphism 
TE Tris/EDTA 
trp trapped 
UTR untranslated region 
vol. volume 
WMISH whole mount in situ hybridization 
wt wildtype 
ZPA zone of polarising activity 
 Short Summary 
This thesis deals with the mapping and cloning of trapped (tpd), a novel zebrafish 
mutant found to disrupt an ortholog of Trap230, a member of the Mediator complex. 
Mediator is a coactivator complex transducing the interaction of DNA-binding 
transcription factors with RNA polymerase II. 
The vertebrate Sox9 transcription factor directs the development of neural crest, otic 
placodes, cartilage, and bone. In zebrafish, there are two Sox9 orthologs, Sox9a and 
Sox9b, which together perform the functions of the single-copy tetrapod Sox9. The 
mutant phenotypes of tpd and the Sox9a/Sox9b double mutant are remarkably 
similar. The results of this thesis show that Trap230 is required for Sox9 activity. In 
addition, I show that Trap230 is required for an early step in pectoral fin induction, 
indicating that it also participates in Sox9-independent signaling events. Moreover, 
additional phenotypes in brain, eye, heart, muscle and gut development as well as 
axon guidance and a general downregulation phenotype of fibroblast growth factor 
expression in tpd mutants are described. These phenotypes may or may not be Sox9-
dependent. This is the first characterisation of a vertebrate Trap230 mutant, and 
reveals a surprisingly specific requirement for Trap230 in mediating Sox9 activity. 
 
 Zusammenfassung 
Diese Dissertation befaßt sich mit der Kartierung und positionellen Klonierung einer 
neuen Zebrafisch-Mutante, trapped (tpd). Es wird gezeigt, daß in ihr das Gen für ein 
Zebrafisch-Ortholog von Trap230 betroffen ist, einer Untereinheit des Mediator-
Komplexes. Der Mediator-Komplex ist ein Coaktivator, der für die Verständigung 
von DNA-bindenden Transkriptionsfaktoren und RNA-Polymerase II zuständig ist. 
Der Sox9 Transkriptionsfaktor steuert in Wirbeltieren die Entwicklung von 
Neuralleistenzellen, Ohr-Plakoden, Knorpel und Knochen. Im Zebrafisch gibt es 
zwei Orthologe von Sox9, Sox9a und Sox9b. Diese erfüllen gemeinsam die Funktion 
einer einzelnen Sox9-Kopie in Tetrapoden. Die Phänotypen der Zebrafisch-Trap230-
Mutante und einer Doppelmutante in Sox9a und Sox9b ähneln sich verblüffend. In 
dieser Arbeit wird gezeigt, daß Trap230 für die Aktivität von Sox9 notwendig ist. 
Zudem hat Trap230 eine wichtige Funktion in einem frühen Schritt der 
Brustflosseninduktion. Dies deutet darauf hin, daß Trap230 auch in Signalwegen und 
bei Entwicklungsprozessen, die unabhängig von Sox9 sind, eine Rolle spielt. 
Darüber hinaus werden zusätzliche Phänotypen der Trap230-Mutante besprochen, 
die Entwicklung von Hirn, Auge, Herz, Muskeln und Darm betreffend, sowie ein 
Defekt in der Führung von Axonen und eine allgemein reduzierte Expression und 
Funktion von Fibroblastenwachstumsfaktoren. Bei einigen dieser Phänotypen könnte 
auch die Interaktion mit Sox9 eine Rolle spielen. Dies ist die erste Beschreibung 
einer Wirbeltiermutante von Trap230. Sie zeigt auf, daß Trap230 erstaunlich 
spezifisch für die Aktivität von Sox9 notwendig ist. 
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